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Zusammenfassung 
 
Der Zellzyklus stellt einen praezise kontrollierten Ablauf von Ereignissen dar, welche in der 
Erzeugung von zwei identischen Tochterzellen gipfeln. Um eine ordnungsgemaeße Abfolge der 
notwendigen Ereignisse zu ermoeglichen produziert die Zelle regulatorische Protein, welche an 
bestimmten Kontrollpunkten das Fortschreiten des Zellzyklus verhinden. Sind alle Voraussetzungen fuer 
das Fortsetzen des Zellzyklus erfuellt, werden Polyubiquitinketten an die inhibitorischen 
Zellzyklusproteine geheftet, wodurch diese fuer die proteasomabhaengige Degradation freigeben  werden.  
Der Anaphase-einleitende Komplex (APC/C) ist ein 1,5 MDa grosser Proteinkomplex bestehend aus 
ueber 12 unterscheidlichen Proteinuntereinheiten.  Am Ende der Metaphase katalysiert der APC/C  die 
Anheftung von Ubiquitinmolekuelketten an die zwei Zellzyklusregulatoren Secruin und CyclinB. Deren 
Degradation fuehrt zum Uebergang in die Anaphase, in der die zwei Schwesterchromatide auf die 
zukuenftigen Tochterzellen aufgeteilt werden. Um eine einwandfreie Aufteilung zu ermoeglichen, muss 
zuerst eine bidirektionale Anheftung beider Schwesterchromatide an den Spindelapparat sichergestellt 
sein, bevor der APC/C akitviert werden kann. Solange diese bidirektionale Orientierung nicht 
gewaehrleistet ist, wird der APC/C durch den Spindelassemblierungs-Kontrollpunkt (SAC) in seiner 
Funktion gehemmt. 
 
Manche Zellzyklusregulatoren enthalten bestimmte Sequenzmotife, sogenannte 
Degradationsmotife, welche diese Proteine als Substrate fuer die APC/C-abhaengige 
Ployubiquitinierungsreaktion  kennzeichnen. Die gelaeufigsten Degradationsmotife sind die D-Box und 
die KEN-Box. Die Rekrutierung dieser Substrate an den APC/C sowie dessen katalytische Aktivierung 
wird durch sogenannte Koaktivatorproteine, Cdc20 oder Cdh1, sichergestellt. Diese Koaktivatoren 
besitzen eine WD40 Domaene, welche auch als Protein-Protein-Interaktionsdomaene bekannt ist. 
Ausserdem sind die C-Box im N-terminus sowie das C-terminale IR-Ende eine wichtige Voraussetzung 
fuer eine funktionelle Interaktion der Koaktivatoren mit dem APC/C. 
 
Mittels Koexpressionsstudien in Hefe- und Insektenzellen konnte gezeigt werden, dass APC/C-
Modellsubstrate spezifisch an die WD40 Domaene von Cdh1 binden. Durch zahlreiche in vitro 
Experimente konnte weiterhin gezeitg werden, dass die C-Box eine wichtige Voraussetzung  fuer eine 
effiziente Rekrutierung dieser Cdh1-Substrat-Komplexe an den APC/C darstellt. Cdh1 C-Box Mutanten 
haben ausserdem negative Auswirkung auf in vitro Ubiquitinierungsreaktionen im Vergleich zu wildtyp 
Cdh1. Ergebnisse aus elektronenmikroskopischen Aufnhamen unterschiedlicher APC/C-Komplexe und 
anschließender 3D Modellierung weisen darauf hin, dass sich die Bindestelle des mitotisches 
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Kontrollkomplexes (MCC) am APC/C teilweise mit der der Koaktivatoren ueberschneidet. MCC-
gebundener APC/C ist stark inhibiert in seiner Faehigkeit, Substrate in vitro zu binden. Diese Ergebnisse 
legen den Schluss nahe, dass der mitotische Kontrollomplex die Substratbindestelle am APC/C 
physikalisch blockiert. 
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Abstract 
 
The cell cycle is a highly ordered and coordinated sequence of events which results in 
two daughter cells emerging from one mother cell. To properly carry out the cell cycle program 
the cell produces regulatory proteins that inhibit the progression to the next stage if they are not 
destroyed. The degradation of mitotic regulators depends on the ubiquitin-proteasome system.  
The Anaphase Promoting Complex/ Cyclosome (APC/C) is a 1.5 MDa ubiquitin ligase 
complex composed of at least a dozen subunits. The APC/C ubiquitylates its specific substrates 
with the help of the activator proteins, Cdc20 and Cdh1, and thereby targets substrates for 
proteasomal destruction. Strict regulation of APC/C activity is essential for faithful chromosome 
segregation and timely mitotic exit. The most prominent mechanism of APC/C control at the 
metaphase-to-anaphase transition is the spindle assembly checkpoint (SAC). The SAC inhibits 
APC/C until every single chromatid pair has been attached to the mitotic spindle and bi-oriented. 
 
The aim of this project was to understand how substrates are recruited to APC/C and if 
substrate recruitment is controlled by the spindle assembly checkpoint (SAC).  
 
All APC/C substrates contain one or more degradation motifs, the most common are the 
D-box and the KEN box, which specifically target them to the APC/C and its activator proteins. 
Substrate recruitment to the APC/C, as well as activation of the APC/C in the ubiquitylation 
reaction, depends on activators, Cdc20 and Cdh1. APC/C activators contain several conserved 
motifs, the most prominent one is the WD40 propeller domain, present in a variety of proteins 
and implicated in protein-protein interactions. By co-expression experiments in yeast and insect 
cells I could show that a WD40 domain of Cdh1 is sufficient to bind an APC/C substrate in a D 
box and KEN box dependent manner.  
Anchoring of activators to the APC/C is mediated by their carboxy-terminal IR tail. 
Efficient binding of activators to APC/C also depends on another conserved activator sequence, 
called the C-box. Through a set of in vitro protein binding experiments I could show that the C-
box is, in addition, also necessary to recruit substrates efficiently to APC/C-activator complexes. 
I could further show that restoring APC/C binding to wild type levels did not restore the activator 
function of C-box mutant Cdh1 in an in vitro ubiquitylation reaction. 
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To understand how the SAC inhibits the APC/C we used single-particle electron 
microscopy to obtain three dimensional models of human APC/C in various functional states: 
bound to a Mitotic Checkpoint Complex (MCC), to Cdc20, or to neither (apo-APC/C). These 
experiments revealed that the MCC binding site on APC/C partially overlaps with Cdc20 binding 
site, which suggested that the MCC might physically prevent substrate binding to the APC/C. To 
test this prediction I performed in vitro substrate binding assays which showed that substrate 
binding to APC/CMCC is strongly reduced. 
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1. Introduction 
 
In biology “life” is a characteristic of all functioning organisms on Earth with heritable 
genetic information which are able to exhibit continued, self-sustaining processes, such as the 
capacity to extract energy from the environment to drive their various functions, to respond to 
changes in the environment, with the ability to grow, and without exception, to reproduce. Cells 
are the basic units of life and cell division is the basic reproductive process of life.  
 
 
1.1 The cell cycle 
 
Once a eukaryotic cell receives a mitogenic stimulus, complex signaling pathways inhibit 
factors that maintain it in quiescent state and the cell enters the cell cycle. The cell cycle is a 
highly ordered and coordinated sequence of events that involves accumulation of cell’s 
components and, importantly, precise duplication of the cell’s genome in S or “synthetic” phase 
of the cell cycle. The duplicated material of the mother cell is then accurately segregated into 
two daughter cells by a spectacular event called mitosis, or M phase. These two phases of the 
cell cycle are separated by two, so called, gap phases, G1 and G2. 
Most of mother cell’s components, the organelles, membranes, proteins and RNAs, are gradually 
doubling throughout the cell cycle, finally resulting in sufficient amounts of all of these 
components for both daughter cells to start their life. The genetic information, however, is 
present as a single copy distributed in a distinct number of chromosome pairs, and it is essential 
for the cell to duplicate it only once per cell cycle. A complex chromosome segregation 
mechanism later ensures that the duplicated genome is precisely distributed into the two daughter 
cells. The right order of events in the cell cycle is essential for the fidelity of cell division. Often 
causally interconnected these cell cycle events are governed by an elaborate regulatory system 
based on feedback control (reviewed by Guardavacarro and Pagano, 2006). Three major 
regulatory checkpoints control three crucial steps in the cell cycle: G1 checkpoint (“start” in 
yeast, and “restriction point” in animal cells) controls entry into the cell cycle in late G1; G2/M 
controls the entry into mitosis; and the metaphase-to-anaphase transition controls the final events 
in mitosis (Morgan, 2007). 
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At the heart of the cell cycle control system is an oscillator based on the activity of 
cyclin-dependent kinases (Cdks). As the cell progresses through the cell cycle the enzymatic 
activities of these kinases change which leads to changes in phosphorylation state, and thus state 
of activation, of proteins that control the cell cycle processes (Morgan, 2007). The levels of Cdks 
do not change during the cell cycle, it is their regulatory subunits, the cyclins, that drive the 
oscillations in their activity. Thus, three parts of the cell cycle can be distinguished: the engine, 
which produces fluctuations in the levels of cyclins and thereby the activity of their associated 
Cdks; the downstream events that the engine drives, such as DNA replication and mitosis; and 
signaling pathways that regulate the engine in response to environment inside and outside of the 
cell (Murray, 2004). Cell cycle stage-specific cyclin synthesis leads to its accumulation which 
results in formation of cyclin-Cdk complexes that drive cell cycle stage specific events. For 
example, in animal cells the A-type cyclins appear at the onset of S phase and contribute to DNA 
synthesis, initiation of chromosome condensation and nuclear envelope breakdown. B-type 
cyclins associate with Cdk1 at the end of G2, to complete chromosome condensation and 
promote spindle assembly (Morgan, 2007). The activity of cyclin-Cdk is fine-tuned by another 
layer of control through phosphorylation and inhibitor binding. It is becoming increasingly 
apparent, however, that the cyclins and Cdks have redundant roles, and that it is their specific 
localization and expression levels that determine their specificity (reviewed in Guardavacarro 
and Pagano, 2006;  Hochegger et al, 2008). Abolishing Cdk activity is necessary for exit from 
mitosis and for loading of pre-replicative complexes (pre-RCs) at the origins of replication in 
G1, and this is conserved throughout the eukaryotic world. Only when E- and A-type cyclins 
accumulate and activate Cdk again at the end of G1, the origins start firing in S phase (reviewed 
by Diffley, 2004). High Cdk activity prevents pre-RC assembly until the end of metaphase, when 
the Cdk activity drops again, thereby ensuring that the DNA is replicated only once per cell 
cycle. Irreversible and unidirectional transitions from one cell cycle stage to the next are 
achieved by destruction of cyclins which inactivates their associated Cdks.  
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1.2 Protein destruction machinery behind the cell cycle engine 
 
All known cyclins, as well as many other cell cycle regulators, are degraded by the 
ubiquitin-proteasome degradation system. Multiple copies of a 7 kDa protein ubiquitin are 
assembled on the protein to be degraded. A polyubiquitin chain of at least 4 ubiquitins serves as 
a signal that targets the modified protein for degradation by the 26S proteasome (Thrower et al, 
2000). The ubiquitylation reaction is performed by a three-enzyme cascade (Figure 1). First, 
ubiquitin is activated by ubiquitin-activating enzyme, E1, which adenylates ubiquitin using ATP 
before it forms a thioester bond between the carboxy terminus of ubiquitin and the sulfhydril 
group of a cysteine in its active site. The activatiated ubiquitin is then transferred to the active-
site cysteine of the ubiquitin conjugating enzyme (E2) in a trans-esterification reaction. The 
third, tightly regulated, step is the transfer of ubiquitin on the target protein by isopeptide bond 
formation between the carboxy terminus of ubiquitin and the ε-amino group of a lysine in the 
substrate protein. Ubiquitin ligase enzymes (E3s) catalyze substrate ubiquitylation, and it is the 
E3s that provide substrate specificity in the ubiquitylation reaction. (reviewed in Pickart, 2001; 
Wickliffe et al, 2009). Depending on whether they themselves form a thioester bond with 
ubiquitin before transferring it to the substrate E3s are divided in two groups. HECT 
(Homologous to E6AP C terminus) type E3s harbor an active-site cysteine which accepts 
ubiquitin before transferring it to a substrate. RING (Really Interesting New Gene) type E3s, on 
the other hand, do not form a thioester bond with ubiquitin. Instead, they bind the E2s charged 
with ubiquitin and the target substrate thereby bringing them into reactive proximity. The 
ubiquitylation of proteins can be reversed by the activity of deubiquitinating enzymes (Reviewed 
by Amerik and Hochstrasser, 2004), therefore whether a protein is degraded or not depends on 
the balance between its ubiquitylation and deubiquitylation. 
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 Figure 1. The ubiquitin-proteasome pathway. A ubiquitin- activating enzyme (E1) forms a thiol ester with the 
carboxyl group of ubiquitin, thereby activating the C terminus of ubiquitin for nucleophilic attack. Ubiquitin-
conjugating enzyme (E2) transiently carries the activated ubiquitin molecule as a thiol ester.  Ubiquitin  ligase (E3) 
transfers the activated ubiquitin from the E2 to the substrate (or ubiquitin) lysine residue. Substrates tagged with a 
polyubiquitin chain are selectively targeted to a multisubunit ATP-dependent protease known as the 26S  
proteasome. Deubiquitinating enzymes (DUBs) associated with the proteasome remove ubiquitin before substrate 
degradation initiates (Reviewed by Pickart, 2001). 
 
The cell cycle engine is controlled by the activity of two RING type ubiquitin ligases. 
The APC/C (Anaphase Promoting Complex/Cyclosome) controls progression through mitosis 
and G1, while the SCF (Skp1-Cul1-F-box) operates at all stages of the cell cycle (reviewed by 
Peters, 1998; Nakayama and Nakayama, 2006). APC/C and SCF share their core subunit 
architecture. The RING-finger subunit (Rbx1/Rbx1/Hrt1 in SCF and Apc11 in APC/C) is the 
catalytic subunit that associates with the ubiquitin-charged E2. The RING-finger subunit is 
anchored to the scaffold cullin protein (Cul1 in SCF and Apc2 in APC/C). Unlike SCF, the 
APC/C has a very complex subunit composition. At least 12 subunits have been identified in this 
1.5 MDa large complex and for many of them we still do not know what their function is.   
Specific substrates are recruited to the SCF by a plethora of so-called F-box proteins that that 
bind substrates via their WD40 or LRR domains (reviewed in Petroski and Deshaies, 2005). 
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Substrate adaptors of the APC/C, Cdc20 and Cdh1, are also WD40 domain containing proteins 
(reviewed in Vodermaier, 2001). A crucial difference between SCF and APC/C is how their 
substrate recognition is regulated. The SCF is constitutively active and it is the phosphorylation 
of substrate proteins that triggers their recognition by the F-box adaptor proteins and their 
recruitment to the SCF (Petroski and Deshaies, 2005). In case of APC/C it is the enzyme itself 
that is being regulated by phosphorylation, regulated activator-protein association and 
association of inhibitors (reviewed in Peters, 2006, and described in more detail below).  
 
 
1.3 The architecture of the APC/C 
 
The APC/C is the most structurally complex ubiquitin ligase of the Cullin-RING family. 
This 1.5 MDa large macromolecule contains one or more copies of at least 12 core subunits, 
termed collectively the apo-APC. In a mitotic cell cycle apo-APC/C associates sequentially with 
2 different activator proteins, Cdc20 and Cdh1, that function as substrate-adaptors (reviewed by 
Peters, 2006; Thornton and Toczyski, 2006).  So far it has been impossible to reconstitute the 
APC/C, from purified subunits, therefore a crystal structure of the complex or of its 
subcomplexes is still lacking. Todays knowledge about the overall structure of  this elaborate 
enzyme mainly comes from genetic studies in yeast (Thornton and Toczyski, 2006) and cryo-EM 
analyses (Gieffers et al.,2001; Dube et al., 2005; Passmore et al.,2005; Ohi et al., 2007; Herzog 
et al.,2009).  
Cryo-EM models of APC/C purified from human cells, Xenopus egg extracts (Gieffers et 
al.,2001; Dube et al.,2005; Herzog et al.,2009), budding yeast (Passmore et al.,2005) and fission 
yeast (Ohi et al.,2007) revealed that the APC/C is an asymmetric, triangular, molecule, 180 by 
200 Å in size, and that it consists of an outer wall that, more or less, encloses a cavity. In the 
structure of the vertebrate APC/C two large domains can be distinguished, a relatively flat 
platform which closes the central cavity together with an “arc lamp”- like structural element. 
Within the enclosed cavity a prominent inner mass can be distinguished (Dube et al., 2005). The 
platform and the arc lamp show a certain degree of flexibility relative to each other, which is 
reduced upon binding of activator Cdh1 (Dube et al.,2005). This raises a possibility that an 
activator-induced conformational change has a role in the catalysis.  
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The APC/C can be rendered nonessential in budding yeast by genetic manipulation (Schwab et 
al.,1997; Thornton and Tocyszki, 2003), which allowed a systematic single subunit-deletion 
analysis and dissection of the APC/C into subcomplexes (Thornton and Tocyszki, 2006). The 
largest subunit Apc1 seems to be a scaffold that associates with two subcomplexes: a 
subcomplex composed of TPR subunits, Apc3 (Cdc27), Apc6 (Cdc16) and Apc8 (Cdc23); and 
the catalytic subcomplex, composed of Apc2, Apc11 and Doc1. The feasibility to isolate the 
catalytic core of APC/C was in agreement with studies of APC/C from human cells, where the 
catalytic core, Apc2 and Apc11, could be separated from the rest of APC/C (Vodermaier et 
al.,2003). Under high salt conditions the Apc2 /11 can be separated from the rest of the APC/C in 
a stable complex with Apc1, 4 and 5 (Vodermaier et al., 2003).  
 
                                      
 
Figure 2. A model of APC/C in a ubiquitylation reaction based on subunit interactions. A more detailed 
description of subunit interactions is in the main text. The catalytic sub-complex is shown in yellow. The E2 enzyme 
is recruited by the RING finger Apc11. The cullin subunit, Apc2, might, in analogy to SCF complexes, serve as a 
scaffold that positions substrate receptor(s) and Apc11-bound E2. The TPR subunits are shown in light gray. Apc7 is 
a TPR subunit found only in vertebrate APC/C, and is not shown in this model. Cdc26 is a chaperone of Cdc16. 
Apc9 is found only in budding yeast. Cdc26, Apc13 (Swm1) and Apc9, seem to have a role in stabilizing the Cdc27 
and Cdc16 association with the rest of the APC/C Substrates (S) are recruited to the APC/C by the activator, Cdh1 in 
this model, and possibly by a core APC/C subunit, Doc1. Activator proteins bind to Cdc27 via their IR tail, and it is 
suspected that they also  interact with Apc2, which might place the the substrate bound activator close to the 
ubiquitin-charged E2 which is recruited by the Apc11. Modified after (Peters, 2006; Thornton et al., 2006). 
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APC/C collaborates with two E2 enzymes from the Ubc4/5 and E2-C family, in humans those 
are UbcH5 and UbcH10, respectively. UbcH5 can also function with other E3s while UbcH10 is 
APC/C-specific (Peters, 2006). RING–finger subunits underlie ubiquitin ligase activity by 
directly binding E2 enzymes (reviewed by Deshaies and Joazeiro, 2009). RING-finger subunit 
Apc11 interacts with the E2 enzyme Ubc4 (Gmachl et al.,2000; Leverson et al., 2000, Tang et 
al.,2001), RING-finger subunits of the SCF also interact with E2s (Zheng et al.,2000; Zheng et 
al.,2002). Recombinant Apc11 alone can form unanchored multiubiquitin in the presence of E1 
and Ubc4. It can also ubiquitylate substrates, but with reduced specificity (Gmachl et al., 2000; 
Leverson et al., 2000). When UbcH10 was in the reaction a heterodimeric complex of Apc2 and 
Apc11 was the minimal catalytic module (Tang et al., 2001). All these results suggest that Apc11 
alone, or together with Apc2, is the catalytic core of the APC/C, and that other subunits of the 
APC/C have a function in regulation and conferring substrate specificity. An interesting finding 
is that the binding of the substrate adaptor, Cdh1, is affected upon Apc2 deletion, indicating that 
Cdh1 interacts closely with the catalytic core (Thornton and Tocyszki, 2006). A small subunit 
Doc1 has been found to associate with the Apc2/11 catalytic core by binding to Apc2 (Thornton 
and Tocyszki, 2006). Doc1 deletion in yeast renders them temperature sensitive (Hwang and 
Murray, 1997), whereas in fission yeast and Drosophila it is an essential subunit (Kominami et 
al., 1998; Pal et al., 2007). The crystal structure of Doc1 (Wendt et al., 2001; Au et al., 2002) 
revealed that it almost entirely consists of a conserved DOC domain that has been found in other 
Doc1 orthologs (Grossberger et al., 1999). The DOC domain is present in multidomain proteins 
that have a role in ubiquitylation reactions and that also contain Cullin homology regions and 
HECT domains, which suggests that the DOC domain may be linked to ubiquitylation reactions 
(Grossberger et al., 1999, Kominami et al.,1998). It is interesting that the DOC domain folds into 
a “jelly-roll” structure that is found in both eukaryotic and prokaryotic proteins, that has a 
function in binding various ligands, such as sugars, nucleotides and polypeptides. Budding yeast 
Doc1 has been proposed to be the substrate receptor within the apo-APC/C (Passmore et al., 
2003). Moreover, kinetic analysis of APC/C lacking Doc1 revealed that its processivity in the 
ubiquitylation reaction is reduced (Carrol and Morgan, 2002, Carrol et al., 2005). A reaction is 
processive if upon one APC/C binding event multiple ubiquitin molecules are assembled on the 
substrate. If the retention of the substrate on the APC/C during multiple rounds of ubiquitylation 
reactions depends on its direct binding to Doc1 is still not clear. Human Doc1 can bind to Cdc27, 
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one of tetratrico peptide repeat (TPR)-containing subunits that were found in vertebrate APC/C 
(Wendt et al., 2001). The TPR motifs are thought to mediate protein-protein interactions. A 
single TPR is composed of a 34 amino acid residue stretch, folded into two anti-parallel α-
helices. Multiple repeats are packed together to form a protein-interacting groove (reviewed in 
Blatch et al., 1999; D’Andrea and Regan, 2003). In APC/C subunit deletion studies in yeast 
TPR-containing subunits, Cdc16, Cdc23 and Cdc27, were found to cluster together in a 
subcomplex (Thornton and Tocyszki, 2006). Apc7 is a TPR subunit that has been found in 
vertebrates that is closely related to Cdc27 (Yu et al., 1998; Peters, 2006). Antibody labeling 
followed by cryo-EM analysis revealed the locations of TPR subunits in human and fission yeast 
APC/C (Herzog et al., 2009; Ohi et al., 2007). Cdc27 antibodies bound to the head-like 
protrusion at the end of the arc lamp domain. Cdc16 and Apc7 were located in the arc lamp 
domain, and are thought to be present in several copies (Herzog et al., 2009). Association of the 
TPR subdomain with the largest subunit Apc1 was dependent on Apc4 and Apc5 (Thornton and 
Tocyszki, 2006). Nothing is known about the function of Apc4 and Apc5. Apc4 is 
bioinformatically predicted to contain a WD40 propeller domain (Peters, 2002). Cryo-EM 
analysis of antibody labeled human APC/C has shown that Apc4 and Apc5 are located at the 
front bottom part of the platform domain (Herzog et al., 2009). The activator proteins Cdc20 and 
Cdh1 were shown to associate with Cdc27 and Cdc23 via their IR tail (Vodermaier et al., 2003; 
Kraft et al.,2005, Matyskiela and Morgan, 2009), a C terminal Ile-Arg motif conserved among 
activator proteins, that they share with Doc1, which was also shown to associate with Cdc27 
(Wendt et al.,2001). Three yeast nonessential subunits, Cdc26, Apc13 (Swm1) and Apc9, seem 
to have a role in stabilizing the Cdc27 and Cdc16 association with the rest of the APC/C 
(Zachariae et al., 1996; Zachariae et al., 1998; Schwickart et al.,2004; Thornton and Tocyszki, 
2006, Wang et al.,2009).  
Although the subunit composition of APC/C is so complex, it is completely inactive 
without the assistance of activator proteins, Cdc20 and Cdh1 (reviewed in Vodermaier, 2001). 
Cdc20 and Cdh1 are essential for the activity of the APC/C and are conserved from yeast to 
humans. In budding yeast a third, meiosis-specific, variant of activator protein, Ama1, was 
identified (Cooper et al., 2000). It is thought that the activator proteins function as substrate 
adaptors for the APC/C (Burton and Solomon, 2005; Kraft et al., 2005), in analogy with the F-
box proteins of SCF. However, it seems that activators have additional functions apart from 
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substrate recruitment (Kimata et al., 2008). Mitotic phosphorylation of APC/C promotes its 
association with Cdc20 in metaphase. Cdc20 recruits substrates to the APC/C until late anaphase 
when it is itself targeted for degradation and replaced by Cdh1 which functions as the substrate 
adaptor until the end of G1 (Figure 3). The current knowledge about the structure and function of 
activator proteins will be summarized in more detail in section 1.6.2. 
 
 
 
Figure 3.  APC/C activation by activator proteins during the cell cycle. APC/C is activated in prometaphase 
(PM) by its association of Cdc20. Cdc20 binding to the APC/C is facilitated by mitosis-specific phosphorylation. 
APC/C-Cdc20 initiates degradation of cyclin A in prometaphase. Cyclin B and securin are also APC/C-Cdc20 
substrates, however, their degradation is delayed until metaphase (M) by the spindle assembly checkpoint (SAC). In 
anaphase (A) and telophase (T) Cdh1 takes over the activating role of the APC/C and keeps it active until the end of 
G1. Modified from (Peters, 2006). 
 
 
1.4 The roles of APC/C in mitosis 
 
Tim Hunt’s legendary discovery of  cyclins “whose synthesis is strongly activated after 
fertilization” of sea urchin eggs and that “appear to be destroyed more or less completely every 
time the embryos divide” (Evans et al, 1983) was the first time when the result of the APC/C’s 
activity was spotted. Cyclin, the activating component of the maturation-promoting factor (MPF) 
drives the cells into mitosis, and its ubiquitin-mediated destruction is required to allow the cell to 
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exit mitosis (Murray et al., 1989; Murray and Kirschner, 1989; Glotzer et al., 1991). About 
twelve years after the cyclin discovery the APC/C was identified as the E3 activity in clam and 
Xenopus egg extracts that is responsible for its destruction (Hershko et al., 1994, Sudakin et al., 
1995; King, Peters et al., 1995). Cdc16 and Cdc23, two APC/C subunits, were identified in a 
genetic screen in budding yeast as genes required for sister chromatid separation at the 
metaphase-to-anaphase transition as well as for cyclin destruction in anaphase and G1 (Irniger, et 
al.,1995).  
Cyclin B is a conserved inhibitor of mitotic exit, from yeast to humans.  Its destruction is 
initiated at the metaphase-to-anaphase transition and is required for Cdk1 inactivation (Clute and 
Pines, 1999). Protein phosphatases subsequently dephosphorylate Cdk1 substrates which is a 
prerequisite for mitotic spindle disassembly, chromosome decondensation, cytokinetic furrow 
formation and nuclear envelope reassembly (reviewed in Sullivan and Morgan, 2007). The 
notion that cyclin B degradation is a prerequisite for cells to exit mitosis came from experiments 
in CSF arrested Xenopus egg extracts (Murray et al., 1989). Before fertilization vertebrate eggs 
are arrested in metaphase of meiosis II by an activity known as cytostatic factor (CSF) (Masui 
and Markert, 1971, reviewed in Tunquist and Maller, 2003). Fertilization-induced calcium burst 
in the egg relieves it from the arrest and the cell exits metaphase II. Calcium-mediated CSF 
release caused cyclin B degradation in Xenopus egg extracts. If, however, cyclin B was made 
indestructible by deleting 90 amino acids at its N terminus, the extract remained arrested in 
metaphase after addition of calcium (Murray et al., 1989). Cyclin B was the first substrate in 
which a “destruction box” (D-box) was identified, (Glotzer et al., 1991), a nine amino acid long 
motif located at the amino-terminus of cyclin B, that the APC/C generally recognizes in its 
substrates. Recognition motifs in APC/C substrates will be described in section 1.5. 
The role of APC/C in regulating sister chromatid separation is one of its two essential 
functions in yeast (Thornton and Toczyski, 2003). At the beginning of mitosis the replicated 
sister chromatids are held together by a ring-like protein complex called cohesin (reviewed by 
Nasmyth, 2001). By metaphase all the chromosomes are condensed and aligned at the cells 
equator, captured by microtubules emanating from the opposing spindle poles. Only when every 
single chromatid pair is bioriented and properly attached, a protease called separase is allowed to 
cleave the cohesin subunit Scc1, which releases the sister chromatids to be pulled apart by the 
spindle apparatus. The importance of the APC/C here comes in spotlight. Separase that cleaves 
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cohesin cannot perform its function while it is bound to its chaperone and inhibitor, securin. 
Only when all the requirements for faithful sister chromatid segregation have been met the 
APC/C gets activated, targets securin for destruction and thereby releases separase to initiate 
anaphase (reviewed by Nasmyth, 2005). Another layer of control of the APC/C over anaphase 
has been found in Xenopus egg extracts (Stemmann et al., 2001). Phosphorylation of separase by 
cyclinB-Cdk1 and its direct binding inhibits the activity of separase and it seems that both 
securin and cyclin B have to be destroyed to allow its activation. 
If you are a metazoan, the APC/C has a third essential role in your cells. High APC/C 
activity at the end of mitosis is maintained in the subsequent G1 phase by replacement of the 
mitosis-specific activator Cdc20 with G1-specific Cdh1. Low Cdk1 activity at the end of mitosis 
allows phosphatases to dephosphorylate Cdh1, thereby promoting its association with the 
APC/C. High APC/C-Cdh1 activity throughout G1 phase keeps the cyclin levels low, and 
thereby creates a window in the cell cycle with low Cdk activity which is a prerequisite for pre-
replication complex (pre-RC) assembly at the origins or replication. Pre-RCs assembly is 
inhibited by Cdk- mediated phosphorylation of its components (reviewed in Diffley, 2004), and, 
in metazoans, also by a protein called geminin. Geminin is present in the nucleus in S, G2 and M 
phase of the cell cycle and prevents the incorporation of Mcm2-7 subunits into the pre-RC 
during these phases of the cell cycle. Geminin is degraded at the metaphase-to-anaphase 
transition and throughout G1 as a result of APC/C-Cdh1 mediated ubiquitylation (McGarry and 
Kirschner, 1998). 
 
 
1.5. Degradation motifs in APC/C substrates and substrate ordering 
 
The targets of the APC/C contain amino acid sequence motifs, so called degrons, usually 
located in low complexity regions of the protein, that are required for their ubiquitylation. The 
most widespread motif is the “destruction-box” (D-box), a somewhat degenerate motif, a 
variation of the sequence RxxLxxxxN (R is arginine, L is leucine, N is asparagine, x is any 
amino acid). Mutation of any of these three residues stabilizes the substrate (Glotzer et al., 1991; 
King et al., 1996). Another short motif that is often present in APC/C substrates is the KEN box, 
with the basic sequence KENxxxN (K is lysine, E is glutamate) (Pfleger and Kirschner, 2000). 
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All APC/C substrates contain one or more copies of each degradation motif, often in 
combination. Other degrons have also been described in certain APC/C substrates, such as GxEN 
in XKid (Castro et al., 2003), or the A-box in Aurora A (Littlepage and Ruderman, 2002). 
Mutation of these recognition motifs tends to inhibit degradation of the substrates in vivo, but 
these sequences alone are generally not sufficient to target a protein for ubiquitylation. One of 
the reasons for this is the fact that the degron itself lacks a conserved lysine residue capable of 
accepting ubiquitin (King et al., 1996). It also seems likely that the context in which the degron 
is placed is important. If the D-box of cyclin B is replaced with a KEN box, Cdh1, but not 
Cdc20, can promote its degradation. This was possible only if the KEN box is placed in the 
location where the D box was and not if it was placed anywhere else in within the N terminus of 
cyclin B (Zur and Brandeis, 2002). A peptide encompassing the D box of fission yeast cyclin B, 
Cdc13, alone has to be 35 times more concentrated than a 70 amino acid long fragment of Cdc13 
that contains the same D box to compete for full length Cdc13 degradation in Xenopus egg 
extract (Yamano et al., 1998). It is sufficient to fuse a D-box-baring fragment of Xenopus cyclin 
B (amino acids 13-66) to Protein A to render it degradable in a cell cycle dependent manner, 
whereas a fragment of 13-53 amino acids is not (Glotzer, 1991). Unlike D box-containing 
fragments of cyclin B, D-box-containing fragment of Xenopus cyclin A1 (amino acids 3-91) was 
unable to render Protein A unstable (King et al., 1996). Studies of chimeric proteins have shown 
that fusing the D-box-containing amino-terminus of Xenopus cyclin A1 to the carboxy-terminus 
of cyclin B1 rendered the fusion protein stable, and it was not the case the other way around 
(Klotzbuecher et al., 1994). One of the best characterized model substrates of APC/C, the 
budding yeast Hsl1, can be reduced to a fragment of 200 amino acids (Hsl1667-872 ) and still be 
degraded with the same kinetics as the full length protein. Further truncation at the N terminus of 
the fragment renders it indestructible, although both D and the KEN box are still present within 
the remaining Hsl1 fragment (Burton and Solomon, 2001).  
Substrate ordering, or the correct sequence of APC/C-mediated ubiquitylation reactions, 
ensures orderly progression of events in mitosis and G1. This is firstly ensured by sequential 
association of APC/C substrate adaptors, Cdc20 and Cdh1, with the APC/C.  Cdc20 recognizes a 
set of substrates from metaphase until end of anaphase, and is then replaced by Cdh1 which 
recognizes specific substrates until the end of mitosis and throughout G1. A nice example of 
substrate ordering through sequential recruitment to the APC/C by specific activators is budding 
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yeast Pds1, Clb2 and Ase1 (Amon et al., 1994; Schwab et al., 1997; Visintin et al., 1997; Juang 
et al., 1997). Pds1, but not Clb2 and Ase1, is specifically recognized by Cdc20 in metaphase, 
which leads to Pds1 destruction and sister chromatid separation. At this time Ase1, involved in 
microtubule bundling in cytokinesis, should stay intact, as well as Clb2 whose destruction causes 
disassembly of the spindle and decondensation of chromosomes. Pds1 destruction, along with 
sister chromatid separation, triggers Cdc14 phosphatase activation, which leads to decline of 
Clb2-mediated phosphorylation. Dephosphorylation of Cdh1 promotes its association with and 
substrate recruitment to the APC/C. Ase1 and Clb2 are Cdh1-specific targets which ensures that 
cytokinesis and mitotic exit occurs only after the sister chromatids have been separated.  
An additional mechanism of substrate ordering is substrate-intrinsic and based on the 
processivity by which the substates are ubiquitylated by the APC/C (Rape et al., 2006). 
According to this model, more processive substrates are degraded before the less processive 
ones, because they accumulate longer ubiquitin chains upon single binding to the APC/C. This 
allows them to reach the chain length threshold faster, and also makes them less sensitive to the 
action of deubiquitinating enzymes (Rape et al., 2006; Stegmeier et al., 2007). It could be that 
the sequential degradation of Cyclin A, cyclin B and cyclin B3 observed in Drosophila embryos 
is also governed by this mechanism. These three substrates are ubiquitylated by APC/C-Cdc20, 
however, cyclin A is degraded before cyclin B, which is in turn degraded before cyclin B3. This 
order of degradation has been proposed to be important for proper mitosis progression, since it 
was found that stable cyclin A arrests cells transiently in metaphase, stable cyclin B arrest cells 
in early anaphase, and stable cyclin B3 later in anaphase (Sigrist et al., 1995). 
Two peculiar substrates that are degraded already in prometaphase, Nek2A and cyclinA, 
are recognized by the APC/C somewhat differently than a typical substrate. Nek2A has been 
shown to be recruited to the APC/C in a Cdc20-independent manner via its C terminal MR tail, 
which resembles the TPR-binding motif found in APC/C activators and Doc1, the IR tail (Hayes, 
et al., 2006). The ubiquitylation of Nek2A by the APC/C, however, still requires the assistance of 
Cdc20 (Hames et al., 2001; Kimata et al., 2008). Degradation of cyclin A depends on its binding 
to Cdk, as a mutation in cyclin A that abolishes Cdk binding stabilizes it (Stewart et al., 1994, 
Geley et al., 2001; Sorensen et al., 2001; Wolthuis et al., 2008). Cdk binding is not sufficient for 
cyclin A ubiquitylation because deletion of a D-box containing segment of cyclin A, with Cdk1 
binding domain intact, stabilizes the protein (Kobayashi et al., 1992; Geley et al., 2001). Type A 
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cyclins have a D box sequence that is instead of 9 amino acids (RxxLxxxxN), 10 or 11 amino 
acids long (RxxLxxxxxxN), and this feature is conserved among cyclin A1 and A2 molecules 
across species, respectively (Geley et al., 2001). Deletion of this motif alone does not stabilize 
human cyclin A2, but if additional 30 amino acids downstream of this sequence are deleted 
cyclin A2 is stabilized. Deleting these 30 amino-acid without the D box sequence does not 
stabilize the protein, indicating that this D box does function as a degradation signal. From this 
result it was concluded that A type cyclins are targeted for ubiquitylation by an “extended D 
box” (Geley et al., 2001). There is still much to be learned about the features of the APC/C target 
proteins that promotes their timely recognition by the APC/C.  
 
 
1.6. Regulation of the APC/C activity 
 
It is crucial for the cell to segregate its replicated chromosomes only when every single 
sister chromatid pair is properly attached and bioriented on the mitotic spindle; to disassemble 
the mitotic spindle, decondense chromosomes and split the cytoplasm in two only when the two 
chromosome sets have been well separated; and to replicate its genome once, and only once, in 
the cell cycle. All these events are governed by regulated proteolysis of its key regulators, 
initiated by the APC/C-mediated ubiquitylation. It is, therefore, essential for the cell to tightly 
regulate the activity of the APC/C.  The APC/C activity is controlled by reversible 
phosphorylation; by sequential and regulated association of its activators; and by association of 
inhibitors, one of which is the effector of the spindle assembly checkpoint (SAC), the mitotic 
checkpoint complex (MCC). 
 
 
1.6.1. Regulation of APC/C by phosphorylation 
 
Several subunits of the APC/C are phosphorylated in mitosis (King et al., 1995; Peters et 
al.,1996; Yamada et al.,1997). These modifications were implicated in mitotic APC/C activation, 
because dephosphorylation of APC/C reduced its activity (Lahav-Baratz, et al.,1995; Peters et 
al.,1996; Fang et al., 1998; Shteinberg et al.,1999). This inactivation was reversible, as in vitro 
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phosphorylation of the dephosphorylated APC/C with Cdk1 could restore its activity (Lahav-
Baratz et al., 1995). The activity of interphase APC/C can be stimulated by Cdk1-mediated 
phosphorylation (Sudakin et al., 1995). Analysis of APC/C purified from mitotic and S phase 
HeLa cells by mass spectrometry revealed that 9 out of 11 subunits were phosphorylated during 
these two phases of the cell cycle, and the great majority of phosphosites were mitosis-specific 
(Kraft et al., 2003). 30 out of 34 mitosis-specific phosphosites were found in the subunits Apc1, 
Cdc27, Cdc16 and Cdc23. The phosphorylation of these subunits in mitosis causes a retardation 
in their gel-mobility (Peters et al., 1996; Kraft et al.,2003). One of the effects of mitosis-specific 
phosphorylation of APC/C subunits seems to be stimulation of the activator protein Cdc20 
association, as in vitro phophorylation of APC/C increases (Kraft et al.,2003) and 
dephosphorylation reduces (Shteinberg et al.,1999; Kramer et al.,2000) the amount of 
recombinant Cdc20 that can be loaded onto APC/C. Mutation of all potential phosphosites to 
alanines in TPR subunits, five in Cdc27, or six in Cdc16, reduces the amount of Cdc20 that co-
purifies with APC/C (Rudner and Murray, 2000). Whether phosphorylation has additional 
functions in stimulating APC/C in mitosis is still not clear. The activator subunit Cdc20 was also 
found to be phosphorylated in mitosis, but this phosphorylation seems not to affect its ability to 
bind or activate APC/C (Kramer et al., 2000). It was proposed that the phosphorylation of Cd20 
has a role in the spindle assembly checkpoint function (Tang et al., 2004; Chung and Chen, 
2003). In vertebrates the two main kinases are known to stimulate APC/C activity in mitosis are 
Cdk1 and Plk1 (Patra and Dunphy, 1998; Descombes and Nigg, 1998 ), but Cdk1 seems to have 
a major role. In vitro phosphorylation experiments have shown that many, but not all in vivo 
APC/C phosphosites are created by Cdk1/cyclinB/p9 complex, a few are created by Plk1, and 
that the efficiency of direct APC/C phosphorylation is increased if both kinases act combined 
(Kraft et al.,2003; Golan et al., 2002). There are indications that Plk1 maintains the APC/C in an 
active state when cyclin B is degraded by antagonizing the activity of a microcystin-sensitive 
phosphatase (Brassac et al., 2000). It was proposed that in fission and budding yeast, as well as 
in human cells protein kinase A (PKA) phosphorylates APC/C and thereby inhibits APC/C 
mediated proteolysis (Yamashita et al., 1996), but its mechanism and physiological relevance 
still remains to be clarified. Cdk1 also phosphorylates the APC/C activator Cdh1 in mitosis, and 
thereby prevents its association with the APC/C (Kramer et al., 2000). The kinase which causes 
the inactivation of APC/C-Cdh1 at the end of G1 seems to differ across species. In Drosophila 
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overexpression of cyclin E stabilizes APC/C substrates. This could be due to cyclin E-mediated 
Cdh1 phosphorylation (Knoblich et al., 1994). In budding yeast Cdh1 homolog, Hct1, is 
inactivated by Cln1, Cln2 and Clb5 which are refractory to the activity of Hct1 (Schwab et al., 
1997; Zachariae et al., 1998). Once established the Cdk1 activity can be maintained by cyclins 
susceptible to Hct1 activity, such as Clb2 and Clb3, during mitosis. Dephosphorylation of 
APC/C and Cdh1 upon exit from mitosis is mediated by Cdc14 phosphatase in budding yeast 
(Visintin et al., 1998, Jaspersen et al., 1999; reviewed by Stegmaier and Amon, 2004). 
Phosphatases in vertebrate cells with analogous activity have not yet been described. 
Dephosphorylation and activation of Cdk1 inhibitor Sic1 in yeast also contributes to 
dephosphorylation of Cdh1, which allows Cdh1 association with APC/C and maintenance of its 
activity until the end of G1 phase. In budding yeast dephosphorylation of Cdh1 causes its export 
from the nucleus to the cytoplasm (Jaquenoud et al., 2002), whereas in HeLa cells this seems not 
to be the case (Miller et al., 2006). 
 
 
1.6.2. APC/C activators Cdc20 and Cdh1 
 
The activity of the APC/C is controlled by the regulated binding of one of several 
activator proteins. In mitosis, the activator Cdc20 (Fizzy in Drosophila, Slp1 in 
Schizocaccharomyces pombe) is required for APC/C activity in anaphase when the Cdk activity 
is high, whereas Cdh1 (Fizzy-related in Drosophila melanogaster, Srw1/Ste9 in 
Schizocaccharomyces pombe , Fzr1 in Homo sapiens) maintains its activity during late mitosis 
and G1 when the Cdk activity is low (reviewed by Yu, 2007). In meiotic cycle-specific activators 
have been described, Ama1 in budding yeast and Cort in Drosophila (Cooper et al., 2000; Swan 
et al., 2007). Cdc20 was one of 32 temperature-sensitive cell division cycle (cdc) genes found in 
a genetic screen in Saccharomyces cerevisiae (Hartwell et al., 1973), which was later 
characterized as a gene whose mutation causes chromosome losses in mitosis (Hartwell and 
Smith, 1985). Mutations in the Drosophila Fizzy gene caused cells in mitosis to arrest in 
metaphase (Dawson et al., 1993). In a screen for cdc genes required for APC-dependent 
proteolysis, Cdc20 was identified as a cdc gene required for APC- dependent degradation of 
Pds1, whereas Cdh1 (Cdc20 homolog 1), in budding yeast also known as Hct1 (Homolog of Cdc 
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twenty 1) was a factor required for APC-dependent degradation of Clb2 and Ase1 (Schwab et al., 
1997; Visintin, et al., 1997). It was later shown that Cdc20 and Cdh1 directly bind to APC/C and 
activate its ubiquitin ligase activity toward cyclin B in vitro (Fang et al., 1998). Cdc20 and most 
genes that encode apo-APC/C subunits are essential for viability in yeast (Zachariae et al., 1998). 
Cdh1 is not essential for viability in yeast (Schwab et al., 1997; Visintin et al., 1997). In 
mammalian cells the APC/C is also essential for the completion of the cell-division cycle (Wirth 
et al., 2004), depletion of Cdh1 by RNA interference (RNAi) in human cells, however, does not 
significantly perturb the cell cycle (Qi and Yu, 2007) and Cdh1-deficient mice are viable 
(Garcia-Higuera et al., 2008).  
Cdc20 and Cdh1 are highly conserved in all eukaryotes, and are characterized by the 
seven WD40 repeat domain in their C terminal region (Visintin et al., 1997). WD40 repeats fold 
into a rigid propeller-like structure, a secondary structure found in many proteins with different 
functions.  No catalytic function has been attributed to the WD40-repeat propeller domain, 
instead it has been proposed to be ideal for protein-protein interaction function (reviewed in 
Smith et al., 1999). The folding of the WD40 propeller of Cdc20 and Cdh1, and thereby the 
activation of APC/C by these activators, is dependent on the CCT chaperonin complex, which 
was shown to associate with the activators throughout the cell cycle (Camasses, et al., 2003). 
Apart from the conserved WD40 motif several other short amino acid stretches in activators were 
found to be conserved. The carboxy terminal IR tail was shown to be required for activator 
binding to the Cdc27 TPR subunit of human and budding yeast APC/C (Vodermaier et al., 2003; 
Thornton et al., 2006; Matyskiela and Morgan, 2009), although the IR tail of Cdc20 seems to be 
dispensable for viability of yeast (Thornton et al., 2006). In the N terminal region of Cdc20 and 
Cdh1 a seven amino acid motif, the C-box, was shown to be essential for the activity of APC/C 
activators. The C-box promotes activator binding to the APC/C, but also to stimulate the activity 
APC/C in a ubiquitylation reaction. (Schwab et al., 2001; Vodermaier et al., 2003; Thornton et 
al., 2006, Kimata et al., 2008). A Cdh1 specific motif (CSM) motif was found MtCcs52A, the 
Arabidopsis thaliana homolog of Cdh1, which is conserved across species from yeast to humans, 
and was implicated in APC/C binding and activation (Tarayre et al., 2004). 
There is increasing evidence that Cdc20 and Cdh1 function as substrate-specific adaptors 
for APC/C, analogous to the function of WD40-propeller containing F-box substrate adaptors of 
SCF, most likely by binding to the substrate via their WD40 domain (Hilioti et al, 2001; Schwab 
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et al, 2001; Burton and Solomon, 2001; Pfleger et al, 2001; Burton and Solomon, 2005; Kraft et 
al., 2005). However, substrate recognition has been attributed to the apo-APC/C as well. Tandem 
copies of the D box containing cyclinB fragment is able to pull down the apo-APC/C that is 
largely free of Cdc20 or Cdh1 from Xenopus egg extracts (Yamano et al., 2004). Yeast Doc1 is 
required for D box-dependent substrate processivity of APC/C in an in vitro ubiquitination 
reaction, suggesting that Doc1 could be the substrate receptor on apo-APC/C (Carrol and 
Morgan, 2002; Carrol et al., 2005). All these findings suggest that both the activators and the 
APC/C itself cooperatively bind substrates (Eytan et al., 2006; Matyskiela and Morgan, 2008, 
reviewed by Yu, 2007). 
 
 
1.6.3. Mechanisms of APC/C inactivation and APC/C inhibitors 
 
Inactivation of APC/C-Cdc20 at the mitotic exit occurs through APC/C-Cdc20 mediated 
degradation of cyclins and thereby inactivation of Cdk1. As a consequence of Cdk1 inactivation 
APC/C is dephosphorylated which allows Cdh1 association. APC/C-Cdh1-mediated 
ubiquitylation and degradation of Cdc20 inactivates the mitotic version of APC/C (Prinz et al., 
1998; Shirayama et al., 1998; Huang et al., 2001). G1/S cyclin expression at the end of G1 phase 
causes phosphorylation of Cdh1 and supposedly its dissociation from the APC/C which thereby 
remains inactive until the next wave of Cdk activation at the mitotic entry. However, several 
reports suggest that Cdh1 remains associated with the APC/C during the interphase and that there 
are other mechanisms involved in the regulation of APC/C-Cdh1 activity. Several 
pseudosubstrates have been found that also inhibit APC/C-mediated ubiquitylation of substrates. 
Acm1 was found to associate with Cdh1 in budding yeast at the cell cycle stages when APC/C-
Cdh1 activity is absent (Martinez et al., 2006). Acm1 interacts with its several D and KEN boxes 
with the substrate binding interface on Cdh1 and thereby prevents ubiquitylation of other 
substrates. Acm1 itself is a substrate of APC/C-Cdc20, and can be ubiquitylated by APC/C-Cdh1 
but with very low efficiency. It is probably a very high affinity substrate which, by having a low 
off rate prevents other substrates binding (Enquist-Newman et al., 2008). This regulatory 
mechanism is reminiscent of the fission yeast meiotic APC/C inhibitor Mes1, which also 
competes with ubiquitylation of other substrates by being ubiquitylated itself (Izawa et al., 2005, 
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Kimata et al., 2008). In vertebrates cyclin A, but not cyclin E, mediates Cdh1 phosphorylation 
and dissociation from the APC/C (Lukas et al., 1999), which poses a question how cyclin A can 
inhibit APC/C-Cdh1 if it is itself a substrate of the same complex. In vertebraes Emi1 (early 
mitotic inhibitor 1), was found to be an E2F-inducible gene product which inhibits APC/C-Cdh1 
at the G1/S transition and thereby allow accumulation of cyclin A (Hsu et al., 2002). In HeLa 
cells Emi1 was shown to associate with the majority of Cdh1 and APC/C in interphase by direct 
interaction with both Cdh1 and APC/C core which is dependent on a D-box sequence and ZBR 
(zinc-binding region) within Emi1, which was shown to compete with substrates for APC/C-
Cdh1 binding and ubiquitylation in vitro. The ZBR function seems to, possibly by steric 
hinderance, inhibit the APC/C activity. If the ZBR is mutated Emi1 becomes an efficient D-box 
dependent APC/C-Cdh1 substrate (Miller et al., 2006). Emi1 in Xenopus egg extracts is able to 
inhibit both APC/C-Cdc20 and APC/C-Cdh1 by preventing substrate binding (Reimann et al., 
2001a; Reimann et al., 2001b). Emi1 phosphorylation by Plk1 targets it for SCF-βTrCP1 
ubiquitylation and degradation in prophase (Hansen et al., 2004). Emi1 homolog in Drosophila is 
a protein called “regulator of cyclinA 1“(Rca1) which specifically inhibits APC/C –Cdh1 and 
allows cyclin A accumulation in G2 (Grosskortenhaus et al., 2002). 
In early mitosis a messenger RNA export factor Rae1 and nucleoporin Nup98 are 
reported to form a complex with APC/C-Cdh1 and thereby specifically inhibit APC/C-Cdh1-
mediated ubiquitylation of securin (Jeganathan et al., 2005). The release of Rae1-Nup98 
complex from the APC/C-Cdh1 coincides with the release of spindle assembly checkpoint 
proteins from APC/C-Cdc20 (spindle assembly checkpoint, SAC, will be described in the next 
section), but the mechanism of this release, and its coordination with the SAC is not clear. 
Another mechanism proposed to inhibit APC/C-Cdh1 at the end of G1 phase is the 
autoregulation of the E2 enzyme UbcH10. At the end of G1 the UbcH10 starts its 
autoubiquitylation and degradation, which allows cyclin A accumulation subsequent 
phosphorylation and inhibition of APC/C-Cdh1 (Rape and Kirschner, 2004). 
 
 
 
 
 
 Introduction  
24 
 
 
1.6.3.1. The spindle assembly checkpoint 
 
Duplicated sister chromatids are alingned at the metaphase plate prior to their 
segregation. This is achieved by capture of kinetochores by the microtubules of the mitotic 
spindle. Kinetochores are large protein structures embedded in centromeric regions of 
chromosomes (reviewed by Westermann et al., 2007; Musacchio and Salmon, 2007, Cheeseman 
and Desai, 2008, Santaguida and Musacchio, 2009). Far from being a simple microtubule-
chromosome interface, the kinetochore is an elaborate molecular machine that controls and 
powers chromosome segregation by harnessing microtubule dynamics. Importantly, the 
kinetochore also functions as a signaling module that monitors its own assembly and microtubule 
attachment status, and in case the attachment does not satisfy certain criteria, produces a 
diffusible “wait anaphase” signal which inhibits the process of chromosome segregation. This 
surveillance mechanism that is active in prometaphase which prevents precocious sister 
chromatid separation is called the Spindle Assembly Checkpoint (SAC) (Figure 4). The effector 
of the SAC is the mitotic checkpoint complex (MCC), consisting of Mad2, BubR1, Bub3 and 
APC/C activator Cdc20, which acts by inhibiting the APC/C. SAC comprises many other 
components, kinases, motor proteins and structural components (reviewed by Musacchio and 
Salmon, 2007). The SAC proteins were shown to concentrate at unattached kinetochores in 
mitosis and are removed from kinetochores as the attachment process advances. The SAC 
monitors two aspects of microtubule-kinetochore interaction, the attachment and the tension 
exerted across the centromere (reviewed by Pinski and Biggins, 2005; Musacchio and Salmon, 
2007).  
Kinetochore capture by the mitotic spindle is a stochastic process, and will give rise to 
intermediate states of attachment. Non-bipolar attachments will the sensed by lack of stretching 
within the kinetochore and this intra-kinetochore stretching is essential for determining the state 
of checkpoint signaling (Maresca and Salmon, 2009; Uchida et al., 2009). Tensionless 
attachments are actively destabilized by the action of Aurora B kinase, which recruits SAC 
proteins (Ditchfield et al., 2003), and unattached kinetochores enter a new cycle of microtubule 
attachment until bipolar attachment is achieved (Tanaka et al., 2002; Lampson et al., 2004). 
Destabilization of microtubule-kinetochore interaction is thought to be achieved by Aurora B 
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mediated phosphorylation of Ndc80/Hec1 and Dam1 complexes, microtubule capture factors, 
(Cheeseman et al., 2002), which reduces their affinity for the microtubules (Cheeseman et al., 
2006, DeLuca et al., 2006). The phosphorylation of kinetochore substrates was shown to depend 
their distance from the inner kinetochore where Aurora B resides, and these substrates become 
separated from the kinase as the attachment becomes bipolar (Liu et al., 2009). In cells in culture 
the SAC can be elicited by treatment with “spindle poisons”. These drugs can cause 
destabilization (e.g. Nocodazol), or stabilization (e.g. Taxol) of microtubules. If the SAC is 
elicited by stabilizing the microtubules with Taxol, it can be overridden my inhibition of Aurora 
B (Ditchfield et al., 2003; Hauf et al., 2003). 
Mad2 is recruited to unattached kinetochores by its binding partner Mad1 (Chen et al., 
1996; Sironi et al., 2001; Shah et al., 2004). The fact that Mad2 is prominently localized to 
unattached kinetochores, and that kinetochores fully saturated with microtubules exhibit no 
detectable Mad2 suggested that Mad2 senses the microtubule attachment to kinetochores (Waters 
et al., 1998). There is increasing evidence that the MCC forms in a two-step process in which 
Mad2 binding to Cdc20 is required to make Cdc20 sensitive to its inhibition by BubR1 (Fang et 
al., 2001; Fraschini et al., 2001; Davenport et al., 2006; Burton and Solomon, 2007; Kulukian et 
al., 2009). Mad2-Cdc20 interaction involves a large conformational change in Mad2 which may 
be the limiting step for the MCC formation (Luo et al., 2002; Sironi et al., 2002). According to 
the “template” model the binding of Mad2 to Cdc20 is facilitated by initial Mad1-Mad2 binding 
at the unattached kinetochore. This interaction causes a large conformational change in Mad2, 
which is converted from the open form (O-Mad2) to a closed form (C-Mad2). The Mad1-C-
Mad2 complex at the kinetochore serves as a template for soluble O-Mad2 to convert to C-Mad2 
and thereby capture Cdc20 (DeAntoni et al., 2005; Luo et al., 2004; reviewed by Musacchio and 
Salmon, 2007). C-Mad2-Cdc20 complex can also serve as a template for the soluble O-Mad2, 
which results in “wait anaphase” signal amplification. Mad2-Cdc20 complexes have been detected in 
yeast and human cell lysates (Tang et al., 2001; Fang et al., 2002; Poddar et al., 2005), but Mad2 has also 
been isolated from yeast and human cell extracts as part of a mitotic checkpoint complex (MCC), which 
also contains Mad3/BubR1, Bub3 and Cdc20 (Fraschini et al., 2001; Sudakin et al., 2001). 
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Figure 4. APC/C-Cdc20 is inhibited by the spindle assembly checkpoint (SAC). A. In prometaphase duplicated 
chromosomes are progressively attached to the mitotic spindle and bioriented. Until every single kinetochore of all 
the chromatid pairs is properly attached to the spindle APC/C-Cdc20 is kept inactive by the spindle assembly 
checkpoint (SAC). This prevents the degradation of two key mitotic APC/C substrates, cyclin B, the activator of 
Cdk1, and securin, the inhibitor of separase. B. Once all the sister chromatids are attached and bioriented, the SAC 
is inactivated, APC/C-Cdc20 gets activated and targets securin and cyclin B for destruction. This allows the protease 
separase to resolve cohesion between chromatid sisters and start anaphase. Inactivation of Cdk1 allows mitotic exit. 
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BubR1 is a kinase which, like Mad2, localizes to unattached kinetochores, but also 
microbutubule-occupied kinetochores that are not under tension (Skoufias et al., 2001). It 
contains a kinase domain at the carboxy terminus which is not required for interaction with other 
MCC components (Hardwick et al., 2000; Davenport et al., 2006), and seems not to be essential 
for the MCC assembly. The kinase activity of BubR1 is activated at the kinetochore by CENP-E 
(Mao et al., 2003, 2005), and kinetochore kinase activity of BubR1 is essential for cell viability 
(Kops et al., 2004). A “GLEBS-like” motif mediates the interaction of BubR1 with the WD40 
propeller-containing protein Bub3, and this is necessary for BubR1 accumulation at kinetochores 
in early mitosis (Wang et al., 2001). Kinetochore localization of BubR1, as well as of Mad2 and 
CENP-E, is dependent on Aurora B kinase activity (Ditchfield et al., 2003). 
 
Recombinant Mad2 and BubR1 can each inhibit APC/C-mediated ubiquitination 
reactions in vitro (Li et al., 1997, Fang et al., 1998; Fang, 2002; Tang et al., 2001a) but MCC 
isolated from HeLa cells is much more potent in this assay (Sudakin et al., 2001). The 
mechanisms of MCC inhibition of the APC/C proposed in the literature vary. In vitro, binding of 
recombinant Mad2 or BubR1 to Cdc20 prevents the association of Cdc20 with APC/C (Reimann 
et al., 2001; Tang et al., 2001a), however, these proteins could also be detected in complex with 
APC/C bound to Cdc20 (Kallio et al., 1998; Morrow et al., 2005; Braunstein et al., 2007). High-
salt treatment or Cdc20 ubiquitination causes dissociation of Mad2 and BubR1 from the APC/C, 
and increases APC/C activity, indicating that Mad2 and BubR1 can inhibit APC/C by physical 
interaction (Braunstein et al., 2007; Reddy et al., 2007). For Mad2 it has also been proposed that 
it inhibits APC/C by reducing substrate release from Cdc20 (Pfleger et al., 2001), and for Mad3 
it has been shown that it binds to Cdc20 as a pseudosubstrate and prevents the association of 
substrates with Cdc20 (Burton and Solomon, 2007; Malureanu et al., 2009).  
Once all the chromosomes are properly attached and bioriented, the SAC is inactivated 
which leaves APC/C free to ubiquitylate its substrates. Several mechanisms contribute to SAC 
inactivation. The key mechanism is the removal of SAC proteins from the kinetochore, that 
depends on dynein motility along microtubules (Howel et al., 2001; reviewed by Musacchio and 
Salmon, 2007). The Mad2 positive feedback loop predicted by the “template” model, is 
dampened by p31comet  which competes with O-Mad2 for binding to C-Mad2 that is bound to 
either Mad1 or Cdc20 (Xia et al., 2004; Vink et al., 2006). Once the SAC signaling from the 
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kinetochore is shut off, the MCC assembled on the APC/C should also disassemble to allow 
activity of the APC/C. There are indications that this is facilitated by UbcH10- and APC/C-
mediated ubiquitylation of Cdc20 (Reddy et al., 2007) 
The spindle assembly checkpoint (SAC) delays degradation of cyclin B and securin until 
all the chromosomes are properly attached, however this does not seem to affect cyclin A and 
Nek2A degradation which starts already in prometaphase (Geley et al., 2001; den Elzen and 
Pines, 2001; Hames et al.,2001). Nek2A has been shown to be recruited to the APC/C in a 
Cdc20-independent manner via its C terminal MR tail, which resembles the TPR-binding motif 
found in APC/C activators and Doc1, the IR tail (Hayes, et al., 2006). For cyclin A it has been 
proposed that its degradation requires Cdk binding, as a mutation that abolishes Cdk binding 
stabilizes cyclinA (Stewart et al., 1994, Geley et al., 2001; Wolthuis et al., 2008). It is not clear 
what the biological relevance of early, SAC-independent, degradation of cyclin A and Nek2A is. 
There are several possible scenarios how the early prometaphase substrates circumvent the SAC-
mediated inhibition of the APC/C (see Discussion). It will be important to address these 
questions in the future.  
 
 
1.7. The aim of this study 
 
The aim of this project was to understand how substrates are recruited to APC/C and if 
this process is controlled by the spindle assembly checkpoint (SAC). 
Not much is known about the interactions of APC/C with its activators and substrates in 
mechanistic terms. Starting from the finding that the WD40 propeller region of activators is 
implicated in substrate recognition, I first asked whether the WD40 domain is sufficient for 
substrate binding, and whether there is specificity in this binding conferred by the degradation 
motifs within the substrates. I also aimed to purify the WD40 domain in complex with a 
substrate for structure determination by X-ray crystallography, which would provide an insight 
into which amino acid residues within the activator and the substrate are involved in their 
interaction and offer an explanation for what determines the specificity of this interaction.  
I have also addressed the question if the stimulation of APC/C in a ubiquitylation reaction 
by activator proteins stems from solely recruiting substrates to the APC/C or they have additional 
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activating functions. It has been observed that the flexibility of the APC/C is reduced upon Cdh1 
binding (Dube et al., 2005), which suggests a possibility that Cdh1 binding has a role in the 
catalytic activity of the APC/C. Activator proteins interact with the APC/C via two conserved 
motifs, the C-box and the IR tail. If the IR tail is deleted, the activator binding is abolished, 
suggesting that the IR tail is the major APC/C-binding motif. Mutation of the C box also 
influences APC/C binding, but has less effect than the IR tail deletion. Mutation in the C-box, 
however, completely abolishes the activity of the APC/C in a ubiquitylation reaction. One of the 
questions addressed in my project was whether the Cdh1 binding deficiency upon C-box 
mutation was the only cause of its inability to activate the APC/C in a ubiquitylation reaction, 
and if this mutation affects substrate recognition by the APC/C-Cdh1. 
Ubiquitylation of substrates in prometaphase by the APC/C is inhibited by the SAC and 
this inhibition is mediated by MCC that binds to the APC/C. How the MCC inhibits the APC/C 
was not known. The fact that one of the components of the MCC, BubR1, binds Cdc20 as a 
pseudosubstrate suggests that the MCC prevents substrate binding to the APC/C. I tested this 
possibility in an in vitro substrate binding assay in which I compared APC/C molecules isolated 
from cells in different SAC conditions in their ability to bind a variety of different substrates. 
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2. Results 
 
2.1 Does the substrate bind the APC/C activator-independently? 
 
APC/C activation requires the association of one of two related activator proteins, 
Cdc20 and Cdh1. Based on several studies (Hilioti et al, 2001; Schwab et al, 2001; 
Burton and Solomon, 2001; Pfleger et al, 2001, Burton et al, 2005; Kraft et al, 2005) it is 
thought that the activators have a role in recruiting the substrates to the APC/C, 
analogously to the substrate adaptors of the SCF complexes. However, several studies 
suggest that substrates are not recognized by activators alone. For example, a mutation in 
the D box of Clb2 or Cdc5 in budding yeast does not abolish their binding to Cdh1 but 
does reduce substrate proteolysis in vivo (Schwab et al, 2001). It is important to mention 
that an APC/C that lacks the Doc1 subunit in budding yeast cannot bind substrates in a 
native gel APC/C binding assay, although the binding of Cdh1 is intact (Passmore et al, 
2003). Removal of Doc1 increases the rate of substrate dissociation from the active site, 
resulting in a decrease in reaction processivity (Carrol et al., 2005, Carol and Morgan, 
2002; Matyskiela and Morgan, 2009). It was found that the presence of substrates 
stimulates activator binding to the APC/C (Burton et al., 2005; Matyskiela and Morgan, 
2009) suggesting that a substrate binding surface on APC/C must exist. Finally, there are 
two reports about the interaction between substrate and the APC/C in the absence of 
activator (Yamano et al., 2004; Eytan et al., 2006). What is important to point out is that 
Eytan et al. reported that in the preparations they used the APC/C contained traces of 
Cdc20, therefore, strictly speaking, they did not examine the apo-APC/C binding to the 
substrates. Experiments with APC/C from Xenopus egg extracts clearly showed that a 
substrate is able to bind the APC/C directly and that this binding was Fizzy independent 
(Yamano et al., 2004), which is contradicting the result from an experiment with budding 
yeast APC/C where no substrate binding at all was detected unless Cdh1 was present 
(Burton et al., 2005).  
All the above listed data supports a model of multivalent substrate recognition by 
the APC/C and its activators, whereby both the APC/C and the activators contribute to 
the substrate binding (reviewed by Yu, 2007). I have tried to answer the question whether 
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apo-APC/C and Cdh1 can bind substrates independently of each other by using purified 
components.  First I wanted to see if activators can stimulate substrate binding to human 
APC/C. 
 
2.1.1 Activators stimulate substrate binding to the interphase and mitotic APC/C 
 
I tested if the activators can stimulate the activity of APC/C isolated from mitotic 
HeLa cells. Mitotic HeLa cells were obtained by prometaphase arrest induced by 
stabilizing microtubules with Taxol. Taxol treatment activates the spindle assembly 
checkpoint, which prevents mitotic progression by inhibiting the APC/C. To obtain an 
active mitotic APC/C, which is not inhibited by the SAC, the Taxol arrest was overridden 
by treating the Taxol-arrested cells with Hesperadin, a small molecule inhibitor of Aurora 
B kinase (see Materials and methods). The mitotic progression of cells released from the 
SAC arrest was prevented by the addition of the proteasome inhibitor, MG132 which 
prevented degradation of securin and cyclin B and thereby inhibited the onset of 
anaphase (This mitotic arrest protocol is schematically represented in Figure 23). 
The APC/C was immunopurified from mitotic HeLa cell extracts with α-Cdc27 (Apc3) 
antibodies coupled to sepharose beads. Next the beead-bound APC/C was incubated with 
recombinant activators, Cdc20 or Cdh1, purified from Sf9 cells. The unbound activators 
were washed away with IP buffer (as described in Materials and methods) and the 
APC/C-activator complex was then incubated in 60nM solution of N70-2x-GST. N70-2x-
GST is a tandem repeat of 70 N terminal amino acids of Cdc13, fission yeast cyclin B, C 
terminally fused to a GST tag (Figure 5A). A substrate specific recognition motif, the D 
box, is located within the N terminal 70 amino acids of Cdc13 (this somewhat artificial 
substrate was used in experiments by Yamano et al., 2004, as well as Eytan et al., 2006). 
N70-2x-GST with both D boxes mutated (dm) was used as a control for unspecific 
binding. The unbound N70-2x-GST was washed away and the bound complex was eluted 
off the beads with a solution containing 0.1M glycine, pH2. The eluates were analyzed by 
SDS-PAGE add Western blotting (Figure 5B). Mitotic APC/C is already bound to 
substantial amounts of endogenous Cdc20 (faster migrating band, “endo”). When no 
activators are loaded on the APC/C, binding of wild type (wt) but not of D box mutant 
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(dm) N70-2x-GST could be detected (compare lanes 1 and 2). Loading the APC/C with 
additional recombinant Cdc20 or Cdh1 stimulated the binding of APC/C to the wild type, 
but not to the D box mutant, N70-2x-GST (compare lane 7 with 8 and lane 9 with 10). 
 
 
A 
 
 
B 
 
 
Figure 5.  Activators stimulate substrate binding to the mitotic APC/C. A. Schematic representation of 
N70-2x-GST constructs. B. APC/C was immunopurified from mitotic HeLa cells in which the spindle 
assembly checkpoint has been inactivated (SAC off) with α-Cdc27 antibodies coupled to sepharose beads. 
Bead-bound APC/C was loaded with a 3μM solution of recombinant 6xHis tagged activators, either with 
Cdc20 or Cdh1, purified from baculovirus infected Sf9 cells. The unbound activators were washed away 
and the APC/C-activator complex was then incubated in 60nM solution of wild type (wt) or D box mutant 
(dm) N70-2x-GST. The unbound substrates were washed away and the APC/C-activator-substrate complex 
was eluted off the beads with 0.1M glycine pH2. The eluates were analyzed by SDS PAGE followed by 
Western blotting. It was blotted only for Cdc20, but not for Cdh1 in this experiment. rec= recombinant, 
endo= endogenous. 
 Results  
33 
 
Next I tested if Cdh1 can stimulate the interphase APC/C in substrate binding. 
APC/C was immunopurified from exponentially proliferating HeLa cells with α-Cdc27 
antibodies coupled to sepharose beads. Recombinant Cdh1 purified from Sf9 cells was 
loaded on the APC/C, the unbound activator was washed off with IP buffer (Materials 
and methods) and the bead-bound APC/C-Cdh1 complex was then incubated in 60nM or 
15nM solution of GST-Hsl1667-872. Hsl1667-872 is a fragment (amino acids 667-872) of 
budding yeast Hsl1 kinase, a well described APC/C substrate that contains a KEN and a 
D box (Burton and Solomon, 2001). I have decided to use this substrate because it is 
more “natural” compared to the N70-2x-GST substrate, namely the distance between two 
degrons is not imposed by cloning. The fact that  Hsl1667-872 contains two different type of 
degrons, the D and the KEN box, will allow addressing questions regarding their 
individual importance in substrate recognition by the APC/C and its activators.  The 
unbound substrate was washed away and the bound complex was eluted with the 
antigenic Cdc27 peptide. The eluates were analyzed by SDS-PAGE followed by Western 
blotting (Figure 6). The faster migrating band on the Cdh1 blot present in lanes 5-12 is 
the endogenous Cdh1 bound to the APC/C purified from the asynchronous population of 
HeLa cells. I assume that the presence of the endogenous Cdh1 allowed wild type (wt) 
GST-Hsl1667-872 binding to the APC/C (lanes 7 and 11). GST- Hsl1667-872  in which the D 
box and the KEN box have been mutated (dk) bound to a much lower extent (lanes 8 and 
12). Adding recombinant Cdh1 to the APC/C increased the amount of wild type (wt, 
lanes 5 and 9), but not of the D box KEN box mutant (dk, lanes 6 and 10) substrate that it 
could capture. From this experiment I could conclude that Cdh1 can stimulate substrate 
binding to the interphase APC/C in a D box and KEN box specific manner. 
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Figure 6.  Cdh1 stimulates substrate binding to the interphase APC/C. A. Schematic representation of 
GST-Hsl1667-872 constructs. B. The APC/C was immunopurified from logarithmically proliferating HeLa 
cells with α-Cdc27 antibodies coupled to sepharose beads. Bead-bound APC/C was loaded with a 0.23μM 
recombinant His6 tagged Cdh1 purified from baculovirus infected Sf9 cells. The unbound Cdh1 was 
stringently washed away and the APC/C-activator complex was then incubated in 60nM or 15nM solution 
of wild type (wt) or D box KEN box double mutant (dk) GST-Hsl1667-872. The unbound substrates were 
washed away and the APC/C-Cdh1-substrate complex was eluted off the beads with 1mg/ml solution of 
Cdc27 antigenic peptide. The eluates were analyzed by SDS PAGE followed by Western blotting. 
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Having confirmed that the activators participate in substrate binding by the 
APC/C I wanted to see if apo-APC/C is able to bind substrates in the absence of 
activators. I assumed that the most straightforward method to obtain apo-APC/C would 
be to immunodeplete HeLa cell extracts of the Cdh1 or Cdc20 prior to APC/C IP. 
However, two antibodies against Cdh1 (one raised against the antigenic peptide 452 
(RINENEKSPSQNRKAKDATSDNGKDC) and the other raised against a recombinant 
protein, antibody Sat106) failed to immunoprecipitate any significant fraction of Cdh1 
from the log phase HeLa extracts (data not shown). A Cdc20 antibody raised against the 
antigenic peptide 450 (RWQRKAKEATGPAPSPMRAANRC), that could 
immunoprecipitate the free Cdc20 pool from mitotic HeLa extracts, failed to remove the 
Cdc20 fraction that was bound to the APC/C, even after three consecutive 
immunodepletion steps (data not shown).  
 
Another approach I have used to purify apo-APC/C is the one used to separate 
APC/CMCC from apo-APC/C particles analysed by cryo-EM (Herzog et al, 2009), starting 
with the hypothesis that during spindle assembly checkpoint arrest all the Cdc20 
molecules are sequestered to the APC/CMCC and that the remaining APC/C is devoid of 
any activator. A mixed population of APC/C molecules was first purified from HeLa 
cells under spindle assembly checkpoint arrest (SAC-on cells) by Cdc27 
immunoprecipitation, followed by elution with a Cdc27 antigenic peptide. The eluate was 
then subjected to APC/CMCC depletion with α-BubR1 antibodies and the remaining 
APC/C was then purified with an antibody against another APC/C subunit, Apc4. This 
fraction of APC/C, however, always contained traces of Cdc20, which could be observed 
after long exposure (Figure 7B, lanes 5, 6 and data not shown).  
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Figure 7.  A small fraction of APC/C isolated from SAC on HeLa cells is bound to Cdc20 
A. Schematic representation of APC/CMCC and apo-APC/C purification from mitotic HeLa cells with an 
active checkpoint (SAC = spindle assembly checkpoint; IP = immunoprecipitation; reIP = re-
immunoprecipitation).  A mixed population of apo-APC/C and APC/C-MCC is purified from SAC-on cells 
by Cdc27 IP. APC/C-MCC is removed from the mixture by BubR1 IP, and the apo-APC/C that remained in 
the supernatant was immunopurified with α-Apc4 antibodies coupled to sepharose beads. B. Western blot 
analysis of Cdc27 peptide eluate, BubR1 reIP and Apc4 reIP glycine pH2.2 eluate. 
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To purify the apo-APC/C would probably be possible by inserting another Cdc20 
depletion step into the purification procedure shown in Figure 7A, prior to Apc4 re-
immunoprecipitation. This would, however, further dilute the APC/C solution that should 
be loaded onto substrates. Typically the concentration of APC/C would be reduced to 
about 90% of the initial concentration by every immunodepletion step (data not shown). 
High concentration of APC/C is essential in the substrate binding experiments, most 
probably because these interactions are weak. An ideal APC/C purification procedure for 
substrate binding assays therefore should involve a single step of immunoprecipitation.  
Although the described purification procedure could have perhaps been improved, I have 
decided to try other, more straightforward ways to purify the APC/C devoid of activators. 
 
The activity of APC/C is regulated by reversible phosphorylation (Lahav-Baratz 
et al., 1995, Peters et al., 1996, Kotani et al., 1998) Although the precise role of mitotic 
APC/C phosphorylation is poorly understood, there are indications that it affects Cdc20 
binding (Kramer et al, 2000, Rudner and Murray, 2000). Cdc20 binds preferentially to 
mitotically phosphorylated APC/C (Kallio et al., 1998, Kramer et al., 1998, 2000). 
APC/C phosphorylation by Cdk1, or Cdk1 and Plk1 combined, increased its ability to 
bind Cdc20 in vitro and correlated with 4-fold and 6-fold increase in APC/C activity, 
respectively. The increase in activity was due to Cdc20 binding (Kraft et al., 2003). It 
was found that the most heavily phosphorylated subunits of the APC/C are the TPR 
subunits, and it may be that this phosphorylation directly regulates the association of the 
IR tail of Cdc20 and APC/C’s TPR subunits (Vodermaier et al., 2003, Kraft et al., 2003). 
From all these studies it seems likely that the mitotic phosphorylation of APC/C 
stimulates Cdc20 binding, however if dephosphorylation of APC/C causes Cdc20 
dissociation was never tested. If that were the case, dephosphorylation of mitotic APC/C 
and washing away Cdc20 could be a way to obtain apo-APC/C.  
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2.1.2 Dephosphorylation of APC/C does not cause dissociation of Cdc20 
 
 To test if dephosphorylation of APC/C causes Cdc20 dissociation, the APC/C was 
immunoprecipitated from mitotic HeLa cells and the bead-bound APC/C was  
dephosphorylated with λ-protein phosphatase. After extensive washing (see Materials and 
methods) the complex was eluted with 0.1M glycine pH2 (Figure 8A). In parallel I have 
purified the APC/C from G2 HeLa cells and subjected it to the same treatment as mitotic 
APC/C/. The G2 APC/C should contain very little, if any, activators bound.  I wanted to 
see if those trace amounts of activators could be removed by APC/C dephosphorylation. 
The efficiency of dephosphorylation of APC/C was verified by increased Cdc27 (Apc3) 
mobility of the mitotic APC/C caused by removal of phosphates (lanes 4, 5, and 6). 
Cdc20 as well as Cdh1, however, remained bound to the APC/C at the same levels as in 
the sample where APC/C was incubated in phosphatase buffer without λ-protein 
phosphatase (lanes 1, 2 and 3). The trace amounts of activators bound to G2 APC/C also 
remained the same after phosphatase treatment. 
It is known that the TPR subunit Cdc27 is a docking site for Cdh1 and Cdc20 IR 
tails (Vodermaier et al.,2003; Thornton et al.,2006). In the experiment described above 
the APC/C was bound to beads coupled to antibodies against an epitope on Cdc27. To 
exclude the possibility that the activators could not be removed from the APC/C because 
the antibody somehow blocked their “exit route”, I immunoprecipitated the APC/C with 
antibodies against another APC/C subunit, Apc4 (Figure 8B). The APC/C was purified 
from mitotic HeLa cells, dephosphorylated with λ-protein phosphatase and washed 
extensively. The complex was eluted off the beads with the antigenic peptide solution. 
Again, the levels of Cdc20 bound to APC/C remained the same after APC/C 
dephosphorylation, regardless of whether the APC/C was anchored to the beads via 
Cdc27 or Apc4 subunit. 
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Figure 8.  Dephosphorylation of APC/C does not cause Cdc20 dissociation. A. APC/C was 
immunopurified from mitotic (SAC OFF) or G2 HeLa cells with sepharose beads coupled to α-Cdc27 
antibodies.  Bead-bound APC/C was incubated in phosphatase buffer (see Materials and Methods) with (+) 
or without (-) λ-protein phosphatase (λ-PPase) for 30 minutes at 30°C. After extensive washing the 
complex was eluted off the beads with 0.1M glycine pH2. Three volumes of the eluates, 10, 7.5 and 5μl, 
were analyzed on SDS PAGE followed by western blotting. The phosphoshift of Cdc27 (Apc3) can be 
observed in the samples treated with λ-protein phosphatase (lanes 4, 5 and 6). B. APC/C was 
immunopurified from mitotic (SAC OFF) HeLa cells with sepharose beads coupled to α-Cdc27 or α-Apc4 
antibodies. Dephosphorylation and washing was carried out as in (A), followed by elution of APC/C with a 
1mg/ml solution of Cdc27 and Apc4 antigenic peptide, respectively. 
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Another reason for Cdc20 remaining bound to dephosphorylated APC/C could be that 
some unknown factors present in the cell remove it after APC/C dephosphorylation. It 
could be that the Cdc20 was not released from the dephosphorylated APC/C because 
these hypothetical factors were missing in the reaction. To test this I dephosphorylated 
the mitotic APC/C in the HeLa cell extract and only after this step the APC/C was 
immunopurified. After extensive washing the immunopurified APC/C was eluted with an 
antigenic peptide. Figure 9 shows that Cdc20 does not dissociate from the APC/C if the 
dephosphorylation occurred in the cell extract. Also Cdc20 remained bound to 
dephosphorylated APC/C in mitotic extracts regardless of whether the extracts were from 
HeLa cells in which the spindle assembly checkpoint was active (SAC on) or inactive 
(SAC off). A detailed description of the method to obtain the mitotic extracts with an 
active or inactive spindle assembly checkpoint is in the Results section 2.4. 
 
A                                                                                            B 
                   
Figure 9.  Dissociation of Cdc20 from the APC/C does not occur if the APC/C is dephosphorylated in 
the HeLa extract prior to IP. Extracts of mitotic HeLa cells with an active (SAC on) or inactive (SAC 
off) spindle assembly checkpoint were incubated with λ-protein phosphatase  (λ-PPase) for 30 minutes at 
30°C. APC/C was immupoprecipitated with sephasose beads coupled to α-Cdc27 antibodies. After 
extensive washing the complex was eluted off the beads with the antigenic peptide. A. Extracts were 
analyzed by SDS PAGE followed by western blotting for Cdc27 subunit of APC/C to confirm that the 
dephosphorylation was efficient. B. Cdc27 peptide eluates were separated by SDS PAGE and blotted for 
APC/C and Cdc20. 
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2.2 Which part of the activator is required and sufficient to bind the substrate? 
 
 
The literature so far has been rather controversial about the substrate recognition 
by the APC/C activators. Different domains of activators were assigned to substrate 
binding and conclusions about the importance of degrons in substrates for the interaction 
with activators varied in studies from different labs (Schwab et al, 2001; Hilioti et al, 
2001; Pfleger et al, 2001; Burton and Solomon, 2001; Sorensen et al, 2001, Eytan et al, 
2006). The sequence of Cdc20 and Cdh1 predicts folding of the C terminal part of the 
protein into a WD40 propeller structure. SCF adaptor proteins Cdc4 and β-TrCP1 share 
this feature with APC/C activators. Structural studies of Cdc4 and β-TrCP1 have clearly 
shown that WD40 domains bind SCF substrates (Orlicky et al, 2003; Wu et al, 2003). 
Conclusions about the involvement of WD40 domain of Cdh1 in substrate 
binding came from two independent studies. Both describe mutations in this domain that 
abolish substrate binding.  
Burton et al (2005) performed a genetic screen and found 9 point mutants within 
the WD40 propeller region of Cdh1 that were all unable to degrade Hsl1 667-872 substrate. 
These mutants were unable to bind the HA-Hsl1 667-872 substrate. All of these mutants 
were also unable to bind the APC/C leaving the possibility that these mutations 
influenced the folding of the protein thereby rendering it nonfunctional. This was never 
tested or excluded.  
Kraft et al (2005) adopted a more sophisticated approach. Assuming that the 
interactions between the activator and the substrate are evolutionarily conserved, given 
their importance for APC/C function, only conserved amino acid residues were mutated 
and mutant activators were tested for substrate binding and APC/C activation.  A cluster 
of conserved amino acids was bioinformatically predicted to reside on the surface of the 
WD40 domain. To avoid disruption of the propeller structure only amino acids residing 
in the loop regions between the β-sheets of the propeller were mutated. Mutating four 
amino acids was sufficient to abolish ubiquitylation of an established APC/C substrate, 
cyclinB (1-87) in vitro. These mutations also reduced photo-crosslinking of a substrate 
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peptide to Cdh1 to background levels. This was also an evidence that substrate binding to 
the activator is required for substrate ubiquitylation. 
 What remained unclear was if the WD40 domain of APC/C activators is sufficient 
for substrate binding, and if so, if is there any specificity of this interaction determined by 
the destruction motifs in substrates. An ideal approach to understand this interaction 
would be to analyze it by X-ray crystallography. 
 
 
2.2.1 The WD40 propeller domain of Cdh1 is sufficient to bind the Hsl1667-872 
substrate 
 
To test the involvement of the WD40 propeller domain of Cdh1 in substrate 
binding, I compared the full length human Cdh1 with the WD40 propeller domain of 
human Cdh1 (amino acids 150-496) in their ability to bind to Hsl1667-872 when co-
expressed in Sf9 cells. The boundaries of the WD40 propeller region were estimated bio-
informatically from the multiple sequence alignment of Cdh1 proteins from different 
species (The Clustal X protein sequence alignment is in the Appendix). Sf9 cells were co-
infected with equal volumes of baculoviruses encoding N terminally Myc3-His6 or HA3-
His6 tagged human Cdh1 and the untagged Hsl1667-872. Hsl1667-872 with mutated D box 
and KEN box (dk) served as a negative control. The complexes were purified from cell 
lysates by pulling on Cdh1 with Ni-NTA resin, and eluted with imidazole. The eluates 
were analyzed by SDS-PAGE and Coomassie staining, shown in Figure 10. The WD40 
propeller domain could bind Hsl1667-872 with comparable efficiency as the full length 
Cdh1. The binding was dependent on the D box and the KEN box on the substrate, as no 
binding could be observed when these two motifs were mutated (dk). When the cells 
were infected with Hsl1667-872 baculoviruses only, no Hsl1667-872 could be eluted off the 
Ni-NTA beads. From this experiment we could learn that the WD40 propeller domain of 
Cdh1 is sufficient to bind substrates, and that this binding is dependent on the D and 
KEN box. 
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Figure 10. The WD40 domain of Cdh1 is sufficient to bind Hsl1667-872 in a D box KEN box dependent 
manner. Sf9 cells were co-infected with baculoviruses encoding Cdh1encoding N terminally Myc3-His6 
or HA3-His6 tagged full length or a N terminally Myc3-His6 tagged WD40 domain of  human Cdh1 and 
the untagged Hsl1667-872. Hsl1667-872 with mutated D box and KEN box (dk) served as a negative control for 
unspecific binding to Cdh1. Cell lysates from insect cells infected with Hsl1667-872 baculovirus only was 
used to control unspecific Hsl1667-872  binding to the Ni-NTA beads. The complexes were purified from cell 
lysates by pulling on Cdh1 with Ni-NTA resin and eluted with imidazole. The eluates were analyzed by 
SDS PAGE and Coomassie staining. FL = full length. 
 
 
To confirm that baculoviruses encoding the wild type (wt) and D box KEN box 
mutant (dk) Hsl1667-872 were expressing proteins at comparable levels the soluble fraction 
of the cell extracts as well as the eluates were blotted for Hsl1 with an α-Hsl1 antibody, 
shown in Figure 11. 
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Figure 11.  Comparable amounts of protein is expressed by baculoviruses encoding Hsl1667-872 wild 
type (wt) and D box KEN box mutant (dk). Equal volumes of soluble fraction of the Sf9 cell extracts as 
well as the Cdh1-pull down imidazole eluates were analyzed by SDS PAGE and blotted for Hsl1667-872  with 
an α-Hsl1 antibody. 
 
 
From the Coomassie stained gel in Figure 10 one could conclude that the 
stoichiometry of the complex might not be 1:1, since it appears that the Cdh1 band stains 
more strongly than the Hsl1667-872  band. To test if the Cdh1 molecules could bind more 
Hsl1667-872 molecules I titrated the amount of Hsl1667-872  baculovirus used for co-infection 
with a constant amount of baculovirus encoding the WD40 propeller domain of Cdh1 
(Myc3H6-Cdh1 WD40).  The complexes were purified the same way as in the 
experiment in Figure 10 and analyzed by SDS PAGE followed by Coomassie staining. 
The apparent stoichiometry could not be improved by increasing the amount of Hsl1667-
872  baculovirus used in co-infection with the Cdh1 baculovirus (Figure 12). From this I 
concluded that the Cdh1 molecules are saturated with the  Hsl1667-872  fragment. 
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Figure 12.  Increasing the volume of baculovirus encoding Hsl1667-872 relative to the Cdh1 baculovirus 
used to infect Sf9 cells does not improve the stoichiometry of the eluted complex. 50% confluent 
adherent Sf9 cell T175 flask culture was infected with 200µl of baculovirus encoding Myc3-H6-Cdh1 
WD40 in combination with 600, 800 and 1000 µl of baculovirus encoding Hsl1667-872 . 42h after infection 
cells were harvested.  The complexes were purified from soluble fractions of cell lysates on NiNTA resin 
and eluted with imidazole. The eluates were analyzed by SDS PAGE and coomassie staining. 
 
 
2.2.2 Co-expression and purification of Cdh1 with Hsl1667-872 in S. cerevisiae 
 
To gain insight into Cdh1 WD40 domain binding to its substrates, I made an 
attempt to purify a stoichiometric complex of  Hsl1667-872 and the WD40 domain of Cdh1 
for X-ray crystallography studies. Cdh1 and Cdc20 are expressed at very low levels in 
insect cells, and for crystallography purposes these protein amounts would not be 
sufficient. The drawback of low expression levels could be overcome by growing large 
cultures of expressing cells. We chose budding yeast Saccharomyces cerevisiae as an 
expression system because these cells can be grown at large scale. Expression in bacteria, 
the usual and optimal expression system used in crystallography, was not an option 
because it has been impossible so far to express soluble Cdh1 in bacteria. This could be 
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due to the fact that Cdc20 and Cdh1 require TRiC/CCT chaperonin for folding (Camasses 
et al, 2003). The TRiC/CCT chaperonin is only present in eukaryotic cells (reviewed in 
Dunn et al, 2001). Another advantage of budding yeast as an expression system is that 
there is a variety of over-expression promoters which would allow control over relative 
expression levels of the two co-expressed proteins. 
 
I placed full length budding yeast Cdh1 and three truncation constructs of Cdh1, 
called WD1 (amino acids 164-567), WD2 (amino acids 195-567) and WD3 (amino acids 
227-567) as well as Hsl1667-872 under GAL1-10 promoter. Cdh1 constructs were N 
terminally tagged with a Flag tag. Protein A was fused the N terminus of Hsl1667-872   and 
was separated from it with a Tobacco Etch Virus (TEV) protease recognition sequence 
(Figure 13).  
 
 
 
Figure 13.  Hsl1 and Cdh1 constructs used in co-expression studies. Protein A was fused with a 
fragment of budding yeast protein Hsl1 (amino acids 667-872) at its C terminus and was separated from 
Hsl1667-872    with a Tobacco Etch Virus (TEV) recognition sequence. Full length and three truncated forms 
of Cdh1, WD1 (amino acids 164-567), WD2 (amino acids 195-567) and WD3 (amino acids 227-567) were 
N-terminally tagged with a Flag tag. 
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A 
 
B 
 
Figure 14 . When over-expressed in yeast full length Flag-Cdh1 is insoluble. Co-expression with 
Protein-A-Hsl1667-872 renders it soluble. A. Flag-Cdh1 full length and truncated forms, WD1 (amino acids 
164-567), WD2 (amino acids 195-567) and WD3 (amino acids 227-567) were over-expressed under 
GAL1-10 promoter in S.cerevisiae. The cells were harvested and lysed, and the soluble fraction of the 
lysate was separated from the insoluble fraction by centrifugation. Total cell lysate and the soluble fraction 
were analysed by SDS PAGE and Western blotting. Cdh1 constructs were detected with an antibody 
against the Flag tag. B. The four Flag-Cdh1 constructs  were co-expressed with Protein A-TEV- Hsl1667-872 , 
and the complex was purified from the cell extracts with IgG sepharose beads. The glycine eluates were 
analyzed by SDS PAGE and Western blotting. Cdh1 was detected with α-Flag antibodies, and the Protein 
A-TEV- Hsl1667-872   was detected with the secondary antibody. Cdh1 bands are marked with a pink star, 
Protein A-TEV- Hsl1667-872   is marked with an orange star. m=marker. 
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All four Cdh1 constructs could be detected in the total cell lysate when over-
expressed in budding yeast (Figure 14A, lanes 1, 2, 3 and 4), however, only the truncated 
forms of Flag-Cdh1, WD1, WD2 and WD3 were soluble (Figure 14A, lanes 5, 6 and 7), 
whereas the full length Flag-Cdh1 was not (Figure 14A, lane 8). Protein A-TEV- Hsl1667-
872  was also soluble when over-expressed (not shown). Co-expression of full length Flag-
Cdh1 with Protein-TEV- Hsl1667-872 rendered Cdh1 soluble (Figure 14B). The Flag-Cdh1-
WD3 construct was expressed at the highest level, therefore I continued to further 
optimize expression and purification conditions with this construct only. 
 
  
 
 
Figure 15.  Cdh1 WD3 and Hsl1667-872   can be co-purified from Saccharomyces cerevisiae. Lysates of 
budding yeast cells that overexpressed ProteinA-TEV-Hsl1667-872   together with Flag-Cdh1 WD3 (lanes 1 
and 2), ProteinA-TEV-Hsl1667-872   alone (lane3)  or Flag-Cdh1 WD3 alone (lane 4) were incubated with 
IgG-coupled sepharose beads, the unbound material was washed away and the beads were incubated  in 
TEV cleavage buffer with (lanes 2, 3, 4) or without TEV protease (lane 1). The eluates were analyzed by 
SDS PAGE and coomassie staining. The expression of all the overexpressed proteins was driven by gal1-
10 promoter 
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The co-expressed Cdh1-WD3 and Hsl1667-872 could be isolated in a complex by 
pulling on the Protein A tag on Hsl1667-872 and cutting the complex off the tag with TEV 
protease (Figure 15, lane 2). When expressed without Cdh1 lower amounts of  Hsl1667-872  
could be eluted (Figure 15, lane 3), compared to levels when the protein was co-
expressed with Cdh1 , indicating that co-expression stabilizes Hsl1667-872 . Besides eluting 
in a complex with Hsl1667-872 , Cdh1-WD3 also seems to bind to IgG sepharose beads 
unspecifically since some of it eluted off  the beads also when no TEV cleavage was 
performed (Figure 15, lane 1). This also indicates that the there may also be free Cdh1-
WD3 in the cell, unbound to Protein A-TEV- Hsl1667-872 .  
 
To increase the proportion of Cdh-WD3 in the cell bound to ProteinA-TEV- 
Hsl1667-872 I placed Protein A-TEV- Hsl1667-872 under a promoter that is stronger than 
GAL1-10, the GAL10-PGK promoter. Figure 16 shows the comparison of TEV eluates 
of Cdh1-WD3 in complex with Hsl1667-872 whose expression was driven by GAL1-10 
promoter (lane 1) and by GAL10-PGK promoter (lane 2). When expressed from GAL10-
PGK promoter the amount of Hsl1667-872 that can be pulled down with Protein A beads 
and eluted with TEV protease is higher than when it is expressed from GAL1-10 
promoter (compare lane 1 with 2 and lane.3 with 4, Figure 16). The stoichiometry of 
Cdh1-WD3 that can be pulled down together with Hsl1667-872 is also changed. When the 
Hsl1667-872 and Cdh1-WD3 bands are compared on the Coomassie gel (Figure 16, lanes 2 
and 4), it seems that the Hsl1667-872 band is stained more than Cdh1-WD3, suggesting that 
not all Hsl1667-872 molecules elute in a complex with Cdh1-WD3, some elute as 
monomers. Mass spectrometry analysis of the co-eluting 70kDa band identified a heat 
shock protein SSA1 as its major component. The samples were concentrated (Figure 16, 
lanes 4 and 5) and further purified by size exclusion chromatography on 
Sephadex200_HR_10/30 column. The eluates that corresponded to the peak fractions in 
the chromatogram were analyzed by SDS PAGE and Coomassie staining, as shown in 
Figure 17.  
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Figure 16.  Protein expression level of Hsl1667-872 is higher when its driven by gal10-PGK promoter 
compared to gal1-10 promoter. Cdh1WD3 under gal1-10 promoter (+) was co-expressed with Hsl1667-872 
under either gal1-10 (+) or gal10-PGK (#) promoter. The complexes were purified as described and 
concentrated by precipitation in 85% ammonium sulphate followed by re-suspension of the complex in 
1/10  of the starting volume. Equal volumes of the eluates (lanes 1 and 2) and of the concentrated samples 
(lanes 3 and 4) were analyzed by SDS PAGE and Coomassie staining. Conc= concentrated eluates. 
 
Analysis of the eluate by size exclusion chromatography confirmed that when expressed 
from the GAL10-PGK promoter the TEV elution contained the complex of Hsl1667-872  
and Cdh1 WD3, which elutes at the molecular weight of about 65 kDa, but it also  
contains Hsl1667-872  monomers, which elute in lower molecular weight fractions. The 
Hsl1667-872 monomers could not be separated from the complex on this gel filtration 
column. The Hsl1667-872 seems to be degraded if it is not bound to the WD40 domain of 
Cdh1, this can be seen as a smear below the Hsl1667-872 band in the lower molecular 
weight fractions, where increasing amounts of monomer elute. 
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Figure 17.  Cdh1WD3 and Hsl1667-872 form a stable complex. The concentrated solution of the 
Cdh1WD3 and Hsl1667-872 complex (Figure 16, lane 4) was purified by size exclusion chromatography 
using  Sephadex200_HR_10/30  column (Amersham). The eluates corresponding to the peak fractions in 
the chromatogram were analyzed by SDS PAGE and Coomassie staining. The BSA-standard peak fraction 
corresponds to the fraction marked with a star, lane 3. 
 
The chaperones co-elute with the complex. Both the complex and the chaperones elute at 
about 65 kD, which suggests that they dissociate from the complex. Below the 
chaperones there is a contaminating band that I suspect to be the BSA, used for 
calibration that stayed in the column. Only the fraction 3 contains a stoichiometric 
complex of Hsl1667-872 and Cdh1-WD3, and the amount of this complex is rather low. The 
eluate loaded on this column was obtained from 2 liters yeast culture.   
 Because of very low yield of the stoichiometric complex, irreproducibility of the 
concentration step by ammonium sulphate precipitation, and inability to remove 
chaperones by ATP treatment I did not pursue this project further.  
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2.3 The role of the C-box 
 
Within the largely non-conserved N terminal part of Cdh1 and Cdc20 a short 
conserved sequence motif was identified whose removal destroyed the ability of budding 
yeast Cdh1 to degrade Clb2 (Schwab et al.,2001). This motif has been shown to be 
essential for the function of budding yeast Cdh1 and to be required for its association 
with the APC/C (Schwab et al., 2001). In another study of the C box in yeast Cdh1 only a 
mild defect in APC/C stimulation by the mutant Cdh1 was reported (Thornton et al., 
2006). Binding of human recombinant Cdh1 was significantly, but not completely, 
reduced if the C box was mutated. However, this mutant of Cdh1 was completely unable 
to activate APC/C (Vodermaier et al., 2003). It remained therefore unclear if the only 
function of the C box was to bind the activator to the APC/C or if it has other functions. 
Recently it has been found that the N terminal part of Cdh1 bearing the C box was 
sufficient to activate the Xenopus laevis APC/C in a ubiquitylation reaction if the 
substrate is recruited to it in an activator independent manner (Kimata et al., 2008). All 
the mentioned reports are of qualitative nature and we decided to study the effect of the C 
box mutation in Cdh1 in a more quantitative manner, using purified components, which 
might allow a clearer view at the role of the C box in mechanistic terms.  
 
 
2.3.1 APC/C binding of Cdh1 with a mutated C box is reduced 10-fold  
 
The IR tail and the C box both contribute to activator binding to the APC/C. The 
first question we asked was what the effect of the C box mutation in Cdh1 was on APC/C 
binding. To answer this question I purified human Cdh1 with a wild type C box (DRFIP) 
and Cdh1 with the C box amino acids mutated to alanines (AAAAA) from Sf9 cells that 
were infected with Baculoviruses encoding these his-tagged Cdh1 constructs (constructs 
published in Vodermaier et al, 2003). The APC/C was purified from exponentially 
proliferating HeLa cells with α-Cdc27 antibody coupled to sepharose beads. A certain 
amount of endogenous Cdh1 bound to the APC/C could always be detected because the 
majority of exponentially proliferating HeLa cells is in the G1 phase. APC/C bound to 
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the α-Cdc27-sepharose beads was then incubated in increasing concentrations of 
recombinant Cdh1, wild type (wt) or C box mutant (Cm). After the unbound activators 
were washed away with IP buffer (see Materials and methods) the APC/C-Cdh1 
complexes were eluted off the beads with a Cdc27 antigenic peptide. The eluates were 
analyzed by SDS PAGE and Western blotting against the APC/C subunit Apc2 and Cdh1 
(Figure 18).  
 
A 
 
 
B 
 
 
Figure 18 . APC/C binding of Cdh1 with a mutated C box is reduced 10-fold.  A. The APC/C was 
isolated from logarithmically proliferating HeLa cells with with α-Cdc27 antibodies coupled to sepharose 
beads. Bead-bound APC/C was loaded with increasing concentrations of wild type (wt) or C box mutant 
(Cm)  recombinant His-tagged Cdh1 purified from baculovirus infected Sf9 cells. The unbound Cdh1 was 
washed away with IP buffer (see Materials and Methods) and the APC/C-activator complex was eluted 
with a 1mg/ml Cdc27 antigenic peptide solution. The same samples were analyzed and blotted for Apc2 
twice, due to apparent unequal loading in lanes 2-5. B. The experiment was carried out as in (A). The 
eluted samples were analyzed by SDS PAGE and Western blotting. Rec.=recombinant, endo = endogenous. 
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The concentration of recombinant C-box-mutant Cdh1 solution that has to be incubated 
with the APC/C is about 10 times higher than the concentration of the recombinant wild 
type Cdh1 to achieve equal binding of these two forms of Cdh1 to the APC/C (compare 
lanes 2 and 5, Figure 18B). 
 
From this experiment we learned that it is possible to compensate for the C-box 
mutant APC/C binding defect by increasing the concentration of Cdh1 that is loaded onto 
the APC/C. Having the binding restored to wild type levels it was possible to ask the next 
question. If the role of the activators is solely to recruit the substrates to the APC/C and if 
the C-box functions solely as an APC/C-interaction motif, restoring wild type binding of 
the Cdh1 Cm to the APC/C the way described above should also restore the wild type 
activator function in a ubiquitylation reaction. I tested this hypothesis by comparing the 
activity of APC/C bound to equal levels of either wild type or C-box mutant Cdh1 in an 
in vitro substrate ubiquitylation assay. 
 
 
2.3.2 Substrate ubiquitylation by the APC/C loaded with C-box mutant Cdh1 is 
impaired 
 
To compare the ability of C-box mutant Cdh1 to activate the APC/C in an 
ubiquitylation reaction with the wild type Cdh1, I purified APC/C from logarithmically 
proliferating HeLa cells with α-Cdc27 antibodies coupled to sepharose beads and loaded 
it with comparable amounts of either wild type (wt) or C-box mutant (Cm) recombinant 
human Cdh1 purified from Sf9 cells, as described above. The APC/C-Cdh1 complex was 
eluted off the beads with a Cdc27 antigenic peptide solution. A fraction of the eluate was 
analyzed by SDS PAGE and Western blotting, to confirm that the levels of recombinant 
wt and Cm Cdh1 that were bound to the APC/C were comparable (Figure 19A). The 
remainder of the eluates was used in an in vitro ubiquitylation assay. The APC/C-Cdh1 
substrate used in the reaction was I125-labeled human cyclin B1 fragment (amino acids 1-
87). The I125-labeled substrate was incubated with APC/C-Cdh1 complex eluates mixed 
with E1, E2, ubiquitin, ATP and ATP-regenerating system and incubated at 37°C for 1, 2, 
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5, or 9 minutes. The whole reaction volume was analyzed by SDS PAGE and 
phosphoimaging (Figure 19B and C).  
 
Comparable levels of C-box mutant and wild type Cdh1 bound to APC/C if they 
were incubated with the APC/C as a 1.1μM solution (Figure 19A, lanes 3, 4, 5) and 0.2 
μM solution (Figure 19A lanes 12, 13, 14), respectively. The corresponding samples in 
the ubiquitylation reaction are underlined in Figure 19B. From this experiment we 
learned that restoring the wild type binding of the C box mutant Cdh1 to the APC/C does 
not restore its activity to wild type levels in an in vitro ubiquitylation reaction. The C box 
mutated Cdh1 has no stimulatory effect in the ubiquitlylation reaction despite its binding 
to the APC/C. Note that the stimulation of APC/C activity that can be observed upon wild 
type Cdh1 pre-binding to the APC/C is not as pronounced as it can be usually seen when 
recombinant activators are added directly to the ubiquitylation reaction. This could be 
due to the fact that the amount of recombinant activator that is retained on the APC/C 
upon pre-binding is relatively low compared to the usual amounts of activator added 
directly to the in vitro ubiquitylation reaction. 
 
The defect in APC/C activation could arise from defective substrate recruitment 
to the APC/C or from defective catalytic activation of APC/C towards a properly 
recruited substrate. To start dissecting this problem I first tested if the substrate 
recruitment to the APC/C by Cdh1 was impaired upon C-box mutation. 
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C 
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Figure 19 .  C box mutation in Cdh1 abolishes its ability to activate the APC/C. A. APC/C purified 
from log phase HeLa cells with an α-Cdc27 antibody coupled to sepharose beads was loaded with 
comparable amounts of wild type (wt) and C box mutant (Cm) Cdh1 (compare lanes 3, 4, 5 for Cm with 12, 
13, 14 for wt Cdh1) . The APC/C-Cdh1 complexes were eluted off the beads with a 1mg/ml Cdc27 
antigenic peptide solution. A sample of each eluate was analyzed by SDS PAGE and Western blotting 
against the APC/C subunit and Cdh1. B. The remaining eluates from A were mixed with ubiquitylation 
reaction mix and  radioactive I125-labeled human cyclin B fragment (amino acids 1-87) as an APC/C-Cdh1 
substrate. The ubiquitylation reaction was carried out for 1, 2, 5 and 9 minutes at 37°C. The reaction was 
stopped by adding 4x sample buffer. APC/C without recombinant Cdh1 was a control for endogenous 
Cdh1-mediated APC/C activation. The whole reaction volume was analyzed on an SDS PAGE gel and 
analyzed by phosphoimaging. Ubiquitlylation reaction timepoints where comparable amounts of 
recombinant Cdh1 were loaded onto APC/C are underlined. C. The phosphoimage ubiquitylation profile 
shown in B was quantified by Image J.  
 
 
2.3.3 Substrate binding by the APC/C loaded with C-box mutant Cdh1 is impaired 
 
The APC/C was isolated from logarithmically proliferating HeLa cells and loaded 
with comparable levels of recombinant wild type or C-box mutant Cdh1, as described 
above. Excess of activator was removed by washing with IP buffer. The bead-bound 
APC/C-Cdh1 complex was then incubated in 150nM solution of recombinant human 
securin. His6-tagged human securin was expressed and purified from E.coli. To prevent 
unspecific binding of the substrate the solution also contained 4mg/ml BSA. The 
unbound substrate was then washed away and the bound complexes were eluted off the 
beads with Cdc27 antigenic peptide solution. The eluates were analyzed by SDS PAGE 
and Western blotting (Figure 20). Some securin binding to the APC/C could be detected 
if no recombinant Cdh1 was additionally bound to it. This binding is due to the 
endogenous Cdh1 (lane 8). The endogenous Cdh1 was present in all samples, and it can 
be seen as a faster migrating thin band on the Cdh1 blot. Loading APC/C with 
recombinant wild type Cdh1 increased the amount of securin it could retain compared to 
the APC/C that was bound to endogenous Cdh1 only (compare lanes 1, 2, 3 with lane 8). 
The increase in securin binding was Cdh1 dose-dependent (lanes 1, 2, 3). However, 
loading comparable amounts of recombinant C-box mutant Cdh1 onto the APC/C had no 
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stimulatory effect in securin binding (lanes 4, 5, 6). From this we could conclude that the 
C-box mutant Cdh1 is impaired in substrate recruitment to the APC/C. 
 
A 
 
 
B 
 
Figure 20.  APC/C loaded with C-box mutant Cdh1 is impaired in securin binding. A. Schematic 
representation of the experimental outline. S = substrate. B. APC/C isolated from log phase HeLa cells and 
loaded with a range of equal  levels of wild type (wt) or C-box mutant (Cm) Cdh1, as described in Figure 
18. The bead bound APC/C-Cdh1 complex was then  incubated in 150nM solution of recombinant human 
His6-tagged securin that was expressed and purified from E.coli. The unbound securin was washed away 
and the bound complex was eluted off the beads with a 1mg/ml Cdc27 antigenic peptide solution. The 
eluates were analyzed by SDS PAGE and Western blotting. Endogenous Cdh1 is a faster migrating band, 
the recombinant Cdh1 runs slower. Two different exposures of the securin blot are shown. 
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To confirm this finding I performed the same experiment with GST-Hsl1667-872 substrate 
(Figure 21). In addition to the wild type (wt) GST-Hsl1667-872 I also looked at D-box 
mutant (dm), KEN box mutant (km) and D box KEN box double mutant (dkm) GST-
Hsl1667-872 binding. As observed with securin, wt GST-Hsl1667-872  binding was increased 
when the APC/C was loaded with recombinant wild type Cdh1 (lanes 2 and 3), compared 
to binding of wt GST-Hsl1667-872  when only endogenous Cdh1 was bound to the APC/C 
(lane 1). Wt GST-Hsl1667-872 binding could also be stimulated by C-box mutant Cdh1 
(lanes 4 and 5) above basal levels (lane 1), but this stimulation was not as high as the one 
seen with recombinant wt Cdh1 (lanes 2 and 3). The difference between wt Cdh1 and C-
box mutant Cdh1 in GST-Hsl1667-872 binding stimulation was more pronounced if the 
KEN box of GST-Hsl1667-872 was mutated (compare lanes 10 and 11 with lanes 3 and 4). 
D box mutant (dm) and D box KEN box double mutant (dkm) GST-Hsl1667-872  did not 
bind above background levels regardless of whether wt or C-box mutant Cdh1 was 
loaded onto the APC/C (lanes 7, 8, and 13, 14, 15, 16). 
 
 
 
 
Figure 21 .  APC/C loaded with C-box mutant Cdh1 is mildly impaired in GST-Hsl1667-872 binding. 
APC/C isolated from log phase HeLa cells and loaded with a range of concentrations of wild type (wt) or 
C-box mutant (Cm) Cdh1, as described in Figure 18. The bead bound APC/C-Cdh1 complex was then  
incubated in 60nM solution of wild type (wt) D box mutant (dm), KEN box mutant (km) or D box KEN 
box double mutant (dkm) GST-Hsl1667-872  that were expressed and purified from E.coli. The unbound  
substrates were washed away and the bound complex was eluted off the beads with 1mg/ml of Cdc27 
antigenic peptide solution. The eluates were analyzed by SDS PAGE and Western blotting. 
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It might be important to point out here that the D box mutation has a stronger effect in 
abolishing Hsl1667-872 binding to APC/C-Cdh1 than the KEN box has, which is 
contradicting previous proposal (Pfleger and Kirschner, 2000 and Burton and Solomon, 
2001, Passmore et al, 2003) that the KEN box is preferentially recognized by Cdh1 and 
the the D box by Cdc20. In the experiment shown in Figure 21 it is clear that a mutation 
in the D box abolishes GST-Hsl1667-872 biding to APC/C-Cdh1 more strongly than the 
mutation in KEN box does (compare lanes 2, 7 and 10). Therefore, the D-box is more 
important for Cdh1 recognition of Hsl1667-872 than the KEN box is. 
 
 
2.3.4 C-box mutation in Cdh1 seems not to affect Hsl1667-872 binding to Cdh1   
 
The reduction in substrate binding by APC/C-Cdh1 when the C-box in Cdh1 is 
mutated could be for two reasons. Either the C-box is directly involved in substrate 
recognition by Cdh1 or the C-box binding to a certain site on APC/C positions the 
substrate-bound Cdh1 in such a way to expose the substrate to a substrate-binding surface 
on the APC/C itself. The latter possibility would fit to a model where the APC/C and the 
activators bind the substrate in a cooperative way, as well as to the observed phenomenon 
of reduced APC/C flexibility upon Cdh1 binding (Dube et al., 2005) 
To exclude the possibility that the C-box is directly involved in substrate binding 
I co-infected Sf9 cells with baculoviruses encoding the untagged substrate Hsl1667-872 
together with either wt or C-box mutant (Cm) human HA3H6-tagged Cdh1. After 42 
hours of co-expression the substrate-activator complexes were purified from Sf9 cells via 
Ni-NTA agarose resin (Figure 22). The amounts of Hsl1667-872 that could co-purify with 
wild type and C-box mutant HA3H6-Cdh1 were very similar (compare lanes 3 and 5). 
The observed binding was specific since mutating the D box and the KEN box in Hsl1667-
872 abolished its binding to both wt and Cm Cdh1 (lanes 4 and 6) and no Hsl1667-872  
binding to the Ni-NTA agarose beads could be observed if HA3H6-Cdh1 was not co-
infected with it (lanes 1 and 2). 
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Figure 22 .  Outside of the context of APC/C the C-box mutant Cdh1 can bind Hsl1667-872 as well as 
the wild type Cdh1.  Sf9 cells were infected with baculoviruses encoding Cdh1encoding N terminally 
HA3-His6 tagged full length human wild type (wt) or C-box mutant (Cm) Cdh1 together with the 
baculovirus encoding an untagged Hsl1667-872. Hsl1667-872 with mutated D box and KEN box (dk) served as a 
negative control for Cdh1 binding. Cell lysates from cells infected with Hsl1667-872 baculovirus only was 
used to control unspecific Hsl1667-872  binding to the Ni-NTA beads. The complexes were purified from cell 
lysates by pulling on Cdh1 with Ni-NTA resin, and eluted off the beads with imidazole. The eluates were 
analyzed by SDS PAGE and Coomassie staining.  
 
 
From this experiment we could conclude that the substrate binding to the activator is not 
impaired by a C-box mutation in Cdh1. However one should be careful with basing such 
a conclusion on an experiment with Hsl1667-872. Equal binding of Hsl1667-872 to wt and Cm 
Cdh1, as well as the fact that the C-box mutation in Cdh1 has a much smaller effect on 
APC/C-Cdh1 recognition of Hsl1667-872 compared to a strong defect in securin binding, 
could also be explained by the latest finding in the Morgan lab (Matyskiela and Morgan, 
2009) that the Hsl1667-872 is a substrate with an extraordinary high affinity for the APC/C-
Cdh1. For this reason additional co-infection experiments with substrates such as securin 
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or Aurora kinases should be done to confirm that the C-box has no direct role in substrate 
recognition by Cdh1. 
 
 
2.3.5 A C-box binding site on APC/C 
 
If the C-box is an APC/C interaction motif, knowing which subunit of the APC/C 
it binds to might help explaining the behaviour of the C-box mutant Cdh1 we could 
observe in the experiments described above. I can think of at least two ways how to find 
out which APC/C subunit it might be. The best candidate for C box binding is Apc2. It 
has been shown that upon Apc2 deletion in budding yeast the amount of Cdh1 bound to 
the APC/C is reduced. This could be relatively easily tested by comparing wild type 
APC/C with APC/C that lacks subunits Apc2 and Apc11 (Δ2/11-APC/C Vodermaier et 
al., 2003) in their ability to bind a C-box containing Cdh1 N- terminal fragment. Another, 
more elaborate and time consuming way would be to map the C-box binding site by cryo-
EM analysis of APC/C loaded with a C-box baring Cdh1 fragment fused to a bulky tag or 
by cross-linking the C-box containing fragment to the APC/C (B. Buschhorn and G. 
Petzold, personal communication). Alternatively, crosslinking of a C-box containing 
fragment of Cdh1 to the APC/C could capture the C-box interacting subunit. 
For all the proposed approaches I needed first to see if it is possible to bind a 
Cdh1 fragment that contains the C-box to the APC/C. To test this I fused N-terminal 116 
amino acids of Cdh1 to the C-terminus of glutathione-S-transferase (GST). The C-box in 
human Cdh1 starts at the amino acid 46 and the WD40 domain starts at amino acid 150. I 
expressed and purified the GST-N116 Cdh1 constructs, both wild type and C-box mutant, 
in E. coli. Five different concentrations of GST-N116 Cdh1 ranging from 1μM to 70nM 
were bound to glutathione sepharose beads and loaded with APC/C in solution that was 
purified from logarithmically proliferating HeLa cells. I could detect no APC/C binding 
to GST-N116 Cdh1 at any concentration (data not shown). This was somewhat surprising 
given that a fragment of N-terminal 159 amino acids of Fizzy (GST-N159 Fizzy) could 
pull out APC/C from Xenopus egg extracts (Kimata et al., 2008). Longer Cdh1 C-box 
baring fragments should be tested in APC/C binding for the purpose of the C-box-binding 
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site determination on the APC/C. Another reason for this discrepancy might lie in the fact 
that I have used interphase HeLa cell extracts, whereas Kimata et al. used CSF arrested 
Xenopus egg extracts. This will have to be resolved in the future. 
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2.4 APC/C inhibition by the SAC 
 
 The association of Mad2 and Mad3/BubR1 with Cdc20 has been studied in some 
detail, but how these interactions lead to inactivation of the APC/C is poorly understood. 
Mad2 is recruited to unattached kinetochores by its binding partner Mad1 (Chen et al., 
1996; Sironi et al., 2001; Shah et al., 2004), where the Mad2-Mad1 heterodimer has been 
proposed to function as a template that catalyzes the assembly of Mad2-Cdc20 complexes 
(DeAntoni et al., 2005; reviewed by Nasmyth, 2005; Mapelli and Musacchio, 2007). 
Mad2-Cdc20 complexes have been detected in yeast and human cell lysates (Tang et al., 
2001a; Fang, 2002; Poddar et al., 2005), but Mad2 has also been isolated from yeast and 
human cell extracts as part of a mitotic checkpoint complex (MCC), which also contains 
Mad3/BubR1, Bub3 and Cdc20 (Fraschini et al., 2001; Sudakin et al., 2001). 
Recombinant Mad2 and BubR1 can each inhibit APC/C-mediated ubiquitination 
reactions in vitro (Li et al., 1997, Fang et al., 1998; Fang, 2002; Tang et al., 2001a) but 
MCC isolated from HeLa cells is much more potent in this assay (Sudakin et al., 2001). 
In vitro, binding of recombinant Mad2 or BubR1 to Cdc20 prevents the association of 
Cdc20 with APC/C (Reimann et al., 2001; Tang et al., 2001a), however, these proteins 
could also be detected in complex with APC/C bound to Cdc20 (Wassmann and Benezra, 
1998; Morrow et al., 2005; Braunstein et al., 2007). High-salt treatment or Cdc20 
ubiquitylation causes dissociation of Mad2 and BubR1 from the APC/C, and increases 
APC/C activity, indicating that Mad2 and BubR1 can inhibit APC/C by physical 
interaction (Braunstein et al., 2007; Reddy et al., 2007). For Mad2 it has also been 
proposed that it inhibits APC/C by reducing substrate release from Cdc20 (Pfleger et al., 
2001), and for Mad3 it has been shown that it binds to Cdc20 as a pseudosubstrate and 
prevents the association of substrates with Cdc20 (Burton and Solomon, 2007; 
Maleureanu et al., 2009).  
 
The state of the APC/C itself was never analyzed in detail in cells with an active 
checkpoint. To gain insight into the mechanism of APC/C inhibition by the MCC, the 
APC/C was isolated from mitotic HeLa cells in which the spindle assembly checkpoint 
was active (SAC-on) or switched off (SAC-off), and compared structurally and 
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biochemically (Herzog et al., 2009). These data indicate that the activation of the spindle 
assembly checkpoint leads to association of BubR1, Bub3 and Mad2 with APC/C-Cdc20. 
Three dimensional models of human APC/C obtained by single-particle electron 
microscopy in various functional states: bound to a Mitotic Checkpoint Complex (MCC), 
to Cdc20, or to neither (apo-APC/C) revealed that the MCC binding site partially 
overlaps with the Cdc20 binding site on APC/C and suggested that the MCC might 
inhibit the APC/C by repositioning Cdc20 (Figure 2 in Herzog et al., 2009). Association 
of checkpoint proteins with APC/C coincides with inhibition of APC/C ubiquitylation 
activity towards securin and cyclin B, but also towards cyclin A and Nek2A, the early 
prometaphase substrates. My contribution to this study was to show that this inhibition is, 
at least in part, caused by the prevention of substrate binding. For this purpose I 
performed in vitro substrate binding assays which I will describe in this chapter in more 
detail. The publication itself (Herzog F, Primorac I, Dube P, Lenart P, Sander B, 
Mechtler K, Stark H, Peters JM. (2009) Structure of the anaphase-promoting 
complex/cyclosome interacting with a mitotic checkpoint complex. Science. 5920:1477-
81) is in the Appendix of this thesis. 
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Figure 23. Protocols to arrest HeLa cells in a SAC on or SAC off state. To obtain HeLa cells with an 
active checkpoint (SAC-on) the cells were arrested in prometaphase by incubation in DMEM medium 
containing Taxol for 17h 40 min. The SAC arrest was overcome (SAC-off) by addition of Hesperadin 1h 
before harvest. To make sure that he cells do not exit mitosis, the proteasome was inhibited with MG132 40 
minutes prior to Hesperadin addition. To reduce the number of variables that differ between SAC-on and 
SAC-off cells, for the last 1h 40 min before harvesting SAC-on cells proteasome inhibitor MG132 was also 
added.  
 
 
To obtain mitotic extracts in a SAC-on state HeLa cells were arrested in 
prometaphase by stabilizing microtubules with Taxol. The SAC-off state was generated 
by overriding the Taxol arrest in SAC-on HeLa cells with Hesperadin, a small molecule 
inhibitor of Aurora B kinase. The mitotic progression of cells released from the SAC 
arrest was prevented by the addition of the proteasome inhibitor, MG132, which 
prevented degradation of securin and cyclin B and thereby inhibited the onset of 
anaphase. To reduce the number of variables that differ between SAC-on and SAC-off 
cells MG132 was added also to the cells in SAC-on condition (Figure 23). 
 
 
2.4.1 Binding of substrates to APC/C isolated from SAC-on cells is reduced 
 
First I compared N70-2x-GST substrate binding to APC/C isolated from HeLa 
cells with an active (SAC-on) or inactive (SAC-off). Substrates were first bound to 
glutathione sepharose beads by incubation in 70nM and 20nM solution of N70-2x-GST 
wild type (wt) or D-box mutant (dm) in buffer A that contained 4 mg/ml of BSA (see 
Materials and methods) at room temperature for 1 hour on an end-over-end rotator. To 
reduce unspecific binding the beads were pre-incubated in Buffer A that contained 2 
mg/ml BSA prior to substrate binding for 30 minutes at room temperature on an end-
over-end rotator. To remove unbound substrates the beads were washed with buffer A.  
APC/C was immunopurified from mitotic extracts of HeLa cells in which the spindle 
assembly checkpoint was active or inactivated, with α-Cdc27 antibodies coupled to 
Protein A beads. The immunoprecipitated APC/C was eluted off the beads with the 
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Cdc27 antigenic peptide. Glutathione beads bound to N70-2x-GST, wt or dm, were then 
incubated in the 4 bead volumes of APC/C peptide elution for another 1h at room 
temperature with end-over-end rotation. Unbound APC/C was washed off glutathione 
beads with Buffer B (see Materials and methods), and the bound proteins were eluted off 
the beads by boiling in 1.5 bead volumes of 2xSDS PAGE sample buffer that contained 
5mg/ml of BSA. The eluted samples were analyzed by SDS PAGE and Western blotting 
(Figure 24). APC/C-Cdc20, isolated from HeLa cells with SAC-off could bind wild type 
N70-2x-GST, but not the D-box mutant (compare lane5 with 6 and lane 9 with 10), 
confirming that the binding observed is specific. No Mad2 or BubR1 was associated with 
the APC/C from SAC-off cells that was retained on wt N70-2x-GST. APC/C-MCC, 
however, could bind very low levels of wild type N70-2x-GST (lanes 3 and 7).  
 
 
 
A 
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Figure 24.  APC/C binding to the N70-2x-GST is impaired when it is isolated from HeLa cells with an 
active spindle assembly checkpoint. A. Schematic representation of the experimental outline. GSH-seph = 
glutathione sepharose beads. B. Glutathion beads bound to the WT or DM N70-2x-GST substrate were 
incubated in a solution of APC/C-MCC or APC/C-Cdc20 purified from mitotic cells extracts obtained from 
HeLa cells in which the SAC was turned on or off, respectively. Unbound APC/C was washed off and the 
beads were boiled in sample buffer, analyzed by separation on an SDS-PAGE gel followed by Western 
blotting. APC/C was detected with antibodies against Apc2 and MCC was detected with antibodies against 
Mad2 and BubR1. The substrate was detected with antibodies against the GST tag. 
 
 
The reduction in the amount of MCC subunits, Mad2 and BubR1, that co-
immunoprecipitate with APC/C upon checkpoint release is not so dramatic (compare the 
input lanes 1 and 2), yet the difference in binding to the substrates between the APC/C 
molecules isolated from two checkpoint states is quite large (compare lane 3 with 5 and 
lane 7 with 9). The reason for this remains unclear.  
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Next I wanted to see if the observed difference in substrate binding between APC/C 
molecules that were isolated from SAC-on and SAC-off cells, when the APC/C in 
solution was loaded on bead-bound substrates, would be the same if the APC/C was 
anchored to the beads. The procedure outline of this type of experiment is shown in 
Figure 25. 
 
 
 
 
Figure 25. Schematic representation of an in vitro substrate binding experiment in which the APC/C 
bound to beads is exposed to substrates in solution. APC/C was purified from mitotic HeLa extracts with 
α-Cdc27 antibody coupled to Protein A sepharose beads. Bead-bound APC/C was then incubated in a 
solution of substrates, as described in the text. 
 
 
APC/C was immunopurified from mitotic HeLa cells with an active or inactive SAC with 
α-Cdc27 antibodies coupled to Protein A beads. The beads were washed with TBS-T and 
subsequently incubated in 3 bead volumes of Buffer A (Materials and methods) that 
contained different concentrations of recombinant substrates for 1 hour at room 
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temperature with end-over-end rotation. To prevent unspecific binding the substrate 
dilutions in Buffer A also contained 4mg/ml of BSA. The unbound substrates were then 
washed away with Buffer B, and the bound proteins were eluted off the beads in 1.7 bead 
volumes of 0.1M glycine solution pH2.2. I have tested three different recombinant 
substrates in this assay, the fission yeast cyclinB construct N70-2x-GST (Figure 26); 
budding yeast H6-Hsl1667-872 (Figure 27) and human H6-securin (Figure 28). All three 
substrates were expressed and purified from E. coli, as described in Materials and 
methods. When the SAC was inactivated (SAC-off) the amounts of MCC components, 
Mad2 and BubR1, that co-immunoprecipitated with the APC/C were reduced (compare 
Mad2 and BubR1 blots in lanes 3 and 4 in Figure 26; compare lane 3 with lane 4 and lane 
5 with lane 6 in Figure 28). Both in the case of N70-2x-GST and H6-securin binding I 
could observe that the presence of MCC proteins on APC/C is inversely correlated with 
its ability to bind the substrate. In the experiment with N70-2x-GST I have compared the 
ability of APC/C from SAC-n and SAC-off cells to bind to substrates diluted in Buffer A 
to 180nM, 70nM, 20nM and 7nM concentration (Figure 26 A, B, C, D, respectively). 
With as little as 7nM substrate concentration I could detect specific binding of the wild 
type N70-2x-GST, but not of the D-box mutant to APC/C from SAC-off cells (Figure 26, 
lane 4 and 6). APC/C from SAC-on cells could bind neither wild type nor D-box mutant 
N70-2xGST at this concentration. At higher concentrations some unspecific binding 
could be detected, but this was much lower than the specific, wild type, N70-2x-GST 
binding to APC/C from SAC-off cells at any of the four concentrations. 
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Figure 26. Comparison of N70-2x-GST binding to APC/C from SAC-on and SAC-off HeLa cells. 
APC/C was immunopurified from mitotic cell extracts obtained from HeLa cells in which the SAC was 
turned on or off, with α-Cdc27 antibodies coupled to Protein A beads . The APC/C- bound beads were then 
washed in TBS-T and subsequently incubated in a Buffer A solution that contained 180nM wild type (wt) 
N70-2x-GST (A), 70nM N70-2x-GST wild type (wt) or D-box mutant (dm) N70-2x-GST (B), 20nM N70-
2x-GST wild type (wt) or D-box mutant (dm) N70-2x-GST (C) and 7nM N70-2x-GST wild type (wt) or D-
box mutant (dm) N70-2x-GST (D). The unbound substrates were washed off the beads with Buffer B and 
subsequently eluted in 1.7 bead volume of 0.1M glycine solution pH2.2. The eluates were analyzed by SDS 
PAGE and Western blotting. APC/C was detected with antibodies against Apc2, MCC was detected with 
antibodies against Mad2 and BubR1, and the N70-2x-GST was detected with antibodies against the GST 
tag. 
 
 
It was interesting to find that the binding of H6-Hsl1667-872 , a substrate that has a very 
high affinity for the APC/C, is also reduced if the APC/C is isolated from cells with an 
active checkpoint (Figure 27). Even at concentrations as high as 700nM the difference in 
binding of H6-Hsl1667-872 to APC/C from SAC-on and SAC-off cells was about eight-fold 
(compare lanes 2 and 3 in Figure 27). 
Finally I performed the same experiment with human securin. To test securin in 
this assay was important because it is, besides cyclin B, one of the two key mitotic 
APC/C substrates whose degradation is inhibited by the SAC. I used human securin in 
this experiment because it is an “isogenic” substrate of the APC/C used in this assay. The 
results of this experiment are shown in Figure 28. 
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Figure 27. Comparison of H6-Hsl1667-872 binding to APC/C isolated from SAC-on and SAC-off HeLa 
cells. APC/C was immunopurified from mitotic cell extracts obtained from HeLa cells in which the SAC 
was turned on or off , with α-Cdc27 antibodies coupled to Protein A beads. The APC/C- bound beads were 
then washed in TBS-T and subsequently incubated in a Buffer A solution that contained H6-Hsl1667-872 at a 
concentration of 700, 280, 70 or 20nM. The unbound substrates were washed off the beads with Buffer B 
and subsequently eluted in 1.7 bead volume of 0.1M glycine solution pH2.2. The eluates were analyzed by 
SDS PAGE and Western blotting. APC/C was detected with antibodies against Apc2, and the APC/C-
bound H6-Hsl1667-872 with an α-Hsl1 antibody (A). Unspecific binding of H6-Hsl1667-872 to Protein A beads 
was controlled by performing the same assay with IgG-coupled Protein A beads instead of α-Cdc27-
coupled  Protein A beads (B). 
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Figure 28. Comparison of human H6-securin binding to APC/C from SAC-on and SAC-off HeLa 
cells. APC/C was immunopurified from mitotic cell extracts obtained from HeLa cells in which the SAC 
was turned on or off, with α-Cdc27 antibodies coupled to Protein A beads. The APC/C- bound beads were 
then washed in TBS-T and subsequently incubated in a Buffer A solution that contained recombinant N-
terminally 6x Histidine (H6) tagged human securin at concentrations 25nM or 10nM. To prevent unspecific 
binding, the substrate solution also contained 4mg/ml of BSA. The unbound substrate was washed off the 
beads with Buffer B and the bound proteins were eluted with a 0.1M solution of glycine pH 2.2. The 
eluates were analyzed by SDS PAGE and Western blotting. APC/C was detected with antibodies against 
Apc2, the MCC was detected with antibodies against Mad2 and BubR1, and the bound H6-securin was 
detected with α-securin antibodies. 
 
 
 From all the experiments described in this section we could conclude that the 
MCC association with the APC/C prevents its binding to substrates. 
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3. Discussion 
 
3.1 Involvement of apo-APC/C and activators in substrate recognition 
 
3.1.1 Interaction of the WD40 domain of Cdh1 with Hsl1667-872   
 
APC/C activation requires the association of one of two related activator proteins, Cdc20 
and Cdh1. Based on several studies (Hilioti et al, 2001; Schwab et al, 2001; Burton and 
Solomon, 2001; Pfleger et al, 2001) it is thought that the activators have a role in recruiting the 
substrates to the APC/C, analogously to the substrate adaptors of the SCF complexes. Mutational 
analysis by Burton et al, (2005) and cross-linking experiments by Kraft et al, (2005), suggest that 
the WD40 domain of activator proteins is involved in substrate recognition. I could show that the 
WD40 domain of Cdh1 is sufficient to bind a D box and KEN box containing fragment of Hsl1 
protein (amino acids 667-872) when co-expressed in insect cells and in budding yeast, and that 
this binding is dependent on the D and the KEN box in Hsl1667-872. I have aimed to co-express 
and purify a stoichiometric complex of the WD40 propeller region of Cdh1 and a fragment of 
Hsl1 encompassing the degrons D and KEN box, in budding yeast Saccharomyces cerevisiae, for 
the analysis of their interaction by X-ray crystallography. I did not pursue this project further for 
several reasons. The yield of the stoichiometric complex was very low. It is known that the 
folding of APC/C activator proteins depends on the CCT chaperonin complex (Camasses et al., 
2003), therefore it is possible that the cell cannot process all the over-expressed Cdh1 proteins 
with its chaperone arsenal. Another problem was that the stoichiometry upon co-expression of 
Cdh1WD40 and Hsl1667-872was unpredictable. This was probably due to the fact that the proteins 
were expressed from two separate plasmids. Cloning the two constructs in one expression 
plasmid would make more sense, or, were the protein levels higher, a second step of re-
immunopurification of the complex could be introduced in the purification procedure. The Hsl1 
fragment I have been using was prone to degradation which introduced heterogeneity to the 
purified sample. Deleting regions surrounding the D and KEN box resulted in reduced binding to 
the WD40 propeller. Deletions with a single amino-acid residue resolution might be necessary to 
find the right length of the Hsl1 fragment that still binds to the WD40 propeller of Cdh1 with 
high affinity, but that is not degraded. It might be worth trying to obtain this same complex, or a 
 discussion  
76 
 
WD40 region of Cdh1 in complex with other substrates, in Sf9 cells. I have used an Hsl1 
fragment as a substrate for this purpose because it binds to activator proteins with unusually high 
affinity, but conditions could be optimized for co-purification of the WD40 region of Cdh1 with 
substrates with lower affinity.  A serendipitous discovery opened a new window of opportunity 
for Cdh1 over-expression in Sf9 cells, namely, tagging this protein with a 3xmyc tag yielded 
about ten-fold more protein that can be purified (Georg Petzold, personal communication). I 
have compared this myc-tagged Cdh1 with an old preparation of 6xHis-tagged Cdh1 in an in 
vitro ubiquitylation assay, and could find that the activity these two versions of Cdh1 can provide 
to the APC/C was comparable. This excluded the possibility that the tag folded back onto the 
substrate-binding interface of Cdh1 and thereby stabilized it. Another problem with expressing 
and purifying APC/C activators is the fact that they are prone to aggregation, therefore the 
purification procedure should be kept as short as possible. I have been succesfully avoiding the 
aggregation of Cdh1 when, instead of dialyzing the protein after the imidazole elution, I 
exchanged the buffer by using a desalting column (NAP-5 column, GE Healthcare) 
 
 
3.1.2 Attempts to purify apo-APC/C 
 
Several findings suggest that, in addition to Cdc20 and Cdh1, the apo-APC/C also 
contributes to substrate binding. A peptide containing tandem copies of the D box is able to pull 
down apo-APC/C that is largely free of Cdc20 or Cdh1 from Xenopus egg extracts (Yamano et 
al., 2004). Yeast Doc1 is required for D box-dependent substrate processivity of APC/C in an in 
vitro ubiquitination assay suggesting that Doc1 plays a rather direct role in the recognition of the 
D box (Carroll et al., 2005). Native-gel binding assays and ‘‘isotope trapping’’ have 
demonstrated that the complex between APC/C and Cdc20 binds to substrates with higher 
affinity than either APC/C largely free of activators or Cdc20 alone (Passmore and Barford, 
2005; Eytan et al., 2006). The presence of substrates stimulates co-activator binding to the 
APC/C (Burton et al., 2005; Matyskiela and Morgan, 2009). I have made an attempt to purify 
apo-APC/C using several methods, but the APC/C I could purify always contained detectable 
amounts of activator proteins. Depletion of mitotic extracts of Cdc20 with an antibody raised 
against a peptide could remove almost all Cdc20 from the extract, as detected by Western blot, 
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however the APC/C purified from these Cdc20-depleted extracts, even after 3 rounds of extract 
depletions before APC/C immunoprecipitation, was still bound to detectable amounts of Cdc20. 
The α-Cdc20 antibody I have used in these depletion experiments was raised against a peptide 
(RWQRKAKEAAGPAPSPMRAANR, kpep 450), located in the amino terminal, low 
complexity region of Cdc20. It is interesting that this peptide encompasses a serine residue, S41, 
which has been shown to be one of six residues in Cdc20 that are phosphorylated by Bub1 in 
human cells and whose phosphorylation is required for the spindle assembly checkpoint function 
(Tang et al., 2004). It could be that the phosphorylation of this residue masked the epitope which 
α-Cdc20 recognizes and thereby prevented depletion of this pool of Cdc20.  This serine was 
however not found to be phosphorylated in the study by Kraft et al., 2003. In this study the 
phosphorylation state of Cdc20 which is bound to the APC/C in mitosis was analyzed. Analysis 
of Cdc20 phosphorylation under spindle assembly checkpoint conditions in Xenopus egg extracts 
showed that phosphorylation of Cdc20 in its amino-terminus is facilitates Mad2 and BubR1 
binding (Chung and Chen, 2003). If one of residues found in this study corresponds to Ser41 in 
human Cdc20 is not clear. 
 
 
3.2 Dephosphorylation of APC/C is not sufficient to cause dissociation of Cdc20 
 
The activity of APC/C is regulated by reversible phosphorylation (Lahav-Baratz et al., 1995, 
Peters et al., 1996, Kotani et al., 1998) Although the precise role of mitotic APC/C 
phosphorylation is poorly understood, there are indications that it affects Cdc20 binding (Kramer 
et al, 2000, Rudner and Murray, 2000). Cdc20 binds preferentially to mitotically phosphorylated 
APC/C (Kramer et al., 1998; Kramer et al., 2000). APC/C phosphorylation by Cdk1, or Cdk1 
and Plk1 combined, increased its ability to bind Cdc20 in vitro and correlated with 4-fold and 6-
fold increase in APC/C activity, respectively. The increase in activity was due to Cdc20 binding 
(Kraft et al., 2003). It was found that the most heavily phosphorylated subunits of the APC/C are 
the TPR subunits, and it may be that this phosphorylation directly regulates the association of the 
IR tail of Cdc20 and APC/C’s TPR subunits (Vodermaier et al., 2003, Kraft et al., 2003). From 
all these studies it seems likely that the mitotic phosphorylation of APC/C stimulates Cdc20 
binding, however if dephosphorylation of APC/C causes Cdc20 dissociation was never tested. I 
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tested this by dephosphorylating immunopurified APC/C, as well as by dephosphorylating 
APC/C in mitotic HeLa extracts, with lambda phosphatase. The efficiency of dephosphorylation 
was confirmed by increased mobility of Cdc27 subunit, however, no reduction in the levels of 
Cdc20 bound to the APC/C could be observed. Therefore it seems that dephosphorylation of 
APC/C is not sufficient to cause dissociation of Cdc20. Studies of APC/C isolated from Xenopus 
egg extracts revealed that the a interphase APC/C contained 2.5-fold less Cdc20 compared to 
mitotic APC/C, however substantial amounts of Cdc20 were bound to the interphase APC/C, 
although it was dephosphorylated, as confirmed by shift in gel mobility of Apc1, 3, 6 and 8, but 
also of Cdc20 mobility shift (Yamano et al., 2004). This interphase APC/C could not bind to 
cyclin B, and it could not stimulate cyclin B destruction in extracts, therefore it seems that it is 
sufficient to dephosphorylate APC/C-Cdc20 in interphase, at least in Xenopus egg extracts, to 
inactivate it, and that dissociation of Cdc20 is not necessary. Cdc20 is an APC/C-Cdh1 substrate, 
and Xenopus egg extracts contain no Cdh1. It could be that the removal of Cdc20 from APC/C 
requires its ubiquitylation, and possibly also degradation, mediated by APC/C-Cdh1. It would be 
interesting to follow up this question.  There are several reports that show that it is possible to 
activate Xenopus interphase APC/C with purified recombinant Cdc20 in vitro (Fang et al., 2002; 
Tang et al., 2004), and that it is possible to bind purified recombinant Cdc20 to human interphase 
APC/C (Georg Petzold, personal communication). Whether the bound Cdc20 in the latter case is 
also able to activate APC/C in an in vitro ubiquitylation assay should be tested. 
 
 
3.3 The role of the C box 
 
The C box was shown to be essential for the function of budding yeast Cdh1 and to be 
required for its association with the APC/C (Schwab et al., 2001). In another study of the C box 
in yeast Cdh1 only a mild defect in APC/C stimulation by the mutant Cdh1 was reported 
(Thornton et al., 2006). Binding of human recombinant Cdh1 was significantly, but not 
completely, reduced if the C box was mutated. However, this mutant of Cdh1 was completely 
unable to activate APC/C (Vodermaier et al., 2003). It remained therefore unclear if the only 
function of the C box was to bind the activator to the APC/C or if it has other functions. Recently 
it has been found that the N terminal part of Cdh1 bearing the C box was sufficient to activate 
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the Xenopus APC/C in an ubiquitylation reaction if the substrate is recruited to it in an activator 
independent manner (Kimata et al., 2008). Insight into the role of the C-box of APC/C activators 
was provided by studies of Nek2A, an extraordinary APC/C substrate. Nek2A does not require 
the substrate-recruiting function of Cdc20, it is recruited independently by its own MR tail. 
However, Cdc20 is still required for Nek2A ubiquitylation. (Hames et al., 2001). Kimata et al, 
(2008) took advantage of this property of Nek2A and have shown that a fragment of 159 amino 
terminal residues of Xenopus Cdc20 (GST-N159 Fizzy) as well as 186 amino terminal residues 
of Cdh1 (GST-N186 Fzr1) could stimulate Nek2A degradation in Xenopus egg extracts, and that 
this stimulation was C-box dependent. Fusing Mes1, a fission yeast APC/C pseudosubstrate that 
contains a D and a KEN box, to the amino terminal 159 amino acids of Fizzy could stimulate 
Mes1 ubiquitylation. This was however, not dependent on the degron motifs in Mes1. How the 
C-box-containing fragment of activator proteins stimulates the ubiquitylation by the APC/C 
remains unclear. 
 All the mentioned reports are of qualitative nature and we decided to study the effect of 
the C-box mutation in Cdh1 in a more quantitative manner, using purified components, which 
might allow a clearer view at the role of the C-box in mechanistic terms. I could show that the 
binding of Cdh1 with a mutated C-box was reduced 10-fold compared to the wild type Cdh1. 
Wild type levels of the C-box mutant (Cm) Cdh1 could be restored by increasing the 
concentration of C-box mutant Cdh1 that was incubated with the APC/C to 10-fold of the 
concentration of the wild type Cdh1. Restoring wild type levels of Cdh1 Cm, however did not 
restore the wild type activation of the APC/C in an in vitro ubiquitylation assay. The defect in 
APC/C activation could arise from defective substrate recruitment to the APC/C or from 
defective catalytic activation of APC/C towards a properly recruited substrate. I could show that 
the substrate binding to APC/C loaded with C-box mutant Cdh1 was impaired. This defect in 
substrate binding I could not compensate for by increasing the substrate concentration. However, 
co-expression experiments of Cdh1 wt or Cm with Hsl1667-872 showed that the C-box mutation 
has no effect on Hsl1667-872 binding.  
My explanation of the listed results is based on a hypothesis that Cdh1 interaction with 
the APC/C via two motifs, the IR tail and C-box, closes or distorts the conformation of APC/C in 
a way that exposes its substrate-binding surface, that can either “take over” the Cdh1-recruited 
substrate or hold it together with Cdh1 in the proximity of ubiquitin-charged E2.  The following 
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findings support this hypothesis: The flexibility of apo-APC/C is reduced upon Cdh1 binding 
(Dube et al., 2005); the IR tail was shown to bind to Cdc27 on APC/C (Vodermaier et al., 2003, 
Passmore and Barford, 2003; Thornton et al., 2006, Matyskiela and Morgan, 2009); and the 
binding of the substrate adaptor, Cdh1, is affected upon Apc2 deletion, indicating that Cdh1 
interacts closely with the catalytic core (Thornton et al., 2006). The latter proposal could not be 
supported by crosslinking experiments with human Cdh1 and APC/C. Bi-functional crosslinkers 
always crosslinked Cdh1 to Cdc27 and no other APC/C subunit. Site-specific crosslinking 
experiments also showed that if the crosslinker amino-acid is located near the C-box in Cdh1, the 
captured APC/C subunit is Cdc27 (Kraft et al., 2005). It might be worthwhile repeating these 
crosslinking experiments using a C-box containing fragment of Cdh1, or testing this finding by a 
different approach. For example, since positions of the two candidate subunits, Apc2 and Cdc27, 
in a 3D model of APC/C are mapped (Herzog et al., 2009) and since the location of a subunit can 
also be mapped by tagging it with a bulky tag (Bettina Buschhorn, unpublished data), a C-box 
fragment fused to a bulky tag could be loaded onto the APC/C and analyzed by cryo-EM. If the 
resolution of the resulting model would be high enough it might be possible to determine which 
APC/C subunit the tag points to. In an attempt to pull down APC/C with a 116 amino-acid long 
C-box containing fragment of Cdh1 I have failed to detect any APC/C binding to this fragment. 
Although the C-box starts at amino-acid 46, it could be that the fragment has to be longer to 
efficiently pull down APC/C. It might be worth repeating this experiment with a longer C-box 
containing Cdh1 fragment, using, interphase and mitotic, Xenopus egg and HeLa cell extracts. It 
would also be interesting to see if the flexibility of APC/C is reduced upon Cdh1 binding when 
its C-box is mutated, as it could be observed with the wild type Cdh1 (Dube et al., 2005).  
 
 
3.4 How does the SAC affect substrate recognition by the APC/C? 
 
An important contribution to understanding how the MCC inhibits the APC/C was the 
structural and biochemical comparison of APC/C species isolated from mitotic HeLa cells in 
which the spindle assembly checkpoint was active (SAC-on) or switched off (SAC-off) (Herzog 
et al., 2009). These data indicate that the activation of the spindle assembly checkpoint leads to 
association of BubR1, Bub3 and Mad2 with APC/C-Cdc20. Three dimensional models of human 
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APC/C obtained by single-particle electron microscopy in various functional states: bound to a 
Mitotic Checkpoint Complex (MCC), to Cdc20, or to neither (apo-APC/C) revealed that the 
MCC binding site partially overlaps with the Cdc20 binding site on APC/C and suggested that 
the MCC might inhibit the APC/C by repositioning Cdc20 (Figure 2 in Herzog et al., 2009). 
When we compared the ability of APC/C isolated from SAC-on and SAC-off cells to bind 
substrates we found that the binding of a variety of substrates to the APC/C upon SAC activation 
is also reduced.  Association of checkpoint proteins with APC/C coincides with inhibition of 
APC/C ubiquitylation activity towards securin and cyclin B, but also towards cyclin A and 
Nek2A, the early prometaphase substrates, in vitro.  
 
 In vivo the spindle assembly checkpoint (SAC) delays degradation of cyclin B and 
securin until all the chromosomes are properly attached, however this does not seem to affect 
cyclin A and Nek2A degradation which starts already in prometaphase (Geley et al., 2001; den 
Elzen and Pines, 2001; Hames et al.,2001). Nek2A has been shown to be recruited to the APC/C 
in a Cdc20-independent manner via its C terminal MR tail, which resembles the TPR-binding 
motif found in APC/C activators and Doc1, the IR tail (Hayes, et al., 2006). This activator-
independent recruitment of Nek2A to the APC/C might overcome the SAC-mediated inhibition 
of APC/C-Cdc20. There are several scenarios that describe how this might be possible, and I will 
come back to this below. What has been puzzling many of those studying the APC/C and its 
regulation by the SAC, is how is it that cyclin A, but not cyclin B, avoids the inhibition of 
APC/C by the MCC and gets degraded in spindle assembly checkpoint arrested cells.  It is not 
known if the degenerate D-box in cyclin A has any role in this, therefore it would be interesting 
to see if cyclin B in which the D-box is replaced by the “extended D-box” characteristic of cyclin 
A could be degraded under SAC-n conditions in the cell. It has been proposed that degradation 
of cyclin A requires Cdk binding, as a mutation that abolishes Cdk binding stabilizes cyclinA 
(Stewart et al., 1994, Geley et al., 2001). Purified recombinant I125-labeled cyclin A alone cannot 
be ubiquitylated in vitro (my observation, not presented in the thesis) contributes to the evidence 
for this mechanism. I have, however, never tested if placing cyclin A into a cyclinA/Cdk/Cks1 
complex would facilitate ubiquitylation of cyclin A in vitro. It has been proposed that Cks1-
mediated recruitment of cyclin A to the APC/C in prometaphase is the mechanism by which 
cyclin A avoids D-box-mediated binding to the APC/C, and thereby circumvents the SAC 
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(Wolthuis et al., 2008).  The proposed mechanism, however, immediately imposes the next 
question. How is it then that cyclin B, although potentially recruited to the APC/C by the same 
mechanism, is not ubiquitylated as cyclin A is? Since both cyclin A and cyclin B share the 
Cks1/p9 subunit as a binding partner, they should both be recruited to the APC/C Cks1-
dependent manner, however, it is not clear what makes the difference between these two cyclins 
that renders one prone to APC/C mediated ubiquitylation and the other not.  Both cyclin A and 
cyclin B associate with Cdk and Cks1 to be able to perform their kinase function, and the 
observed binding to the APC/C could simply be because APC/C is a Cdk1 substrate (Patra and 
Dunphy, 1998; Rudner and Murray, 2000). It has been elegantly shown that the Xenopus Cks1 
homolog, p9, is not required for cyclin B degradation once the APC/C is phosphorylated and 
thereby activated (Patra and Dunphy, 1998). Following cyclin A degradation in the same 
experimental setting might answer the question if p9 is required for its degradation.  
 
The above mentioned model of cyclin A recruitment and ubiquitylation by the APC/C 
also further implies that the MCC binding to the APC/C does not influence the catalytic activity 
of the enzyme. This contrasts our observation that APC/C-MCC shows reduced overall 
ubiquitylation activity, not only towards cyclin B and securin, but also cyclin A and Nek2A 
(Herzog et al., 2009, Figure S2). Prometaphase substrates might be ubiquitylated by the APC/C 
before the SAC becomes fully active. Although recruited to the APC/C Cdc20- independently, 
both Nek2A and cyclin A still need Cdc20 for their ubiquitylation (Hames et al., 2001; Geley et 
al., 2001). Based on this one could imagine that the prometaphase substrates are recruited to the 
APC/C before the SAC becomes fully active and before the MCC is assembled on the APC/C; 
and that substrates that are already recruited to the APC/C are refractory to inhibitory factors and 
will proceed with the ubiquitylation process. In line with this hypothesis is the observation that 
neither Mad2 nor BubR1 inhibit the ubiquitin ligase activity of pre-formed Cdc20-APC/C, and 
that Mad2 and BubR1 have an inhibitory effect on Cdc20-APC/C only if Cdc20 is pre-incubated 
with these proteins, and then bound to the APC/C (Fang, 2002, figure 2D). Could it be that all 
the cyclin A molecules are already bound to the APC/C-Cdc20 as a substrate when the fully 
active MCC starts to be assembled? One could further speculate that cyclin A in these pre-
assembled complexes with APC/C-Cdc20 “reserves” Cdc20 for its ubiquitylation, and once the 
ubiquitylation is over, and this trimeric complex disassembles, cyclin A is sent for degradation to 
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the proteasome and free Cdc20 can be captured by the SAC signalling into the MCC.  In line 
with this idea is the fact that BubR1, the pseudosubstrate that blocks the substrate-binding 
surface on APC/C-Cdc20 (Burton and Solomon, 2007) stays cytoplasmic until the nuclear 
envelope breakdown (Björn Hegemann, personal communication), and also with the fact that 
cyclin A is predominantly nuclear from S phase onwards (Pines and Hunter, 1991), which gives 
cyclin A time to bind APC/C-Cdc20. If this is early enough to allow cyclin A binding of Cdc20 
before Mad2 captures Cdc20 remains an open question. The observation that cyclin A associates 
with Cdc20 in G2 and early M phase and that this complex is devoid of Mad2 feeds this 
speculation (Wolthuis et al, 2009, Figure 3).  
There are several ways one could test if cyclin A prometaphase, SAC-independent, 
degradation depends on its pre-binding to APC/C-Cdc20. Cells could be arrested in mitosis and,  
before cyclin A degradation starts,  proteasomal degradation could be inhibited for a short period 
of time by MG132, thereby creating a window during which cyclin A could be ubiquitylated 
(and deubiquitylated once it is released from APC/C), the MCC could fully assemble, and only 
then release the proteasome from inhibition, but leave it in SAC-on condition, and look if cyclin 
A degradation is inhibited as that of cyclin B. This experiment is based on an assumption that, if 
there is a pre-assembled cyclin A APC/C-Cdc20 complex, it disassembles during the proteasome 
inhibition period, with a ubiquitin chain, which is subsequently removed by deubiquitinating 
enzymes without being degraded by the proteasome. Another, possibly more straightforward and 
based on less assumptions, way would be to arrest cells in mitosis, allow the APC/C-MCC to 
fully assemble, and only then add exogenous cyclin A and cyclin B and compare the kinetics of 
their degradation. To avoid the difficulty of injection of proteins or mRNAs into rounded up, 
mitotic cells, an inducible plasmid-based system to express these proteins in the cell could be 
used. 
In our in vitro experiments where we compared the APC/C from SAC-on and SAC-off 
HeLa cells in ubiquitylation assays or substrate binding assays, the APC/C isolated from these 
cells was already fully bound to the MCC. This “final” form of APC/C-MCC did not 
discriminate between IVT generated substrates in a in vitro ubiquitylation assay, the APC/C 
isolated from cells with an active SAC did show reduced ubiquitylation activity towards cyclin A 
and Nek2A, as it did towards cyclin B and securin, compared to the APC/C isolated from cells 
with an inactive SAC (Herzog et al., 2009). This implies that the MCC binding has a negative 
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impact on overall activity of the APC/C. It has been observed that upon MCC binding the 
flexibility of APC/C is reduced (Herzog et al., 2009), this rigid state could also contribute to 
inactivity of APC/C-MCC. We could also show that the ability of APC/C to bind a variety of 
substrates is reduced in SAC-on conditions. This can be at least partially explained by BubR1-
mediated blocking of Cdc20 substrate-recognition surface (Burton and Solomon, 2007; 
Malureanu et al., 2009). The substrates we tested were substrates whose destruction is prevented 
by the SAC. The next obvious question is if the binding of Nek2A and cyclin A to APC/C 
isolated from SAC-on cells is reduced compared to their binding to APC/C from SAC-off cells. 
To answer this question I am going to use recombinant Nek2A expressed and purified from E. 
coli. Answering the same question with cyclin A will be somewhat complicated by the fact that a 
Cdk/Cks1/cyclin A complex might be necessary to be used as a substrate.  
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4. Material and methods 
 
4.1 Material 
4.1.1 cDNA constructs 
Site directed mutagenesis was performed using QuikChange® Site-Directed Mutagenesis Kit. 
cDNA species tag vector 
Hsl1 (aa667-882) S.cerevisiae N‘ Protein A pRS-424-GAL1-10 (trp) 
Hsl1 (aa667-882) S.cerevisiae N‘ Protein A pM346-GAL-PGK (leu) 
Cdh1  S.c N‘ flag pRS-426-GAL1-10 (ura) 
Cdh1 (aa164-567) S.c N‘ flag pRS-426-GAL1-10 (ura) 
Cdh1 (aa195-567) S.c N‘ flag pRS-426-GAL1-10 (ura) 
Cdh1 (aa227-567) S.c N‘ flag pRS-426-GAL1-10 (ura) 
Nek2A Homo sapiens N‘ his6 pME33 
N70-2x wt-wt S. pombe C‘ GST pET16 
N70-2x wt-dm S. pombe C‘ GST pET16 
N70-2x dm-wt S. pombe C‘ GST pET16 
N70-2x dm-dm S. pombe C‘ GST pET16 
N70-1x wt S. pombe C‘ GST pET16 
N70-1x dm S. pombe C‘ GST pET16 
Hsl1 (aa667-882) wt S.cerevisiae N‘ GST pGEX-TEV 
Hsl1 (aa667-882) dm S.cerevisiae N‘ GST pGEX-TEV 
Hsl1 (aa667-882) km S.cerevisiae N‘ GST pGEX-TEV 
Hsl1 (aa667-882) dm km S.cerevisiae N‘ GST pGEX-TEV 
Nek2A KD H. sapiens N‘ his6 pET16 
Nek2A KD H. sapiens N’ GST pGEX-TEV 
Securin (aa1-172) H. sapiens C‘ his pET16 
Securin (aa1-172) H. sapiens C‘ GST pET16 
 
H.s. cyclin B1, 1-87, -myc-his6 in pTrcHis2A was generated by Michael Gmachl. 
N70-2x-GST wt-wt and dm-dm were a gift from Hiroyuki Yamano. 
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4.1.2 Baculoviruses 
Baculoviruses are generated using the BAC-to-BAC expression system (Invitrogen, Carlsbad 
California, USA). 
cDNA species tag vector 
Cdh1 wt H.sapiens N‘ HA3-his6 pFastBAC1 
Cdh1 wt H.sapiens N‘ myc3-his6 pFastBAC1 
Cdh1 C box mutant H.sapiens N‘ HA3-his6 pFastBAC1 
Cdh1 C box mutant H.sapiens N‘ myc3-his6 pFastBAC1 
Hsl1 (aa667-882) wt S.cerevisiae No tag pFastBAC1 
Hsl1 (aa667-882) dm S.cerevisiae No tag pFastBAC1 
Hsl1 (aa667-882) km S.cerevisiae No tag pFastBAC1 
Hsl1 (aa667-882) dm km S.cerevisiae No tag pFastBAC1 
 
H.s. his6-HA- Cdh1 wt and Cm were generated by Hartmut Vodermaier. 
H.s. his6-HA-Cdc20 was generated by Edgar Kramer. 
 
 
4.1.3 Antibodies 
 
Antibodies raised against Apc2, Cdc27, Apc4, Cdh1 and Cdc20 have been described (Kramer et 
al., 1998; Gieffers et al., 1999; Kramer et al., 2000; Gieffers et al., 2001; Vodermaier et al., 
2003).  
Antibodies against BubR1, Mad2 and Bub3 were generated by Gregor Kohlmaier and Franz 
Herzog. 
 
protein „name“ species Produced in working dilution 
BubR1 1676 H.s. rabbit 1µg/ml 
Mad2 283/2 H.s. rabbit 1µg/ml 
Bub3 0525 H.s. rabbit 1:500 (serum) 
Cdh1 452 H.s rabbit 1µg/ml 
Cdh1 Sat106 H.s. rabbit 1µg/ml 
Cdc20 450/2 H.s. rabbit 1µg/ml 
Apc2 APC2-30 H.s. Mouse (monoclonal) 1:100 (supernatant) 
Cdc27 03338 H.s. rabbit 1µg/ml 
Apc4 761 H.s. rabbit 1µg/ml 
Hsl1 1113 S.c. rabbit 1µg/ml 
Hsl1 1114 S.c. rabbit 1µg/ml 
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Commercial antibodies: 
antigen supplier species Working dilution 
GST Amersham Biosciences goat 1:500 
Flag Sigma-Aldrich mouse 1:1000 
 
 
4.2 Methods 
 
4.2.1 HeLa cell culture 
 
4.2.1.1 Cultivation of HeLa cells 
 
Adherent HeLa cells were typically grown in 245x245cm tissue culture dishes and 37°C in the 
presence of 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% 
(v/v) fetal bovine serum (PAA Laboratories GmbH, Pasching Austria), 0.3µg/ml L-glutamine 
(Sigma-Aldrich), 100 units/ml penicillin (Sigma-Aldrich) and 100µg/ml streptomycin (Sigma-
Aldrich). 
 
 
4.2.1.2 Mitotic arrest of HeLa cells 
 
To arrest cells in mitosis by activating the spindle assembly checkpoint (SAC-on), we treated 
logarithmically proliferating cells at 70% confluency with 10µM taxol (Paclitaxel, Sigma-
Aldrich, St.Louis, MO) for 16h. Taxol stabilized microtubules and thereby prevented tension 
establishment between kinetochore sisters which activated the SAC and arrested cells in 
prometaphase-like state.  
To synchronize cells in a mitotic state in which the SAC is inactivated (SAC-off), the Taxol 
arrested cells were treated with 100nM Hesperadin for 60 minutes (Boeringer Ingelheim, Vienna, 
Austria) to override the checkpoint. Hesperadin is a small molecule inhibitor of Aurora B kinase 
which corrects improper microtubule-kinetochore attachments and is therefore essential for SAC 
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signaling. To prevent cells exiting mitosis, 40 minutes prior to Hesperadin treatment the cells 
were treated with 10µM of proteasome inhibitor MG132 (Sigma-Aldrich). By inhibiting the 
proteasome MG132 prevents securin and cyclin B1 degradation and thereby prevents the 
anaphase onset and renders cells arrested in metaphase. To compare the two mitotic populations 
(SAC-on and SAC-off) that differed in only one variable the SAC-ON cells were also treated 
with 10µM MG132 100 minutes before harvesting. 
 
 
4.2.1.3 Synchronization of HeLa ells by double thymidine arrest-release 
 
HeLa Kyoto cells that were 90% confluent were split 1:10 into DMEM medium (10% FBS, 
0.3µg/ml L-glutamine, 100 units/ml penicillin) containing 0.2mM Thymidine (Sigma T1895). 
Cells were incubated in thymidine under standard conditions for 24 hours when they were 
washed twice with prewarmed (37°C) PBS and relased into fresh DMEM medium (10% FBS, 
0.3µg/ml L-glutamine, 100 units/ml penicillin) for 8 hours. The second thymidine arrest in 2mM 
thymidine was 16 hours long after which the cells were again released into fresh DMEM (10% 
FBS, 0.3µg/ml L-glutamine, 100 units/ml penicillin) after two washes in PBS. G2 cells were 
harvested 4 hours after the second thymidine release.  
 
 
4.2.2. Recombinant protein expression 
 
4.2.2.1 Yeast transformation 
 
0.5ml of overnight culture of wt (700) yeast strain was diluted into 50 ml YEP-glucose medium, 
to obtain an OD600=0.2 and was subsequently incubated in a shaker at 30°C until the colony 
reaches OD600=0.8 (maximum 1). The cells are spun at 3500 rpm in for 5 minutes at room 
temperature. 
The cells were the washed in 1 ml 1M LiAc and re-suspended in 350μl of 1M LiAc. 30 μl of this 
cell suspension was then mixed with 1μl of miniprep DNA (100 ng/ μl), 10 μl (10 mg/ml) of pre-
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heated salmon sperm DNA and 112.5 μl 50% PEG 3350 and subsequently incubated in a 
thermomixer (Eppendorf, Hamburg, Germany) at 1200rpm for 30 minutes at room temperature. 
After this 15 μl of 60% glycerol was added and continued shaking for another 30 minutes 
shaking at room temperature. After this second incubation the cells were heat-shocked for 10 
minutes in a waterbath at 42°C. As the transformed plasmids (pRS-424 (-trp) and pRS-426 (-
ura), a gift from Prakash Arumugam, Nasmyth lab) contained auxotrophy markers, 300 μl of 
H20 were added to cells after the heatshock, of which 125μl were plated onto selective plates 
using glass beads. The cells were grown on selective plates at 30°C. 
 
 
4.2.2.2 Recombinant protein expression in S. cerevisiae 
 
50 ml of appropriate selective minimal medium (-ura, -trp and –leu media were prepared by the 
IMP media kitchen) containing 2% raffinose was inoculated from a single colony from the 
selective plate. The culture was grown over night at 30°C shaking. 
the over-night culture was diluted the next day to OD600 = 0.2 in the same medium and the 
culture was grown at 30°C until OD600 = 0.6  when protein expression was induced by adding 
galactose to the culture  to final concentration of 2%. The cells were further grown in the shaking 
incubator 30°C for 4-5 hours, and harvested by centrifugation at 1500g for 5 minutes at 4°C. The 
cell pellet was washed in 3 pellet volumes of ice cold water twice and frozen in liquid nitrogen. 
 
 
4.2.2.3 Recombinant protein expression in E.coli 
 
N702x-GST, N701x-GST, GST-Hsl1 (aa667-872), H6-securin, Cyclin B- myc-his(1-87aa)  
N702x-GST is a tandem repeat of 70 N-terminal amino acid residues of fission yeast cyclin B, 
Cdc13, fused with a C-terminal GST (glutathione-S-transferase) tag. N70-1x-GST is a single 
repeat of the 70 N-terminal amino acid residues of fission yeast Cdc13 fused with a C-terminal 
GST (glutathione-S-transferase) tag. GST-Hsl1 (aa667-872) is a fragment of budding yeast 
protein Hsl1 described previously (Burton and Solomon, 2001), fused N-terminally with a GST 
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(glutathione-S-transferase) tag.  Cyclin B- myc-his(1-87aa) is the N-terminal 87 residues of 
human cyclinB1. The constructs were expressed and purified from  E.coli BL21(DE3) strain. An 
overnight starter culture was diluted into two liters of LB medium to OD600=0.1. The culture 
was grown at 37°C until OD600=0.6 when the expression of recombinant proteins was induced 
with 1mM IPTG (isopropyl-1-thio-β-D-galactopyranoside). Proteins were expressed at 37°C for 
2h. 
 
H6-Nek2A KD, GST-Nek2A KD, securin(1-172) 
H6-Nek2A KD is a kinase-deficient mutant of human Nek2A generated by mutating a single 
amino acid residue in the kinase domain, D141A, by site directed mutagenesis system 
(Invitrogen). The construct was expressed and purified from BL21 E.coli strain. An overnight 
starter culture was diluted into two liters of LB medium to OD600=0.1. The culture was grown at 
37°C until OD600=0.6 and then transferred to 18°C .The expression of recombinant proteins was 
induced with 1mM IPTG. Proteins were expressed at 18°C for 4h. 
 
 
4.2.2.4 Recombinant protein expression in Sf9 cells 
 
Sf9 cells were grown in Grace’s medium supplemented with 10% (v/v) of Fetal Bovine Serum 
(FBS Gold, PAA Laboratories) 0.3µg/ml L-glutamine, 100 units/ml penicillin at 27°C.  A 
confluent culture was split 1:5 into T175 flask (Nunc). The next day the 50% confluent culture 
was infected with 1ml of p4 baculovirus stock. This method was later modified, and different 
volumes (200-800µl) of  BV p3 stock were used for infection instead. Proteins were expressed 
for 42-48h by growing the cultures at 27°C. The cells were harvested by tapping the flasks and 
washing off remaining cells with PBS. The cells were spun down at 500g in 50ml Falcon tubes 
and pellets were never frozen before purification. 
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4.2.3. Protein purification 
 
4.2.3.1 Coupling antibodies to beads  
 
The antibodies were bound and crosslinked to Affiprep protein A beads (BioRad). One volume 
protein A beads is washed twice with 10 volumes of TBS-T (20 mM Tris-HCl pH 7.5, 150 mM 
NaCl, 0.05% Tween-20). Beads are resuspended in 10 volumes TBS-T, and affinity purified 
Cdc27 antibodies are added in a ratio of 1.5 mg antibody per 1 ml of beads Beads are then 
incubated on an over-end rotator for 1 hour at room temperature. After three washes with TBS-T 
and two washes with 0.2 M sodiumborate solution (titrated to pH 9 with HCl), the beads are 
resuspended in 20 volumes of 0.2 M sodiumborate solution (pH 9) and, while mixing, solid 
dimethylpimelimidate (Sigma-Aldrich) is added to a final concentration of 20 mM. The mixture 
is rotated at room temperature for 30 minutes. The cross-linking reaction is stopped by washing 
the beads twice with 20 volumes of a buffer containing 150 mM NaCl and 200 mM Tris-HCl, pH 
7.5, by incubating the beads each time for 10 minutes on a end-over-end rotator. The antibody-
coupled beads are then washed twice with TBS-T and stored in TBS-T containing 0.05% NaN3 
at 4 °C. 
 
 
4.2.3.2 Purification of human APC/C form HeLa cells 
 
HeLa cells pellets were thawn on ice and resuspended in 0.3 pellet volume lysis buffer (20mM 
Tris pH7.5, 150mM NaCl, 5 % glycerol, 2 mM EDTA, 0.05 % Tween 20) containing protease 
inhibitors (0.1 M PMSF, 20 μg/ml each aprotinin, pepstatin, and leupeptin) and phosphatase 
inhibitors (4μg/ml okadaic acid (Alexis), NaF 20 mM, 20 mM  beta-glyerophoshate, 10 mM Na-
pyrophosphate, 1 mM Na-Vanadate). The cell suspension was passed several times through 
syringe needles (1-2 x 0.8 mm and 4-5 x 0.4 mm in diameter) and the extract was cleared by 
centrifugation (13000 rpm, 30 minutes, 4°C). APC was isolated with antibodies against Cdc27 or 
Apc4. Antibodies were coupled to protein A beads (BioRad) and crosslinked using DMP as 
described. Typically the concentration of HeLa cell extract obtained using this method was 20-22 
 material and methods  
92 
 
mg/ml. The lysate was incubated on an end-over-end rotator at 4°C for 60-90 min with 1/10 
volume of antibody coupled beads. The APC/C-bound beads were washed 3x with TBS-T, of 
which 2x was with incubation for 5 minutes on an end-over-end rotator at 4°C. The APC/C was 
eluted off the beads by incubation in the 1mg/ml antigenic peptide buffered solution (20 mM 
Tris pH 7.5, 5% glycerol, 0.1% Tween-20 (Sigma-Aldrich), 1mM DTT).  
 
 
4.2.3.3 Purification of H6-tagged activators from Sf9 cells 
 
Cell pellet of one T175 flask was resuspended in 300µl lysis buffer (50mM Tris-HCl pH 7.5, 
150mM KCl, 0.1% Tween20, 10% glycerol, 0.2mM PMSF, 10μg/ml of aprotinin, pepstatin and 
leupeptin each). Cells were lysed by passing them through a needle 4-5 times with 2-3 minutes 
breaks. The soluble protein fraction was obtained by centrifugation of the homogenized cell 
extract at 13000rpm, 20minutes at 4°C in an Eppendorf table top centrifuge. The supernatant was 
incubated with 20µl of Ni2+-NTA agarose beads (Qiagen) per harvested flask for 1 hour at 4°C 
on an end-over-end rotator. Samples were washed 3 times with wash buffer (50mM Tris pH7.5, 
300mM KCl, 10% glycerol, 0.1% Tween20), of which 2 times were with 5 minute incubation 
with rotation at 4°C. The proteins were eluted by incubating the protein-bound Ni2+-NTA 
agarose beads in two volumes of elution buffer (50mM Tris pH7.5, 300mM KCl, 10% glycerol, 
250mM imidazole) for 15 minutes at 4°C. Imidazole was removed from the eluates by running 
them on a desalting column (NAP-5 column, GE Healthcare) in storage buffer (50mM Tris-HCl 
pH7.5, 150mM KCl, 10% glycerol, 1mM DTT). Fractions containing the highest co-activator 
concentrations were pooled and aliquoted. Aliquots were frozen in liquid nitrogen. 
 
 
4.2.3.4 Purification of activators co-expressed with Hsl1667-872 in Sf9 cells 
 
Cell pellet of one T175 flask was resuspended in 300µl CytoBuster (Novagen) that contained 
0.2mM PMSF, 10μg/ml of aprotinin, pepstatin and leupeptin each. After 30 minutes of 
incubation at 4°C with end-over-end rotation the soluble protein fraction was obtained by 
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centrifugation of the homogenized cell extract at 13000rpm, 20minutes at 4°C in a Heraeus 
Biofuge table top centrifuge. The supernatant was incubated with 20µl of Ni2+-NTA agarose 
beads (Qiagen) per harvested flask for 1 hour at 4°C on an end-over-end rotator. Samples were 
washed 3 times with wash buffer (50mM Tris pH7.5, 300mM KCl, 10% glycerol, 0.1% 
Tween20), of which 2 times were with 5 minute incubation with rotation at 4°C. The proteins 
were eluted by incubating the protein-bound Ni2+-NTA agarose beads in two volumes of elution 
buffer (50mM Tris pH7.5, 300mM KCl, 10% glycerol, 250mM imidazole) for 15 minutes at 
4°C. 
 
 
4.2.3.5 Purification of GST-tagged substrate proteins from E.coli 
 
N702x-GST, N701x-GST, GST-Hsl1 (aa667-872), GST-securin, GST-Nek2A KD 
E.coli pellets were resuspended in 2V of lysis buffer (50mM Tris-HCl pH7.5, 150mM KCl, 
0.01%Tween20, 10% glycerol, 1mM β-mercaptoethanol, 1 tab of Complete EDTA-free (Roche) 
per 20ml of cell suspension) and sonicated. The sonicated cell suspension was centrifuged 
(16000rpm, 30 minutes, SS34 rotor). The soluble fraction, whose concentration was typically 
10mg/ml, was then incubated with GSH-Sepharose beads (Amersham), with lysate/ bead volume 
= 1/0.05, for 1h at 4°C on an end-over-end rotator. The beads were washed once with wash150 
buffer (50mM Tris-HCl pH7.5, 150mM KCl, 0.01% Tween20), two times with wash300 buffer 
(50mM Tris-HCl pH7.5, 300mM KCl, 0.01% Tween20) and then once again with wash150 
buffer. Each washing step was a 5 minute incubation in the wash buffer on an end-over-end 
rotator at 4°C. The bound protein was eluted three times with 2.5 bead volumes of elution buffer 
(50mM Tris HCl pH7.5, 150mM KCl, 0.01% Tween20, 0.5mM β-mercaptoethanol, 50mM 
reduced glutathione), each time rotating for 15 minutes at 4°C. the eluates were dialysed in 
dialysis buffer (20mM Tris-HCl pH7.5, 150mM KCl, 10% glycerol, 0.5mM β-mercaptoethanol) 
for 3 hours and over night. Eluates were stored in aliquotes at -80°C.  
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4.2.3.6. Purification of H6-tagged substrate proteins from E.coli 
 
Frozen cell pellets were resuspended in 1 pellet volume of Lysis buffer (50mM Tris-HCl pH8, 
150mM KCl, 2 mM β-mercapto-ethanol, 1% Triton, 1 tab of Complete EDTA-free (Roche) per 
20ml of cell suspension). The cell suspension was incubated on ice for 30 minutes, and then 
sonicated (in the “rosetta” or in a 50ml Falcon tube) 6 x 10s with 10s pauses (settings of the 
sonicator:  duty cycle: 50%, output control: microtip limit). The lysed cells were then spun at 
13000rpm for 30 at 4°C in a SS34 rotor, Sorwall centrifuge. NiNTA agarose beads (Qiagen) 
equilibrated with Lysis buffer were incubated in the cleared cell lysate for 1 hour at 4°C with 
end-over-end rotation, spun at 500g. The beads were then washed twice with Wash buffer 1 (50 
mM Tris-HCl pH 8, 500 mM KCl, 0.5% TritonX-100, 2 mM β-mercapto-ethanol, 20mM 
imidazole), with 5 minutes incubation with rotation at 4°C; then washed twice with Wash Buffer 
2 ( 50 mM Tris-HCl, pH8, 150mM KCl, 0.5% TritonX-100, 2 mM β-mercapto-ethanol) with 5 
minutes incubation  with rotation at 4°C, then once with Wash buffer 2 without TritonX-100 
with 5 minutes incubation with rortation at 4°C.The proteins were eluted by two subsequent 
incubations in 2 bead volumes of Elution buffer (50mM Tris-HCl pH8, 150mM KCl, 250mM 
Imidazole, 2 mM β-mercapto-ethanol) for 20-30 minutes at 4°C on an end-over-end rotator. 
Imidazole was removed by dializing the eluates in Dialysis buffer (50mM Tris-HCl pH8, 
150mM KCl, 10% glycerol , 0.5mM DTT) at 4°C. First dialysis was carried out for 2 hours, and 
the second over night. The eluates were aliquoted and frozen in liquid nitrogen. 
 
 
4.2.3.7 Purification of proteins expressed in S.cerevisiae 
 
Frozen cell pellets were thawn on ice and resuspended  in 2 pellet volumes of TLB buffer (20 
mM Tris-HCl, pH 7.9, 10 mM MgCl2, 5 mM CaCl2, 5% glycerol, 1 mM DTT , 100 mM 
ammonium sulfate, 150 mM NaCl). Complete© (Roche) protease inhibitor tab per 50ml of cell 
suspension just before use. The cells were lysed in French Press 2x at 2.1 kbar , incubated on ice 
during the procedure. The lysate was cleared by centrifugation in SS34 rotor, 19,000 rpm 40 
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minutes at 4°C. the lysate was subsequently incubated with 1/10 volume of IgG sepharose ™ 6 
Fast Flow (Amersham) beads in a 0.8x4 cm Poly-Prep column (BIORAD). 
Prior to incubation with the lysatem the beads were activated by washing them first in TBS pH 
7.5 and then with 0.5 M HAc/NH4Ac pH 3.4. this is repeate once more, and at the end the beads 
were washed with TBS until the pH was 7.5 again. 
The beads were incubated in the lysate for 3 hours at 4°C and subsequently washed in the Poly-
Prep column with at least 100 bead volumes of TLB. The beads were then transfered to 1.5ml 
Eppendorf tube, spun down at 2000rpm for 5 min, in a Sowrall tabletop centrifuge. The buffer 
was remover and the beads were resuspended in 3.5 bead volumes of AcTEV lysis buffer 
(Invitrogen). DTT was added to 1mM final concentration and 3µl of TEV protease (Invitrogen). 
The reaction was incubated with end-over-end rotation over night at 4°C.  
 
 
4.2.4 Oxidative Iodination of proteins 
 
An N-terminal fragment of human cyclin B1 (amino acids 1-87, -myc-his6) was iodinated using 
the chloramin T procedure according to Parker (Parker, 1990). 2–10 μg of the protein to be 
labelled was incubated in a 30 μl reaction containing 24µl 250 mM Tris-HCl, pH 8.0, 3µl 
chloramin T (10mg/ml) and 3 μl Na125I (DuPont NEN, NEZ-033A, pH 8-10, 100μCi/μl) for 3 
minutes at room temperature. To stop the reaction, 10 μl of 1M DTT was added, and the mixture 
was dialyzed for four hours in a Slide-A-Lyzer Mini Dialysis unit with a molecular weight cut 
off of 3.5 kDa (Pierce, Rockford, IL) against 2x250 ml of XB buffer for 2 hours each. (10 mM 
Hepes-KOH pH 7.7, 100 mM KCl, 2 mM MgCl2, 0.1 mM CaCl2 and 1 mM DTT). The 
iodinated protein was then mixed 1:1 with 87 % glycerol and stored at -20 °C.  
 
 
4.2.5 In vitro ubiquitylation of iodinated APC/C substrates 
 
To measure the activity of the immunopurified APC/C, the complex was incubated with 
ubiquitin, E1 and E2 enzyme and analyzed for it’s ability to form polyubiquitin chains on a 
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substrate protein. For ubiquitylation assays, 1-3 μl APC/C bound antibody beads were used in 
XB buffer containing purified E1 (0.26 μM), UbcH10 (6.2 μM), ubiquitin (0.3 mM), ATP 
regenerating system (7.5 mM creatine phosphate, 1 mM ATP, 1 mM MgCl2, 0.1 mM EGTA, 30 
U/ml rabbit creatine phosphokinase type I (Sigma-Aldrich)) in a total volume of 7-10 μl. As a 
substrate, we used an iodinated proteins. Ubiquitylation reactions catalyzed by human APC/C 
were incubated at 37°C and 1400 rpm in a thermomixer (Eppendorf, Hamburg, Germany). The 
reaction was stopped by the addition of 4x sample buffer (125 mM Tris-HCl pH 6.8, 4% SDS, 
20% Glycerol, 200mM DTT, 0,02% Bromphenolblue). Radiolabeled substrates could be 
detected by autoradiography which allowed quantification of the reactions. 
 
 
4.2.6. In vitro protein binding assays 
 
4.2.6.1 In vitro binding of activators to the APC/C 
 
The APC/C was purified from HeLa cells as described in 4.4.2 with protein-A sepharose beads 
(BioRad) coupled to α-Cdc27 antibodies. Bead bound APC/C was incubated for 30 minutes at 
4°C on a end-over-end rotator in 2 bead volumes of a recombinant activator solution in IP buffer 
(20 mM Tris pH 7.5, 150mM KCl, 10% glycerol, 0.1% Tween 20 (Sigma). 0.5 mM DTT) that 
contained 4mg/ml of BSA. The unbound activators were washed by washing the beads 4x in 20 
bead volumes of IP buffer, of which 2x was with 5 minute incubation at 4°C on a end-over-end 
rotator. 
 
 
4.2.6.2 In vitro substrate binding assay: APC/C on beads 
 
The APC/C was purified from HeLa cells as described in 4.4.2 with protein-A sepharose beads 
(BioRad) coupled to α-Cdc27 antibodies. Bead bound APC/C was incubated for 60 minutes at 
room temperature on a end-over-end rotator in 3 bead volumes of a substrate protein solution in 
buffer A ( 50mM Tris-HCl pH 7.5, 10% glycerol, 1mM DTT) that contained 4mg/ml BSA. The 
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unbound substrate was washed off by washing the beads 3 times in 40 bead volumes of buffer B 
(50mM Tris-HCl pH 8, 150 mM NaCl, 0.5% Tween 20, 5 mM EDTA). The bound proteins were 
eluted off the beads wither by a solution of 0.1M Glycine pH2.2 (adjuste with HCl) or by 
incubating the beads in a buffered solution that contained 1mg/ml of antigenic peptide (20mM 
Tris-HCl pH 7.5, 5% glycerol, 0.1% Tween 20, 0.5mM DTT) 
 
 
4.2.6.3 In vitro substrate binding assay: substrate on beads, APC/C in solution 
 
To prevent unspecific binding 20 μl of glutathione sepharose beads (Glutathione High 
Performance, GE Healthcare) for 30 minutes at room temperature on an end-over-end rotator in 
50μl Buffer A (50mM Tris-HCl pH 7.5, 10% glycerol, 1mM DTT) that contained 2 mg/ml BSA 
prior to substrate binding. The beads were subsequently incubated in 30μl of substrate solution in 
Buffer A that contained 4mg/ml BSA at room temperature for 1 hour on an end-over-end rotator. 
To remove unbound substrates the beads were washed 3 times with 560μl of buffer A, of which 
the second time the beads were incubated for 5 minutes on an end-over-end rotator at room 
temperature.  The APC/C, was immunopurified from extracts of HeLa cells as described in 4.4.2, 
with Cdc27 antibodies coupled to protein A beads and eluted by incubating the beads in a 
buffered solution that contained 1mg/ml of antigenic peptide (20mM Tris-HCl pH 7.5, 5% 
glycerol, 0.1% Tween 20, 0.5mM DTT). Substrate–bound glutathione were then incubated in the 
80μl (4 bead volumes) of APC/C peptide elution for another 1h at room temperature with end-
over-end rotation. Unbound APC/C was washed off glutathione beads with Buffer B (50mM 
Tris-HCl pH 8, 150 mM NaCl, 0.5% Tween 20, 5 mM EDTA), and the bound proteins were 
eluted off the beads by boiling in 30μl (1.5 bead volumes) of 2xSDS PAGE sample buffer that 
contained 5mg/ml of BSA. 
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4.2.7  In vitro dephosphorylation of APC/C 
 
Dephosphorylation of APC/C bound t beads: 25µl beads were incubated in 50µl of reaction buffer ( New 
England Biolabs. 5µl of 10x buffer, 5µl of 10x MnCl2, 40 µl MonoQ) with 4µl of lambda phosphatase 
(New England Biolabs) for 45minutes at 30°C  at 400rpm shaking in the termomixer (Eppendorf) Since 
the beads settle down at this low rpm, they were pipetted up and down every 5-10  mins. The beads were 
subsequently washed three times with TBS-T of that the last two times were with 5 minute incubation on 
a end-over-end rotator. The APC/C was then  eluted with 2 bead volumes of 0.1M glycine solution pH2.2. 
Dephosphorylation of APC/C in HeLa extracts: to 110µl of mitotic HeLa extract (SAC-on and SAC-off) 
13µl of 10x phosphatase buffer (New England Biolabs),  13µl 10x MnCl2 and 9µl  Lambda phosphatase 
(New England Biolabs). 30 minuites at 30°C, 700rpm shaking. 
 
 
4.2.8  Ammonium sulphate precipitation  
 
(NH4)2SO4 crystals were chrushed to make it a powder. To obtain 85% saturation 0.57g was 
added to 1ml of protein solution. The (NH4)2SO4 power was added into the protein solution 
stepwise in small portions during 30 minutes while the protein solution was being stirred with a 
magnetic stirrer, on ice. when all the (NH4)2SO4 poeder was added to the solution, it was stirred 
for additionaly 30 minutes on ice, after which it was centrifuged at 4400 rpm in an Heraeus 
Biofuge  tabletop centrifuge at 4°C for 15 minutes. The pellets were resuspend in TLB buffer 
(see Methods section 4.2.3.7) for storage on ice. 
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5. Appendix 
5.1 Clustal X multiple protein sequence alignment of Cdh1 homologs 
A selected set of ortholog sequences was identified using NCBI BLAST (Altschul, PMID: 
92546942231712). A multiple amino-acid sequence alignment was performed using the Multiple 
Alignment using Fast Fourier Transform 
(MAFFT) algorithm (Katoh, PMID: 12136088), and graphically processed using Clustal X 
software (Larkin, PMID: 17846036). The sequences are the following:  
 
Cdh1_Hs: gi|6463679|dbj|BAA86954.1| [Homo sapiens],  
Cdh1_Mm: gi|9789959|ref|NP_062731.1| [Mus musculus],  
Cdh1_Xl: gi|2326943|emb|CAA74576.1| [Xenopus laevis],  
Cdh1_Am: gi|66562652|ref|XP_623291.1|[Apis mellifera],  
Cdh1_Dm: gi|2326419|emb|CAA74575.1| [Drosophila melanogaster],  
Cdh1_Ce: gi|17538129|ref|NP_496075.1| [Caenorhabditis elegans],  
Cdh1_Cn: gi|50257089|gb|EAL19804.1| [Cryptococcus neoformans var. neoformans B-3501A],  
Cdh1_Um: gi|71019667|ref|XP_760064.1| [Ustilago maydis 521],  
Cdh1_Sp: gi|6138904|emb|CAB59693.1| [Schizosaccharomyces pombe],  
Cdh1_At: gi|20259635|gb|AAM14174.1| [Arabidopsis thaliana],  
Cdh1A1_A: gi|79482624|ref|NP_194022.3| [Arabidopsis thaliana],  
Cdh1_An: gi|67525015|ref|XP_660569.1| [Aspergillus nidulans FGSC A4],  
Cdh1_Sc: gi|6321435|ref|NP_011512.1| [Saccharomyces cerevisiae]. 
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Structure of the Anaphase-Promoting
Complex/Cyclosome Interacting with a
Mitotic Checkpoint Complex
Franz Herzog,1* Ivana Primorac,1 Prakash Dube,2 Peter Lenart,3 Björn Sander,2
Karl Mechtler,1 Holger Stark,2† Jan-Michael Peters1†
Once all chromosomes are connected to the mitotic spindle (bioriented), anaphase is initiated
by the protein ubiquitylation activity of the anaphase-promoting complex/cyclosome (APC/C)
and its coactivator Cdc20 (APC/CCdc20). Before chromosome biorientation, anaphase is delayed
by a mitotic checkpoint complex (MCC) that inhibits APC/CCdc20. We used single-particle electron
microscopy to obtain three-dimensional models of human APC/C in various functional states: bound
to MCC, to Cdc20, or to neither (apo-APC/C). These experiments revealed that MCC associates
with the Cdc20 binding site on APC/C, locks the otherwise flexible APC/C in a “closed” state,
and prevents binding and ubiquitylation of a wide range of different APC/C substrates. These
observations clarify the structural basis for the inhibition of APC/C by spindle checkpoint proteins.
Chromosome segregation is delayed by thespindle checkpoint until all chromosomesare connected to both poles (bioriented)
of the mitotic or meiotic spindle. Defects in this
checkpoint can lead to aneuploidy, which is asso-
ciated with tumorigenesis, congenital trisomies,
and aging (1). The spindle checkpoint is activated
in prometaphase by the presence of kinetochores
that are not properly attached to microtubules or
not under tension by spindle-pulling forces (2, 3).
The checkpoint inhibits Cdc20, which activates
the ubiquitin-protein ligase APC/C inmitosis and
helps to recruit substrates to APC/C. APC/C ini-
tiates chromosome segregation by ubiquitylating
cyclin B, an activating subunit of cyclin-dependent
kinase 1 (Cdk1), and securin, an inhibitor of the
protease separase. After ubiquitin-mediated deg-
radation of these proteins, separase becomes ac-
tive and dissolves the cohesion between sister
chromatids (4).
Inhibition of Cdc20 by the spindle checkpoint
depends on mitotic arrest–deficient 2 (Mad2) (5).
This protein associates with Cdc20 at unattached
kinetochores (6–9). In animal cells, Cdc20 is also
inhibited by association with budding uninhibited
by benzimidazoles–related 1 (BubR1) and its bind-
ing partner budding uninhibited by benzimidazoles
3 (Bub3). Mad2 and BubR1-Bub3 can bind to
Cdc20 either separately (10, 11) or simultaneously,
forming a MCC (12), and these proteins can as-
sociate with APC/C (13–16). Similar complexes
exist in yeast, in which a BubR1-related Mad3
protein might inhibit Cdc20 as a pseudosubstrate
(17, 18).
Structural information will be essential to
understand how checkpoint proteins inhibit
APC/CCdc20, but it is known only how Mad2
interacts with a short Cdc20 peptide (19, 20).
We therefore analyzed with single-particle elec-
tron microscopy (EM) the structure of APC/C
that is bound to checkpoint proteins. We first
established conditions under which checkpoint-
inhibited APC/C could be purified and char-
acterized these complexes biochemically. We
isolated APC/C from human HeLa cells that had
been arrested in prometaphase by the microtubule-
stabilizing agent Taxol, which keeps the check-
point active. For comparison, we purified APC/C
fromTaxol-arrested cells in which the checkpoint
had been inactivated by hesperadin, an inhibitor
of Aurora B kinase (15, 21). Quantitative fluo-
rescence microscopy of chromosome morphology,
cyclin B levels, and kinetochore association of
Mad2, BubR1, and Bub1 confirmed that cells
had been arrested in prometaphase with either
an active or inhibited spindle checkpoint (fig.
S1). Mass spectrometry (table S1) and SDS–
polyacrylamide gel electrophoresis (SDS-PAGE)
followed by silver staining (Fig. 1A) or semi-
quantitative immunoblotting (Fig. 1B) revealed
that four times more BubR1, Bub3, and Mad2
were associated with APC/C in cells in which the
checkpoint was active than in hesperadin-treated
cells. The amount of Cdc20 bound to APC/Cwas
twofold greater when the checkpoint was active,
perhaps because checkpoint proteins stabilize
APC/C–Cdc20 interactions. Immunoprecipitation
of BubR1 confirmed that more BubR1, Bub3,
Mad2, and Cdc20 were bound to APC/C when
the checkpoint was active (Fig. 1A and table S1).
In a reconstituted system, ubiquitylation of cyclin
B and securin was reduced to 17% when APC/C
was isolated from cells with an active checkpoint
as compared with reactions mediated by APC/C
from cells with an inactive checkpoint. This dif-
ference was even greater when samples were nor-
malized to the amounts of APC/C–associated
Cdc20, which is rate-limiting for APC/C activity
(Fig. 1, C and D). Surprisingly, APC/C from cells
with an active checkpoint was similarly less
active toward cyclin A and never-in-mitosis A
(NIMA)–related kinase 2A (Nek2A), which are
normally degraded in prometaphase when the
checkpoint is active (Fig. 1E and fig. S2). The
checkpoint appears not to inhibit APC/CCdc20 in
a substrate-specific manner, as was proposed to
explain Nek2A degradation in prometaphase (22),
but by recruiting substrates before checkpoint ac-
tivation, as shown for cyclin A (23).
Similar results were obtained when APC/C
was isolated from cells with active or inactive
checkpoints that were obtained with a different
protocol in which cells had not been treated with
hesperadin (fig. S3), indicating that hesperadin
caused changes in APC/C’s subunit composition
and activity by checkpoint inhibition and not by
an unrelated mechanism. Our results therefore
indicated that checkpoint activation leads to asso-
ciation of BubR1, Bub3, and Mad2 with APC/C
and to the general inhibition of APC/C’s ubiqui-
tylation activity. However, our SDS-PAGE–silver
staining analysis of APC/C from cells in which
the checkpoint is active suggested that BubR1,
Bub3, and Mad2 were present in substoichio-
metric amounts relative to APC/C (Fig. 1A). We
therefore separated APC/C purified from cells
with an active checkpoint into different sub-
populations (Fig. 1F). We first captured a sub-
population of APC/C with BubR1, Cdc20, or
Mad2 antibodies and then isolated the remaining
1Research Institute of Molecular Pathology, Dr. Bohr-Gasse 7,
1030 Vienna, Austria. 2Max-Planck-Institute for Biophysical
Chemistry, Am Fassberg 11, 37077 Goettingen, Germany.
3European Molecular Biology Laboratory, Meyerhofstraße 1,
69117 Heidelberg, Germany.
*Present address: Institute of Molecular Systems Biology,
Eidgenössische Technische Hochschule Zurich, 8093 Zurich,
Switzerland.
†To whom correspondence should be addressed. E-mail:
hstark1@gwdg.de (H.S.); peters@imp.univie.ac.at ( J.-M.P.)
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particles with antibodies to the APC/C subunit
Apc4 (Fig. 1, G and H, and fig. S4). These ex-
periments revealed that cells with an active
checkpoint contained two forms of APC/C.
One contained BubR1, Bub3, Cdc20, and Mad2,
whereas the other one lacked all of these pro-
teins. We refer to these forms as APC/CMCC and
apo-APC/C, respectively. In cyclinB–ubiquitylation
assays, the specific activities of APC/CMCC and
apo-APC/C were similarly low (Fig. 1I). Puri-
fied Cdc20 and the related coactivator Cdc20
homolog 1 (Cdh1) activated apo-APC/C in a dose-
dependent manner, suggesting that this form of
APC/C is inactive because it is lacking a co-
activator. In contrast, APC/CMCC could be stim-
ulated by coactivators only to a small degree,
indicating that this form of APC/C represents a
truly inhibited state (Fig. 1I).
To understand how checkpoint proteins inhibit
APC/C, we determined the structures of APC/CMCC,
apo-APC/C, and APC/CCdc20. We isolated APC/
CMCC by means of sequential immunoprecipitation
with antibodies to Cdc27 and BubR1. We iso-
lated apo-APC/C with antibodies to Apc4 from
the supernatant of the BubR1 immunoprecipita-
tion. After a peptide elution, both samples were
further purified by use of glycerol density-gradient
centrifugation (24) and analyzed by use of both
negative staining at low temperatures and un-
stained cryo-EM in a vitrified buffer (Fig. 2, figs.
S5 and S6, and table S2). We used a technique
based on three-dimensional (3D) alignment of
random conical tilt (RCT) reconstructions and
subsequent 3Dmultivariate statistical analysis for
initial structure determination and simultaneous
unsupervised analysis of the heterogeneity in the
data set. For apo-APC/C, we identified three con-
formers that differ mainly in the relative orienta-
tion of their twomajor domains: the platform and
Fig. 1. Biochemical characterization of APC/CMCC and
apo-APC/C. (A) SDS-PAGE–silver-staining analysis of APC/C
and MCC from cells in which the checkpoint was active
(SC on) or inhibited (SC off). (B) Semiquantitative immu-
noblot analysis of APC/C from cells in which the checkpoint
was on or off. (C andD) Cyclin B ubiquitylation activity of
APC/C isolated from cells in which the checkpoint was on
or off, analyzed with SDS-PAGE and autoradiography (C)
and quantified (D). (E) Checkpoint activation reduces
APC/C activity similarly toward prometaphase (cyclin A
and Nek2A) and metaphase substrates (cyclin B and
securin). Ratios of ubiquitiylation by the two APC/C sam-
ples were calculated for each substrate in three inde-
pendent experiments. Error bars indicate SD of themean.
(F) Schematic representation of APC/CMCC and apo-APC/C
isolation from cells with an active checkpoint (reIP, reim-
munoprecipitation). (G and H) Immunoblot analyses of
complexes obtained in (F). (I) Cyclin B ubiquitylation ac-
tivities of APC/CCdc20 from cells with an inactive checkpoint
and of APC/CMCC and apo-APC/C from cells with an ac-
tive checkpoint. APC/C levels were normalized to Apc2.
APC/CMCC and apo-APC/C were preincubated with various
concentrations of recombinant Cdc20 or Cdh1. Cyclin B
ubiquitylation was quantified after 4- and 8-min reaction
times. Data represent three independent experiments
and error bars indicate SD of the mean.
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the arc lamp domains (Fig. 2A and 3D-PDF
S1) (25). The initial RCT 3D structures were
used to determine the handedness (fig. S7) and
as templates for further refinement of the existing
subpopulations of apo-APC/C (Fig. 2A). We
suspect that these conformers represent the struc-
tural variability of apo-APC/C in solution and
represent a continuum of flexible states (for an
animation of the corresponding movements, see
movie S1).
In the APC/CMCC sample, a large additional
density was found inserted into the “front” side of
the platform domain (Fig. 2C, red, and 3D-PDF
S2). The 3D volume of this density element cor-
responds to a mass of 180 to 200 kD, slightly less
than MCC’s theoretical mass of 236 kD (if every
subunit is present once). We confirmed that this
mass represents MCC by identifying the location
of BubR1 by means of antibody labeling (fig.
S8). To obtain a 3D model of APC/CCdc20, we
bound recombinant Cdc20 to purified apo-APC/C
and determined the structures as above. In 30%
of APC/C molecules, we found an additional
globular 50-kD mass on the front side of APC/C
in a location that overlaps with the site to which
MCC is bound in APC/CMCC (Fig. 2B and fig.
S9). The Cdc20 density does not fully overlap
with the MCC density and is ~20 Å away from
a perfect fit. The precise position of Cdc20 may
thus change upon MCC binding to APC/C (Fig.
2D). APC/CCdc20 showed similar conformational
flexibility as apo-APC/C.
Comparison of the apo-APC/C and APC/CMCC
structures revealed a number of differences in addi-
tion to the presence of an extramass inAPC/CMCC.
To interpret these changes, we mapped the 3D
location of APC/C core subunits with antibody
labeling (fig. S8). Antibodies to Apc1, Apc4, and
Apc5 bound to distinct sites in the platform do-
main with Apc5 at the bottom, Apc4 at the front,
and Apc1 at the right-hand side (Fig. 3, A and B).
The volumes of the labeled domains are con-
sistent with the predicted masses of Apc1, Apc4,
and Apc5 (Fig. 3B). The modeling of these sub-
units into the APC/C 3D structure suggests that
Apc5 is close to the interface of the platform
and arc lamp domains, and the mass accommo-
dated by Apc1 spans from the front to the inner
mass (Fig. 3B). Part of the subunit that we iden-
tified asApc4 has a ring-shaped structure (Fig. 3B,
right), which is consistent with bioinformatic analy-
ses that Apc4 contains an N-terminal propeller-
shapedWD40domain (4). Cdc27 antibodies bound
to the headlike protrusion that is located at the
top end of the arc lamp domain (Fig. 3A). We
confirmed that Apc2 is located at the inner
mass on the front side of APC/C (25), residing
in close vicinity to Apc1 and Cdc27 (Fig. 3, A
and B). Antibodies to Cdc16 and Apc7 were
bound at multiple locations on the arc lamp do-
main (fig. S8), presumably because these sub-
units are present in more than one copy per
APC/C molecule (25). The arc lamp domain
is bent and has an unusual repetitive regularity
(Fig. 3B), features that are characteristic of tetra-
tricopeptide repeat (TPR) domains present in
Cdc16 and Apc7 and also in Cdc27 and Cdc23.
These observations indicate that a major part
of the arc lamp domain consists of TPR subunits.
With the exception of Apc2 and Apc4 topology,
our 3D model of subunit topology is consistent
with the 2D positions of subunits determined in
fission yeast APC/C (26).
This subunit map indicates that MCC binds
in the vicinity of Apc2, Apc4, and Apc5, which
are located toward the right-hand side of MCC
(Fig. 3, B, D, and E, and 3D-PDFs S1 and S2).
On the left-hand side, MCC contacts the arc lamp
domain, which suggests that MCC also interacts
with TPR subunits. Little if any conformational
flexibility was observed among populations of
APC/CMCC. Instead, APC/CMCC adopts a closed
conformation (Fig. 3D). In addition, Apc4 is bent
upward by 35° in APC/CMCC as compared with
its position in apo-APC/C, and the position of a
more centrally located subunit, possibly Apc2,
is also changed (Fig. 3E). This rearrangement
might be required forMCC binding and, together
with a higher curvature of the arc lamp, results
in a more compact appearance of APC/CMCC as
compared with that of apo-APC/C.
To understand the functional consequences of
these structural changes, we compared the inter-
actions of different forms of APC/C with the
ubiquitin-conjugating enzyme UbcH10 and sub-
strate proteins. Binding of UbcH10 to APC/C
was reduced to 50% when the checkpoint was
active (fig. S10). It is unlikely that this small
change can explain the almost complete inhibi-
tion of APC/C by checkpoint proteins. In con-
trast, we saw a substantial reduction in substrate
binding to checkpoint-inhibited APC/C. When
APC/C was isolated from cells with an active
checkpoint, much less binding of an N-terminal
fragment of fission yeast cyclin B or of full-length
human securin was detected as compared with
the binding that was observed with APC/C
from cells in which the checkpoint was inhib-
ited (Fig. 4, A to C). As reported (27), binding
of cyclin B to APC/C required the presence of a
destruction box (D box) in the substrate (Fig. 4,
A and B). Similar results were obtained when a
D box–containing fragment of budding yeast
Hsl1 was used as a substrate (fig. S11). Even a 35-
fold increase in substrate concentration resulted
Fig. 2. Localization of Cdc20 and MCC bound to APC/C, analyzed by negative-staining EM. (A)
Distinct conformers of apo-APC/C isolated from cells with an active checkpoint. (B) Localization of
recombinant Cdc20 (purple) bound to apo-APC/C. A model of Cdc20’s WD40 propeller is projected
onto APC/C. (C) 3D structure of APC/CMCC. MCC is labeled in red. (D) Superposition of the MCC (red)
and Cdc20 (purple) densities shown from orthogonal directions.
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in less Hsl1 binding to APC/C from cells with an
active checkpoint, as compared with Hsl1 bind-
ing to APC/C from cells in which the checkpoint
was inactive.
Our data indicate that activation of the spin-
dle checkpoint leads to association of BubR1,
Bub3, and Mad2 with APC/CCdc20, in which
the checkpoint proteins occupy a site that par-
tially overlaps with the Cdc20 binding site. The
association of checkpoint proteins with APC/C
coincides with inhibition of APC/C toward a
broad range of prometaphase and metaphase
substrates, indicating that checkpoint activation
inhibits APC/C generally and not in a substrate-
specific manner. This inhibition is at least in part
caused by the prevention of substrate binding,
which agrees well with the proposed role of Cdc20
as a substrate adaptor (28, 29) and of yeast Mad3
as a pseudosubstrate inhibitor (17). Partial over-
lap of positions of Cdc20 binding to APC/CCdc20
and APC/CMCC raises the possibility that APC/C
inhibition may be mediated by MCC-induced
repositioning of Cdc20. MCC binding also in-
duces conformational changes in APC/C itself
and appears to lock it in a closed conformational
state.
Fig. 4. MCC inhibits the binding of substrates to APC/C.
(A) A tandem fragment of wild-type (wt) or D-box mu-
tant (dm) fission yeast cyclin B was immobilized on glu-
tathione beads at the indicated concentrations, and
binding of APC/C from cells with checkpoints on or off
was analyzed with SDS-PAGE immunoblotting. (B) APC/C
from cells with checkpoints on or off was bound to beads
coupled with antibody to Cdc27, and binding of solu-
ble wild-type or D-box mutant cyclin B was analyzed in
the same manner as in (A). (C) The binding of full-
length human securin to APC/C was analyzed in the
same manner as in (B).
Fig. 3. APC/C subunit topology and structural changes
upon MCC binding. (A) APC/C subunits were localized
with antibody labeling. Antibody epitopes are marked
on the surface of the APC/C 3D model, and the label-
ing accuracy is indicated by the size of the differently
colored areas. (B) Models of Apc1, Apc2, Apc4, Apc5,
and Cdc27 were docked into the 3D density of the
APC/C reconstruction. (C) The apo-APC/C structure in
its most open conformation. (D) The APC/CMCC structure
with a closed conformation. (E) Conformational changes
induced by MCC binding to APC/C.
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A Functional Genomics Approach
Reveals CHE as a Component
of the Arabidopsis Circadian Clock
Jose L. Pruneda-Paz, Ghislain Breton, Alessia Para, Steve A. Kay*
Transcriptional feedback loops constitute the molecular circuitry of the plant circadian clock. In
Arabidopsis, a core loop is established between CCA1 and TOC1. Although CCA1 directly represses
TOC1, the TOC1 protein has no DNA binding domains, which suggests that it cannot directly
regulate CCA1. We established a functional genomic strategy that led to the identification of CHE, a
TCP transcription factor that binds specifically to the CCA1 promoter. CHE is a clock component
partially redundant with LHY in the repression of CCA1. The expression of CHE is regulated by
CCA1, thus adding a CCA1/CHE feedback loop to the Arabidopsis circadian network. Because
CHE and TOC1 interact, and CHE binds to the CCA1 promoter, a molecular linkage between
TOC1 and CCA1 gene regulation is established.
The circadian system provides an adaptiveadvantage by allowing the anticipationof daily changes in the environment (1, 2).
For example, in plants, the resonance between
the internal timekeeper and environmental cues
enhances their fitness and survival (3, 4).
Circadian networks are composed of multiple
positive and negative factors organized in in-
terlocked autoregulatory loops (1, 2). In Arabi-
dopsis thaliana, the molecular wiring of these
regulatory circuits is mainly based on transcrip-
tional feedback loops (5, 6). The core clock
stems from the reciprocal regulation between the
evening-phased pseudoresponse regulator TIMING
OF CAB EXPRESSION 1 (TOC1) and the two
morning-expressed MYB transcription factors
CIRCADIAN CLOCK ASSOCIATED 1 (CCA1)
and LATE ELONGATED HYPOCOTYL (LHY)
(7). CCA1 and LHY are DNA binding proteins
that repress TOC1 expression through direct
binding to its promoter region (7, 8). In con-
trast, no functional domains have been recognized
in the TOC1 protein (9), and direct regulators of
CCA1 or LHY expression have never been iden-
tified (5, 6, 10).
Functional redundancies among gene families
provide barriers to identifying clock-related tran-
scription factors by classic forward genetic screens.
Thus, to uncover direct regulators of CCA1/LHY,
we implemented an alternative genomics approach
in which the yeast one-hybrid system was used
to screen a collection of transcription factors for
their binding to the CCA1/LHY regulatory re-
gions (fig. S1). The high-throughput design of
this strategy allowed us to test several tiled frag-
ments for each promoter, thus minimizing the
negative effect that the distance from the cis ele-
ments to the TATA box has over transcriptional
activation in yeast (11). We termed this approach
“promoter hiking.” Because most clock compo-
nents identified to date exhibit a circadian pattern
of mRNA expression, we created a comprehen-
sive library of circadian-regulated transcription
factors (table S1) (12). We identified a transcrip-
tion factor that belongs to the class I TCP (TB1,
CYC, PCFs) family (13) (Arabidopsis Genome
Initiative locus identifier At5g08330), hereafter
referred to as CCA1 HIKING EXPEDITION
(CHE). CHE specifically binds to the CCA1 pro-
moter fragment encompassing nucleotides (nt)
–363 to –192 (Fig. 1A) but not to any of the
LHY promoter fragments tested (Fig. 1B and fig.
S2). Consistent with this result, a motif present in
the promoter fragment bound matches the consen-
sus class I TCP-binding site (TBS) (GGNCCCAC)
(14). The binding of CHE to the TBS in the CCA1
promoter (GGTCCCAC) was confirmed by elec-
trophoretic mobility shift assays (EMSAs) (Fig.
1C) and was further corroborated by the yeast
one-hybrid system with a synthetic TBS trimer
(fig. S2).
To address whether CHE regulates CCA1 in
vivo, we performed assays in Arabidopsis proto-
plasts in which the CCA1 promoter activity was
monitored with a CCA1::LUC+ reporter construct.
The overexpression of CHE when a 35S::CHE ef-
fector construct was used caused a reduction of the
luciferase activity, suggesting that CHE functions
as a repressor of CCA1 (fig. S3). This possibility is
consistent with the observation that CHE mRNA
levels oscillate 9 hours out of phase with the CCA1
transcript (Fig. 1D). Moreover, we demonstrated
that CHE protein accumulates in the nuclei (Fig. 1,
E and F) and that both CHE and CCA1 exhibit a
similarly broad tissue expression pattern (Fig. 1, G
and H). If CHE act as a repressor through binding
to the TBS, mutations in this motif should result
in increased CCA1 promoter activity. This hy-
pothesis was confirmed by using promoter::LUC+
fusions (Fig. 1I and fig. S4), indicating that the
TBS mediates a repressor function. Altogether,
these results support the notion that CHE direct-
ly represses CCA1 promoter activity in a TBS-
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Materials and methods 
 
Cell culture  
HeLa cells were grown in DMEM supplemented with 10% FCS, 0.2 mM L-glutamine, 100 
units/ml penicillin and 100 g/ml streptomycin (all Sigma) and were plated on 12-well plates 
containing an 18 mm diameter coverslip for immunofluorescence microscopy (IFM), or on 
145-mm tissue culture dishes (Greiner bio-one) for subsequent protein purification. For 
synchronization prior to IFM studies, cells were treated with 2 mM thymidine for 24 hr, 
released for 6 hr, and then treated with 10 µM Taxol (Paclitacxel, Sigma) for 4 hr. For the last 
100 min the proteasome inhibitor MG132 (Sigma) was added at 10 µM final concentration. 
To obtain mitotic cells which were arrested in the presence of an active (on) or inhibited (off) 
spindle checkpoint, cells were incubated without or with 100 nM of the Aurora B inhibitor 
Hesperadin (Boehringer-Ingelheim, Vienna) for the last 60 min, respectively. Alternatively, 
following the 6 hr release cells were incubated for 4 hr with 50 ng/ml Nocodazole (Sigma). 
Nocodazole was washed out and cells were incubated for 2 hr with MG132 alone or MG132 
plus 100 ng/ml Nocodazole. For synchronization prior to protein purification, cells were 
initially arrested by incubating them either with 10 µM Taxol or with 50 ng/ml Nocodazole 
for 14 hr. Subsequently, cells were treated as described in the synchronization protocol for 
IFM analysis. For the cytospin-IFM experiments cells were synchronized as for protein 
purification. 
 
Immunofluorescence microscopy 
Cells were fixed with 4% formaldehyde in PBS at room temperature on coverslips or after 
spinning them onto slides by Cytospin (Shandon Brand). After fixation samples were 
permeabilized with 0.5% Trition-X100 in PBS for 15 min and thereafter blocked with 10% 
FCS in PBS containing 0.01% Triton-X100. Samples were incubated for 1 hr each at room 
temperature with primary and secondary antibodies and mounted with ProLong Gold 
(Molecular Probes). Images were taken on a Zeiss Axioplan 2 microscope using a 100x Plan-
Apochromat objective lenses (Carl Zeiss, Jena) equipped with a CoolSnapHQ CCD camera 
(Photometrics).  
Antibodies were used at the following dilutions: human Crest (Cortex Biochem) 1:1000; 
mouse anti-cyclin-B (GNS1, Santa Cruz Biotechnology) 1:500, rabbit anti-Mad2 (Covance) 
1:500; mouse anti-Bub1 (MBL International) 1:500; rabbit anti-BubR1 (see below) 1:1000. 
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Alexa 488, Alexa 568 and Alexa 633 labeled secondary antibodies as well as DAPI were from 
Molecular Probes (Invitrogen). 
Image processing and quantification 
Images were acquired as raw 12-bit images taken at identical exposure times within each 
experiment. Images were processed in ImageJ (http://rsb.info.nih.gov/ij/). Images shown in 
the same panel have been scaled identically. Quantification of kinetochore intensities was 
done as previously described by Hoffman et al. (1) implemented in an ImageJ macro. For 
each measurement, at least 25 kinetochores were measured from at least 5 different cells. 
Cyclin-B levels were measured as average cytoplasmic intensity. 
 
Immunoprecipitation experiments 
Antibodies raised against pApc1 (phosphorylated S355), Apc2, Cdc27, Apc4, Apc5, Apc7, 
Cdh1 and Cdc20 were described previously (2-6). Antibodies against BubR1, Mad2 and Bub3 
were raised by immunizing rabbits with human BubR11-715, Mad2 and Bub3 protein. BubR11-
715 and Mad2 were recombinantly expressed in E. coli and Bub3 in Baculovirus infected Sf9 
insect cells. Preparation of cell extracts and immunoprecipitation (IP) using antibodies 
crosslinked to beads (Affi-prep protein A beads, BioRad) were described elsewhere (7).  
Re-immunoprecipitation (reIP) experiments 
APC/C was affinity-purified from HeLa cells arrested with an active checkpoint using Cdc27 
antibody-crosslinked beads. The native complex was eluted with 2 bead volumes of 1 mg/ml 
antigenic peptide dissolved in IP buffer (20 mM Tris-HCl pH7.5, 150 mM KCl, 10% glycerol, 
0.1% Tween and 0.5 mM DTT). Two subpopulations of APC/C were separated by 
consecutive reIP. 3 volumes of APC/C peptide eluate were incubated first with 1 volume of 
BubR1, Cdc20 or Mad2 antibody coupled beads and second with anti-Apc4 beads. Beads 
were washed 3 times by resuspending them in 20 bead volumes of IP buffer for 5 min at 4°C 
and APC/C was recovered by elution with the antigenic peptides or 100 mM glycine-HCl at 
pH 2.2.  
Cdc20 and Cdh1 were bound to the mix of both APC/C species immobilized on Cdc27 beads 
by incubating them with 3.6, 1.8 or 0.9 µM of either of the coactivators in IP buffer. 2 bead 
volumes of coactivator dilution were mixed with 1 volume APC/C beads on a rotary shaker 
for 30 min at room temperature. The excess of coactivator was removed by washing the beads 
4 times with 50 volumes IP buffer prior to peptide elution and separation of the two APC/C 
populations by reIP. His6-tagged Cdc20 and Cdh1 were expressed in Baculovirus-infected Sf9 
insect cells (8). 
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Mass spectrometry 
Tryptic peptides were loaded onto the trap column at a flow rate of 20 µL/min with mobile 
phase A (5% acetonitrile, 0.1% formic acid) and were washed for 10 min. The sample was 
eluted from the trap column and separated on the separation column with a gradient from 0% 
to 50% mobile phase B (80% acetonitrile, 0.08% formic acid) in 30 min at a flow rate of 300 
nL/min. Eluting peptides were ionized with a spray voltage set to 1.5 kV. CAD fragmentation 
and spectra acquisition were carried out in the linear ion trap using a data dependent neutral 
loss MS³ method. Acquired data (Xcalibur RAW-file) was converted into Sequest DTA-files 
using the program extract_msn, part of Sequest Bioworks Browser (version 3.2 - Thermo 
Electron), and further merged into Mascot generic files using Mascot Daemon (Matrix 
Science).  For peptide identification a database search against a custom database containing 
all relevant proteins was performed using Mascot (Matrix Science; version 2.2.0). 
All nano-HPLC separations were performed using UltiMate 3000 Nano-LC system (Dionex 
Benelux) equipped with a trap column (PepMap C18, 300 µm). Mass spectrometric analyses 
were conducted on a hybrid linear ion trap / Fourier transform ion cyclotron resonance 
(FTICR) mass spectrometer (LTQ-FT Ultra, ThermoElectron). The mass spectrometer was 
equipped with a nano-electrospray ionization source (Proxeon Biosystems). Metal coated 
nano ESI needles were used (New Objective).  
 
In vitro ubiquitylation assay 
To measure the ubiquitylation activity of immunopurified APC/C, 1-3 µl APC/C bound 
antibody beads were used in XB buffer (10 mM Hepes-KOH, pH 7.7, 100 mM KCl, 2 mM 
MgCl2, 0.1 mM CaCl2 and 1 mM DTT) containing purified E1 (0.5 µM), UbcH10 (8.2 µM), 
ubiquitin (0.3 mM), ATP regenerating system (7.5 mM creatine phosphate, 1 mM ATP, 1 
mM MgCl2, 0.1 mM EGTA, 30 U/ml rabbit creatine phosphokinase type I (Sigma)). Human 
His-E1 and His-UbcH10 were expressed in E.coli and purified on a Ni-NTA resin (8). To 
charge UbcH10 with ubiquitin before addition of APC/C and substrate, E1, UbcH10, 
ubiquitin and ATP were preincubated at 36°C for 5 min. The substrate, an iodinated human 
cyclin-B1 fragment (amino acid residues 1-87, 3.5 µM) and APC/C bound beads were 
incubated with the reaction mix in a total volume of 10 µl at 36°C and 1200 rpm in a 
thermomixer (Eppendorf). The reaction was stopped by the addition of 4 x SDS sample 
buffer. The radiolabel of the substrate protein allowed detection by SDS-PAGE and 
autoradiography and the quantification of substrate-ubiquitin conjugates over time was 
performed with ImageJ (http://rsb.info.nih.gov/ij/). 
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Full length human cyclin-A2, cyclin-B1, securin and Nek2A were generated by coupled 
transcription/translation in rabbit reticulocyte lysates (TNT, Invitrogen). APC/C bound 
antibody beads were incubated with 10 µl reaction mix containing 2-3.5 µl of IVT-substrate, 
5 µM MG132 and 2.3 µM ubiquitin aldehyde (Sigma). 
 
Preparation of APC/C for electron microscopy 
APC/C was isolated on Cdc27 antibody beads from lysates of HeLa cells (7). Bound protein 
was washed four times with 50 bead volumes of TBS (20 mM Tris-HCl, pH 7.6, 150 mM 
NaCl and 0.5 mM DTT). APC/C was eluted with TBS containing 1 mg/ml Cdc27 peptide for 
15 minutes at 4°C. The excess of peptide was removed and APC/C particles were stabilized 
by applying the APC/C peptide eluate onto a glycerol density gradient containing 
glutaraldehyde. This procedure is called GraFix and was described by Kastner et al. (9). 
 
Negative staining electron microscopy at low temperatures 
Purified APC/C or APC/C-antibody complexes were adsorbed to a thin film of carbon and 
then transferred to an electron microscopic grid covered with a perforated carbon film. The 
bound APC/C particles were stained with 2% uranyl formate, blotted and air dried for ~1 min 
at room temperature. For negative staining at low temperatures (10) the grids were 
subsequently plunged into liquid nitrogen. Under these conditions samples are not fully 
dehydrated because glycerol in the sample prevents complete evaporation of water from the 
grid. Evidence for the presence of water can directly be obtained by exposing the specimen to 
the electron beam immediately after cryo-transfer in the electron micorscope (fig. S6). Images 
were recorded at a magnification of 155.000 x on a 4k x 4k CCD camera (TVIPS GmbH) 
using two-fold pixel binning (1.8 Å/pixel) in a Philips CM200 FEG electron microscope 
(Philips/FEI) operated at 160kV acceleration voltage. APC/C-antibody complexes were 
imaged at room temperature using the same magnification. The number of particles used for 
each project varies between ~8700 and ~73.000 and the obtained resolutions are in the range 
of 19-35 Å. The highest resolution was obtained for the negative stain 3D reconstruction of 
apo-APC/C (19 Å). Details about image statistics and resolution are provided in table S2.  
 
Unstained cryo-electron microscopy 
GraFix peak fractions were subjected to desalting spin columns (Zeba spin columns, Pierce) 
to remove glycerol. APC/C was bound to a thin layer of carbon and flash frozen into liquid 
ethane (11). Images were recorded using the same procedure and the same microscope as 
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described for negative staining at low temperatures. We have used unstained cryo-EM and 
negative staining EM for 3D structure determination of apo-APC/C (fig. S5) as well as 
APC/CMCC (Fig. 2C).  
 
Processing of electron microscopy images 
Particle images (200 x 200 pixel) were selected using the semi-automated software boxer as 
part of the Eman package. Images were coarsened by a factor of two resulting in 100 x 100 
pixels per image with a sampling of ~3.8 Å/pixel. After CTF correction (12), images were 
aligned using an exhaustive multi-reference alignment based on resampling to polar 
coordinates (13). Characteristic views were obtained by averaging after multivariate statistical 
analysis and classification (14). Angular reconstitution (15) was used to determine the relative 
orientations of the projection images prior to computing the 3D reconstruction.  
We have performed supervised classification based on projection matching to separate apo-
APC/C from APC/CMCC or APC/CCdc20 complexes. Projection matching was also used to 
separate the three different conformations that we found for the apo-APC/C complex. 
Initially, these three different conformations were obtained by the random conical tilt 
reconstruction technique (16). 3D structures were visualized with the software AmiraDev 2.3 
(TGS Europe, Merignac Cedex). 
 
Localization of APC/C subunits and the coactivators Cdc20 and Cdh1 by negative 
staining EM 
Loading of recombinant Cdc20 and Cdh1 in vitro 
N-terminally His6-tagged human Cdc20 and Cdh1 were expressed in Baculovirus-infected Sf9 
cells and purified via the His-tag (8). Apo-APC/C was purified from HeLa cells arrested with 
an active checkpoint by Cdc27-IP followed by consecutive reIP as described. Apo-APC/C 
bound to beads was incubated with ~0.5-1.0 µM recombinant Cdc20 or Cdh1 for 30 min at 
4°C. Beads were washed three times with 50 volumes of TBS and eluted with the antigenic 
peptide. In case of Cdh1, experiments were also performed in parallel with APC/C isolated 
from Xenopus interphase egg extracts (7). 
Antibody labeling 
Peptide eluted human APC/C preparations were incubated with decreasing concentrations of 
pApc1, Cdc27, Apc4, Apc5, Cdc16, Apc7 and BubR1 antibodies starting at a molar APC/C to 
IgG ratio of 2:1. At the antibody concentration yielding a high percentage of APC/C dimers, 
samples were processed using the GraFix protocol and analyzed by negative staining EM. 
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The concentration of particles on the EM grid was chosen to be very low to ensure that 
APC/C dimers were not formed accidentally by the presence of large amounts of APC/Cs. 
200-300 APC/C dimers were selected for each antibody labeling experiment to determine the 
antibody binding sites. First the projection direction of each APC/C monomer was determined 
and a rectangular plane was drawn in 3D, perpendicular to the imaging plane at the antibody 
binding site. The x,y dimensions of the rectangular planes reflect the uncertainties of detecting 
the binding site of the antibody (fig S8). However, in case of Apc1, Cdc27, Apc4, Apc5 and 
BubR1 labeling experiments the rectangular planes did precisely intersect in 3D describing a 
single spot on the surface of APC/C. We were thus able to determine the location of APC/C 
subunits at an accuracy that is reflected by the size of the spheres shown in Fig. 3A. In case of 
Apc7 and Cdc16 the labeling was considerably less accurate, possibly due to the presence of 
multiple copies of these subunits. Single labeling spots were not obtained in those cases. 
However, both proteins were found to be located in the “arc lamp” domain of APC/C. 
 
Random conical tilt 3D reconstruction 
The recently published 3D structure of the fission yeast APC/C (17) has mirrored handedness 
with respect to the Xenopus APC/C 3D structure determined by Dube et al. (18). We have 
therefore repeated the random conical tilt experiment of negatively stained human apo-APC/C 
to solve the handedness problem. 8859 tilted image pairs were collected in negative stain and 
350 random conical tilt 3D reconstructions were computed. Individual RCT 3D models were 
aligned by an automated exhaustive 3D alignment via polar coordinates combined with a 
weighted averaging procedure (19). The entire procedure was first tested with a 70S E. coli 
ribosome data set to make sure that the obtained handedness is correct. We have obtained a 
well defined consensus 3D structure of human APC/C (fig. S5) which unambiguously 
confirms the handedness that we have determined for Xenopus APC/C (18). In addition to 
providing the APC/C structure with correct handedness, the set of aligned RCT 3D 
reconstructions was subjected to three-dimensional multivariate statistical analysis and 
classification to analyse the structural variation within one single data set. Using this 
unsupervised classification procedure, three distinct structures of the apo-APC/C were 
obtained that differ in their relative orientation of the two major APC/C domains. The 
obtained structures were subsequently refined using standard projection matching techniques 
(Fig. 2A, apo-APC/C). 
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Crosslinking of UbcH10 
UbcH10 was covalently linked to the heterobifunctional crosslinker Sulfo-GMBS (N-[g-
Maleimidobutyryloxy]sulfosuccinimide ester, Pierce) via its free –SH groups as described by 
Vodermaier et al. (5). APC/C was purified on Cdc27 antibody beads from lysates of HeLa 
cells arrested in mitosis with an active or inhibited checkpoint. Beads were equilibrated in 20 
mM HEPES pH 7.5, 100 mM NaCl. For crosslinking, 12 µl APC/C bound beads were mixed 
with UbcH10-GMBS or unmodified UbcH10 at a final concentration of 1 or 2 µM in a total 
volume of 30 µl. After 2 to 15 min incubation at 25°C, samples were washed twice with 20 
mM HEPES pH 8.0, 100 mM NaCl and were incubated for 10 min at pH 8.0 and 25°C. 
APC/C was eluted with 1.5 volumes of 1 mg/ml of the antigenic peptide and analyzed by 
SDS-PAGE and immunoblotting. To quantify crosslinking of UbcH10 to APC/C a 
fluorescently labeled (Alexa 630) secondary antibody was used and the signal intensities were 
measured by a Odyssey scanner (LI-COR Biosciences). 
 
In vitro substrate binding assay 
A tandem fragment of the N-terminal 70 residues of fission yeast cyclin-B Cdc13 (20), full 
length human securin and the fragment of Hsl1667-872 were expressed in E.coli and purified. 
APC/C was isolated by Cdc27-IP and peptide elution from lysates of HeLa cells arrested with 
checkpoint on or off. 
Glutathione-sepharose beads (Amersham) were first equilibrated in buffer A (50 mM Tris-
HCl pH7.5, 10% glycerol, 1 mM DTT) containing 2 mg/ml of BSA on a rotary shaker at 
room temperature for 1 hr. 20 µl of glutathione-sepharose were incubated with different 
dilutions of wild type or D-box mutant cyclin-B protein in 30 µl of buffer A containing 4 
mg/ml BSA for 1 hr (Fig. 4A). The beads were washed 3 times with buffer A and mixed with 
80 µl of APC/C eluate for 1 hr at RT. Subsequently, the excess of soluble APC/C was 
removed, beads were washed 3 times with buffer B (50 mM Tris-HCl, pH7.5, 150 mM NaCl, 
0.5% Tween, 5 mM EDTA) and bound proteins were eluted with 30 µl 2 x SDS sample buffer 
containing 5 mg/ml BSA. 
Conversely, 15 µl samples of APC/C bound beads were incubated with various dilutions of 
wild type or D-box mutant cyclin-B (Fig.4B), wild type securin (Fig. 4C) or wild type Hsl1667-
872 (fig. S11) protein in 45 µl of buffer A containing 4 mg/ml BSA for 1hr at room 
temperature. Beads were washed with buffer B and bound proteins were eluted off the beads 
with 25 µl of 100 mM glycine-HCl, pH 2.2.  
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Supplementary Figures 
 
 
Figure S1 
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Figure S1. Immunofluorescence microscopy of HeLa cells arrested in mitosis with an 
active or inhibited checkpoint using the Taxol/Hesperadin protocol.  
(A) HeLa cells were arrested either in prometaphase by activating the spindle checkpoint (SC 
on) with Taxol or in a metaphase-like state (SC off) by overriding the Taxol-arrest with the 
Aurora B inhibitor Hesperadin, and by blocking anaphase onset by the addition of the 
proteasome inhibitor MG132 (see Materials and Methods). Cells were fixed and analyzed by 
immunofluorescence microscopy (IFM) using the indicated antibodies.  
(B) Quantification of the IFM staining intensities shown in (A) (AU, arbitrary units).  
(C) HeLa cells were synchronized in a checkpoint on or off state using the Taxol/Hesperadin 
protocol with an initial 16 hr Taxol treatment (see Materials and Methods). Cells were 
harvested by mitotic shake off and fixed after Cyctospin. Bub1 and BubR1 localization was 
analyzed by IFM and DNA was visualized by DAPI.  
(D) Cells were classified according to their Bub1, BubR1 and DNA staining. 
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Figure S2 
 
 
 
Figure S2. In vitro ubiquitylation of securin, cyclin-B1, cyclin-A2 and Nek2A reveals 
similarly reduced APC/C activity towards all substrates upon MCC binding.  
35S-labeled human full-length securin, cyclin-B1, cyclin-A2 and Nek2A were generated by in 
vitro translation. APC/C purified from checkpoint on or off cells and the 35S-labeled substrate 
proteins were incubated with E1, UbcH10, ubiquitin and ATP for the indicated times. 
Substrate ubiquitylation was analyzed by SDS-PAGE and quantified by autoradiography. 
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Figure S3 
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Figure S3. An alternative protocol using Nocodazole to arrest HeLa cells in mitosis with 
an active or inhibited spindle checkpoint.  
(A) HeLa cells were arrested either in prometaphase by activating the spindle checkpoint with 
Nocodazole (SC on) or in a metaphase-like state (SC off) by washing out Nocodazole and 
blocking progression of the released cells to anaphase by adding the proteasome inhibitor 
MG132. Cells were fixed and analyzed by immunofluorescence microscopy (IFM) using the 
indicated antibodies and DAPI to visualize DNA.  
(B) Quantification of the IFM staining intensities of BubR1 and Mad2 at kinetochores.  
(C) HeLa cells were arrested in a checkpoint on or off state using the Taxol/Hesperadin or the 
Nocodazole release protocol (see Materials and Methods). APC/C complexes were 
immunoprecipitated from lysates of the differentially synchronized cells by Cdc27 antibodies. 
A dilution series of the purified proteins were analyzed by SDS-PAGE and immunoblotting 
using the indicated antibodies. From 1 to 1/4, 1, 0.75, 0.5, and 0.25 volumes were loaded.  
(D) APC/C was immunopurified from checkpoint on or off arrested HeLa cells obtained by 
the Nocodazole release protocol. The in vitro ubiquitylation activities of these two APC/C 
preparations were assessed using an iodinated fragment of human cyclin-B as a substrate. 
Reactions were stopped at the indicated time points and analyzed by SDS-PAGE and 
autoradiography.  
(E) Quantification of the in vitro ubiquitylation assays shown in (D) revealed an eight-fold 
reduction of cyclin–ubiquitin conjugation upon association of MCC with APC/C. 
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Figure S4 
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Figure S4. Re-immunoprecipitation experiments to separate APC/C species isolated 
from Hela cells arrested with an active checkpoint.  
(A) APC/C was purified from HeLa cells arrested with an active checkpoint by 
immunoprecipiation (IP) with Cdc27 antibody and peptide elution (Fig. 1F). APC/CMCC was 
isolated by Mad2-IP from the Cdc27 peptide eluate. Remaining APC/C particles were 
recovered by Apc4-IP from the supernatant of the Mad2-IP. Bound proteins were eluted with 
100 mM glycine-HCl (pH 2.2) and analyzed by SDS-PAGE/immunoblotting. Note that the 
majority of BubR1, Bub3 and Cdc20 co-IP with Mad2, indicating that Mad2 is a 
stoichiometric component of APC/CMCC. 
(B) Schematic representation of an experiment designed to test if APC/CCdc20 is present in 
HeLa cells arrested with an active checkpoint. 
(C) Immunoblot analysis of protein complexes obtained in (B). Note that no APC/CCdc20 
could be detected by Cdc20 reIP, suggesting that cells with an active checkpoint contain very 
little if any APC/CCdc20. 
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Figure S5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S5. Comparison of unstained cryo- and negative stain electron microscopy.  
Unless indicated otherwise, APC/C structures presented in this paper were obtained using 
negative staining EM at low temperatures. Stabilization of APC/C during GraFix allowed us 
to remove glycerol from the gradient fractions and to perform also unstained cryo-imaging of 
APC/C embedded in vitrified buffer. The 3D reconstructions obtained by both techniques for 
apo-APC/C (shown here) and for APC/CMCC (Fig. 2C) are very similar. The resolution 
obtained for the unstained cryo-EM reconstructions is considerably lower than the resolution 
obtained by negative staining at low temperatures (table S2). This can be attributed to the 
final buffer exchange step which is important to remove glycerol for unstained cryo-EM but 
which has significantly affected the integrity of APC/C particles.  
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Figure S6 
 
Figure S6. Water evaporation upon illumination under the electron beam is observed in 
samples negatively stained at low temperatures. The test was carried out shortly after cryo-
transfer of the grid to avoid any artefacts by ice contamination inside the microscope column. 
Focusing the electron beam on a small area reveals a bright spot in the center due to water 
evaporation. As a control, the grid was allowed to warm up to RT inside the microscope and 
then the test was repeated on an adjacent area. In this case (representing normal negative stain 
conditions at room temperature) no water was evaporated after focusing the beam at an 
increased magnification for 30 seconds. These observations indicate that APC/C molecules 
are still hydrated when using negative staining at low temperatures in contrast to conventional 
negative staining. 
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Figure S7 
 
Figure S7. Random conical tilt 3D reconstruction of apo-APC/C.  
The random conical tilt (RCT) technique (16) in combination with a maximum-likelihood 
based alignment and weighted averaging approach (19) was used to corroborate the 
handedness of the APC/C reconstruction (18). The RCT 3D reconstruction of human apo-
APC/C is depicted on the left showing the correct handedness of the APC/C reconstruction. 
Recently, a 3D model of fission yeast APC/C has been published which shows overall 
similarity to the structure of vertebrate APC/C (17), but the handedness of the yeast 3D 
reconstruction appears to be the mirrored version of the one we determined previously for 
Xenopus APC/C (18). Ohi et al. (17) did not determine the handedness of their 3D 
reconstruction. We therefore performed additional RCT analyses and confirmed the 
handedness of human APC/C as it is shown here. The entire RCT procedure was first 
calibrated with a 70S ribosome and subsequently applied in exactly the same way for the 
APC/C to ensure the correct handedness of the APC/C reconstruction. The correct handedness 
of APC/C now allows reliable docking experiments using known X-ray structures or 
homology models (Fig. 3B).  
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Figure S8 
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Figure S8.  Antibody labeling of APC/C subunits and of BubR1.  
Antibody labeling experiments were performed for the APC/C subunits Apc1, Cdc27, Apc4, 
Apc5, Apc6, Apc7, and for the MCC subunit BubR1,. The complexes were purified according 
to the GraFix protocol (9). The concentration of APC/C on the EM grid was intentionally 
kept low to make sure that trimeric complexes (two APC/C particles bound to one antibody) 
were analyzed, and not two APC/C particles which were coincidentally positioned next to 
each other. The orientation of the APC/Cs within the APC/C-antibody complex was evaluated 
based on the known structure of APC/C. The exact binding sites of the antibody at the 
interface between two APC/Cs cannot be exactly determined in a single image. Rectangles 
were thus modeled to the APC/C 3D structure at the respective binding sites of the antibody 
and the binding site was determined as the main crossing 3D area of all rectangles. This 
method provides unique labeling positions for most of the proteins studied. Only for Cdc16 
and Apc7 a larger area was covered by the rectangles preventing a detailed interpretation. 
Cdc16 and Apc7 antibodies revealed a more disperse localization pattern at the arc lamp 
domain which may reflect the presence of at least two copies of Cdc16 and Apc7 per APC/C 
while there is only a single copy of all other subunits studied. 
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Figure S9 
 
 
Figure S9. Cdh1 labeling of human and Xenopus APC/C. 
In parallel to the Cdc20 labeling experiments, recombinant Cdh1 was bound to human apo-
APC/C and analyzed by negative staining EM (left panel). We identified a single protein mass 
bound in a position that is similar to the position of Cdc20 in human APC/CCdc20 (Fig. 2B). In 
contrast to this situation, we had previously observed two extra densities in the Xenopus 
APC/C structure following binding of recombinant Cdh1 (18). However, only the position on 
the right side was previously interpreted as a Cdh1 binding site because only this site could be 
confirmed by Cdh1 antibody labeling experiments (18). We therefore re-analyzed the 
Xenopus APC/CCdh1 complex using the new GraFix sample preparation protocol (9) which led 
to a 3D reconstruction of significantly higher quality (right panel). The new Xenopus 
APC/CCdh1 3D reconstruction shows again two extra densities, one on the right hand side, and 
one in a central position where Cdh1 can also be seen in human APC/C. It is therefore 
possible that APC/C contains more than one Cdh1 binding site. Which of these sites is 
functionally more important, and why two sites can only be detected in Xenopous APC/C will 
require further investigation. 
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Figure S10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 23
Figure S10. MCC association correlates with a twofold reduction in binding of APC/C to 
UbcH10 in vitro.  
(A) APC/C was isolated on Cdc27 antibody beads from Hela cells arrested in a checkpoint on 
or off state. UbcH10 was covalently linked to the bifunctional crosslinker Sulfo-GMBS. 2 or 
1 µM of UbcH10-GMBS or UbcH10 were incubated with APC/C for 6 to 15 min. Bound 
proteins were analyzed by SDS-PAGE and immunoblotting. Binding of UbcH10 was 
quantified using a fluorescently labeled secondary antibody. The UbcH10 signal intensity was 
measured by a Odyssey scanner and normalized to the levels of Apc2 present in the sample. 
(B) Quantification of UbcH10 crosslinking to APC/C from checkpoint off or on cells under 6 
different conditions.   
(C) Input levels of UbcH10 and UbcH10-GMBS were visualized by immunoblotting with a 
fluorescently labeled secondary antibody. 
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Figure S11 
 
 
 
 
 
 
 
Figure S11. MCC binding reduces interaction of APC/C with substrate proteins in vitro. 
APC/C was immunoprecipitated by Cdc27 antibody coupled beads from lysates of checkpoint 
on or off arrested HeLa cells. A wild type Hsl1 fragment was applied to APC/C carrying 
beads at the indicated concentrations. The excess of Hsl1 was washed off and levels of bound 
Hsl1 were analyzed by SDS-PAGE/immunoblotting. 
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Table S1. Mass spectrometric analysis.  
Protein complexes immunoprecipitated with Cdc27, Cdc20 und BubR1 antibodies from cells 
arrested in a checkpoint on or off state were identified by LC-MS. The numbers listed 
represent the ratio of Mascot score and the molecular mass (M) of the identified proteins and 
are a qualitative index for identification. (nd, not detected) 
 
 
 
 
 
 
 
 
M (Da) 
Score/MW 
IP Cdc27 Cdc20 BubR1 
SC On Off On Off On Off 
        
APC/C subunits        
Apc1 218528 12.2 12.2 10.7 10.5 10.3 8.8 
Apc2 94624 13.0 12.3 10.5 9.7 10.4 5.4 
Cdc27 92893 13.8 10.6 10.6 10.3 10.8 9.4 
Apc4 92856 14.2 15.2 12.8 10.3 13.8 8.9 
Apc5 85707 21.5 21.7 22.4 21.5 19.4 10.9 
Cdc16 72408 14.3 16.6 14.7 12.9 14.7 11.1 
Apc7 67440 17.6 17.6 19.2 16.7 16.5 17.1 
Cdc23 69588 21.4 22.6 18.2 17.6 17 13.3 
Doc1 25352 8.9 12.2 9.6 9.8 11.5 6.6 
Cdc26 9771 22.1 25.9 18.7 18.1 21.6 15.9 
Apc11 10518 8.8 11.9 nd nd nd nd 
Apc13 (Swm1) 8516 10.1 19.7 nd nd nd nd 
        
APC/C activator        
Cdc20 55078 10.9 9.6 12 14.1 12.1 12.5 
Cdh1 55544 7.1 7.4 nd nd nd nd 
        
SC        
BubR1 120753 14.3 12.4 16.8 15.3 20.3 20.7 
Bub3 37330 11.5 10.8 12.5 13.2 15.5 17.9 
Mad2 23666 8.3 7.6 14.4 6.9 16.5 10.3 
Bub1 123451 nd nd 3.6 12.0 14.7 15.8 
Mad1 83274 nd nd nd nd nd nd 
        
APC/C regulators        
Cdk1 (Cdc2) 34117 5.5 26.3 7.8 15 nd nd 
Cdk2 34089 nd 9.2 6.6 13.8 nd nd 
Cks2 9854 nd 7.8 nd nd nd nd 
Emi1 51427 nd 8.3 nd nd nd nd 
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Table S1. continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MW (Da) 
Score/MW 
IP Cdc27 Cdc20 BubR1 
SC On Off On Off On Off 
        
APC/C substrates        
Nek2A 52130 10.7 10.4 nd 2.1 nd nd 
cyclin-A2 48696 2.4 6.7 5.9 14.2 nd nd 
cyclin-B1 48591 nd 5.3 nd nd nd nd 
        
Kinetochore        
Hec1 (Ndc80) 74380 nd nd nd 2.7 12.9 15.4 
Nuf2 54637 nd nd nd nd 8.8 7.9 
Spc24 22486 nd nd nd 8.1 19.5 nd 
Spc25 26194 nd nd nd 6.9 10.3 12.8 
Mis12 24466 nd nd nd nd 9.3 9.8 
Zwint-1 35747 nd nd nd 5.3 11.6 12.5 
DC8 32569 nd nd nd 4.7 7.5 14.8 
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Table S2. Statistics of EM image analysis.  
Summary of several APC/C complexes studied by EM. Human apo-APC/C and APC/CMCC 
were studied by unstained cryo-EM as well as negative staining at low temperatures. All other 
complexes were studied only by negative staining at low temperatures. A higher number of 
disintegrated APC/C particles is observed in unstained cryo-EM images. The occupancy of 
MCC binding in the APC/CMCC is also significantly reduced (43% compared to 56%) in the 
sample used for unstained cryo-EM.  
 
Sample EM Method Number of Particles 
Percentage 
of binding Resolution 
Human apo-APC/C unstained cryo 8731 -      ~35 Å 
Human apo-APC/C negative stain 46996 -   19-25 Å 
Human APC/C-MCC unstained cryo 73389 43%      ~32 Å 
Human APC/C-MCC negative stain 41760 56%   20-25 Å 
Human APC/C-Cdc20 negative stain 15760 30% ~27 Å 
 
 
 
 
 
 
 
Movie S1. The movie shows an animated morphing scene between different populations of 
apo-APC/C that were found to be present in one single sample. It is important to note that the 
transition between the different populations is just an animation to illustrate the major 
structural differences, namely a different relative orientation of the "platform" and "arc lamp" 
domain. 
 
3D-pdf S1 and 3D-pdf S2. The 3D-pdf files S1 and S2 display 3D models of human apo-
APC/C and APC/CMCC, respectively. The MCC protein mass of APC/CMCC is coloured in red 
visualizing the contacts formed between MCC and APC/C (Adobe Reader 9). 
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6. Abbreviations 
 
Å                                   Angström 
ab                                  antibody 
amp                               ampicillin 
APC/C                          anaphase-promoting complex/cyclosome 
ATP                              adenosine triphosphate 
a.u.                               arbitrary unit 
bp                                 base pairs 
BSA                             bovine serum albumin 
cDNA                          complementary DNA 
cdc                               cell devision cycle 
Cdk                              cyclin dependent kinase 
Cm                               C box mutant 
3 D                              three-dimensional 
DMP                           dimethylpimelimidate 
DNA                           deoxyribonucleic acid 
dm                               D-box mutant 
dkm                             D-box and KEN box double mutant 
DMEM                       Dulbecco's Modified Eagle Medium 
DMSO                        dimethylsulfoxyde 
DTT                            dithiothreithol 
DUB                           deubiquitinating enzyme 
E1                               ubiquitin-activating enzyme 
E2                                ubiquitin conjugating enzyme 
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E3                              ubiquitin ligase 
E. coli                        Escherichia coli 
EDTA                       ethylenediamine tetraacetic acid 
EM                            electron microscopy 
FL                             full length 
GAL                          galactose 
GST                          glutathione-S-transferase 
h                                hour 
HA                            epitope on influenza virus hemagglutinin (sequence:YPYDVPDYA) 
H6                             His-tag comprising 6 histidines 
HECT                       homology to E6-AP C-terminus 
H.s.                           Homo sapiens 
IR                              isoleucine-arginine 
IgG                           immunoglobulin G 
IPTG                         isopropyl β-D-1-thiogalactopyranoside 
IVT                           in vitro translation 
kDa                           kilo Dalton 
km                            KEN box mutant 
LB                            Luria-Bertani 
leu                             leucine 
log                            logarithmic 
MCC                        mitotic checkpoint complex 
MDa                         mega Dalton 
min                           minute 
MR                           methionine-arginine 
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myc                           human c-myc epitope (sequence: EQKLISEEDL) 
Ni-NTA                     nickel-nitrilotriacetic acid 
noc                             nocodazole 
OD600                       optical density at 600 nm 
PAGE                        polyacrylamide gel electrophoresis 
PBS                           phosphate buffered saline 
PCR                           polymerase chain reaction 
PEG                           polyethylenglycole 
PGK                          phosphoglycerate kinase 
PMSF                        phenylmethylsulphonyl fluoride 
PVDF                        polyvinylidene fluoride transfer membrane 
RING                        really interesting new gene 
RNA                          ribonucleic acid 
rpm                            revolutions per minute 
S                                Svedberg 
SAC                           spindle assembly checkpoint 
S. c.                           Saccharomyces cerevisiae 
SCF                           Skp1/Cul1/F box 
SDS                          sodium dodecyl sulphate 
Sf                              Spodoptera frugiperda 
S. p.                           Schizosaccharomyces pombe 
TBS                           tris-buffered saline 
TBT-T                       tris-buffered saline with Tween20 detergent 
TEV                          tobacco etch virus 
TPR                           tetratrico peptide repeat 
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trp                           tryptophane 
ura                          uracil 
v/v                          volume per volume 
WB                        Western blot 
WD                        tryptophane aspartate 
wt                           wild type 
YPD                       yeast extract peptone dextrose 
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